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In the Dutch legal system, individuals who have committed a violent crime and suffer from a 
mental disorder are sometimes held only partially responsible for the crimes they have committed. 
In some cases, the person is not held fully accountable for the committed crime because he/she 
was unable to grasp the full consequences of his/her actions due to the presence of at least one 
severe mental disorder. In this case, the individual who has committed the crime can be judged 
(partially) insane. The Dutch legal system knows five categories in which an individual can be 
considered insane, indicating the level of accountable responsibility for committing the crime. 
These categories range from 1) Fully responsible/ Not insane at all, whereby a mental disorder 
did not influence a person’ s judgement at all to 5) Fully irresponsible/Insane for the crime due 
to the overruling effects of the mental disorder on a person’s judgement. In cases of (at least 
partial) insanity, the judge can order the person to be treated on the order of the state. This system 
is called the Dutch Entrustment Act, or ‘terbeschikkingstelling’ (TBS) (van Marle, 2002). With a 
few exceptions, TBS can only be given for crimes with a minimal sentence of at least four years, 
indicating that the crime was characterized by a particular severity of violence, such as murder, 
manslaughter, arson or sexual offending. In cases where TBS is given, the judge considers the 
risk for criminal reoffending particularly high if the offender is not treated properly for his/her 
mental illness. The offender can then be submitted to an inpatient forensic psychiatric facility, 
and is, from this point forward, called a forensic psychiatric patient rather than an offender. The 
primary aim of the TBS sentence is to protect society and offer treatment that reduces the chance 
for criminal recidivism (van Marle, 2002).
In the Dutch general population, about 4 out of 10 people between the age of 18 and 64 have 
suffered or will suffer from a mental disorder at some point in their lives. The most common 
mental disorders in the Netherlands include mood disorders like depression or bipolar disorder, 
anxiety disorders, and substance use disorders (SUD’s) (Trimbos, 2010). In prison populations, the 
prevalence of mental disorder is higher than in the general population. 50 to 80% of male prisoners 
are diagnosed with a personality disorder (e.g., Edens, Kelley, Lilienfeld, Skeem, & Douglas, 2015; 
Fazel & Danesh, 2002), with antisocial personality disorder being the most common. Personality 
disorders describe “an enduring pattern of inner experience and behavior that deviates markedly 
from the expectation of the individual’s culture”, with inflexible and pervasive patterns across a 
broad range of personal and social situations, which leads to significant distress or impairments 
in social, occupational or other important areas of functioning (definition of personality disorders 
DSM-5, American Psychiatric Association, 2013, p. 849). Often times, personality disorders are 
present in combination with other mental disorders. In 2011, a profiling study into the descriptive 
characteristics of forensic psychiatric patients in the Netherlands showed that these patients usually 
present with an average of 3.5 diagnoses per patient (Van Nieuwenhuizen et al., 2011). Most 
common disorders are SUD, schizophrenia, attention-deficit/hyperactivity disorder (ADHD), 
impulse control disorders, and cluster B personality disorders, such as antisocial, borderline or 
narcissistic personality disorder (Van Nieuwenhuizen et al., 2011). 
Impulsivity as a key characteristic for mental disorders associated with offending 
Individuals with mental illness tend to exhibit inadequate coping mechanisms in response to 
stressful situations. Their behavior is often times rash and impulsive and can, in some cases, 
lead to acting-out behavior with significant negative consequences in the long term, such as the 
use of violence and committing criminal acts (Samuels, 2011; Pompili, Carlone, Silvestrini, 
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& Nicole, 2017). Most of the disorders commonly found in forensic psychiatric patients are 
characterized by high levels of impulsivity. For example, ADHD is characterized by “a persistent 
pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning” (DSM-5, 
APA, 2013, p. 123). Significantly elevated impulsiveness is also found in violent offenders with 
schizophrenia (Enticott, Ogloff, Bradshaw, & Fitzgerald, 2008), whereas in antisocial personality 
disorder, a “long term pattern of […] impoverished moral sense or conscience, as well as a 
history of crime, legal problems, or impulsive and aggressive behavior” is a diagnostic criteria 
(DSM-5, APA, 2013, p. 866). Borderline personality disorder is characterized by a “pervasive 
pattern of instability of interpersonal relationships, […] marked by impulsivity beginning by 
early adulthood and present in a variety of contexts” criterion (DSM-5, APA, 2013, p. 872). In 
these contexts, impulsive behavior can possibly be harmful to oneself and/or others and has been 
associated with aggression or criminal behavior and risk-taking behavior (Black, Serowik, & 
Rosen, 2009; Verdejo-Garcia, Lawrence, & Clark, 2008). 
Impulsivity can be defined as a dysfunctional personality trait, resulting in a tendency for 
an individual to display behavior that is performed with little or inadequate forethought and 
little consideration for consequences of the own behavior (e.g., Caswell, Bond, Duka, & 
Morgan, 2015; Evenden, 1999). It is increasingly seen as a multifaceted construct, which has 
been extensively studied in developmental and personality psychology. Impulsivity influences 
information processing at various stages (Clark, Robbins, Ersche, & Sahakian, 2006), and while 
there is an ongoing debate in the literature about the number and exact nature of different aspects 
of impulsivity, the following aspects have been identified as key elements of impulsivity: 1) 
response initiation, defined as responding before complete processing of a stimulus has occurred 
(Dougherty et al., 2009), which can sometimes also be called reflection impulsivity (Caswell et 
al., 2015), 2) response inhibition, a failure to inhibit a prepotent response (Dougherty et al., 2009), 
also labelled ‘motor impulsivity’ (Caswell et al., 2015), and 3) reward sensitivity, responses that 
favor short-term positive outcomes despite negative consequences in the long term (Dougherty et 
al., 2009). In dual-processing models, behavior is seen as the result of two qualitatively different 
processes, where impulsive (associative) processes compete against reflective processes (Wiers, 
Ames, Hoffmann, Krank, & Stacey, 2010; Stacy & Wiers, 2010). These dual-processing models 
also resemble neurocognitive models of impulsivity, where impulsive behavior is viewed as 
stemming from a failure of prefrontal cortex systems (‘top down-systems’) (Volkow, Fowler, 
& Wang, 2003), that, in healthy individuals, regulate ‘bottom-up’ urges of immediate reward 
(Stevens et al., 2014) generated in the limbic structures such as amygdala (Kulacaoglu & Kose, 
2018; Siever, 2008). An individual’s response to an immediate reward is also the result of a 
learning experience, where the association with a certain stimulus is valued in terms of its 
motivational impact (Wiers et al., 2010), determining the positive or negative reinforcement of a 
stimulus (Boog, Goudriaan, van de Wetering, Deuss, & Franken, 2013). 
Differences between individuals regarding the positive reinforcing impact of a stimulus is called 
‘reward sensitivity’, and determines the strength of an individual’s urge to approach a certain 
stimulus (Boog et al., 2013; Wiers et al., 2010). Individuals high in ‘reward sensitivity’ are more 
likely to pay attention to and subsequently pursue reinforcing stimuli (Gullo & Dawe, 2008). 
While an individual’s tendency to pursue a stimulus is also influenced by environmental factors 
such as family and peers (Gullo & Dawe, 2008), there is a lot of evidence in the scienti-fic 
literature about the crucial impact of adolescence in the manifestation of reward sensitivity, and 
subsequently, cognitive (dis-)inhibition in response to reward (Gullo & Dawe, 2008). Adolescence 
therefore can be seen as a period of heightened risk to engage in impulsive, and possibly harmful 
behavior that has long lasting effects for later life. Associations between elevated levels of 
impulsivity during childhood and early adolescence, and a heightened risk to develop substance 
abuse problems in adulthood have been observed (Hentges, Shaw, & Wang, 2017). Subsequently, 
for disorders high in impulsivity, increased prevalence of SUD is rather common (Machielsen et 
al., 2012; Simpson, Grimbos, Chan, & Penney, 2015; Van Nieuwen-huizen et al., 2011). 
Impulsivity and its relation to substance use disorder
Substance use disorder can be seen as a chronic condition of biopsychosocial nature that results 
in serious impairments in cognition and behavior (Sokhadze, Cannon, & Trudeau, 2008). When 
moving from recreational to compulsive drug use, the use of an addictive substance is continued 
despite the negative consequences of prolonged drug abuse. Poor response control is associated 
with rapidly escalating drug use, where control over drug intake is lost and drug use starts to 
become compulsive (Perry & Carroll, 2008). The urge for using is associated with tension, 
dysphoria and other negative states (Weddington et al., 1990), which can only be relieved by 
continuing intake of the addictive substance. Drug use then provides immediate reinforcement 
(Verdejo-Garcia et al., 2008), despite the long-term negative effects for almost all aspects of a 
person’s life (De Wit & Richards 2004; Madden, Petry, Badger, & Bickel, 1997). High levels of 
impulsivity are strongly associated with the development, maintenance and relapse in substance 
abuse and addiction (e.g., Jentsch & Taylor, 1999; Volkow et al., 2003), and alcohol, stimulant, 
and opioid abusing individuals tend to have higher levels of impulsivity as compared to non-
abusing controls (Loree, Lundahl, & Ledgerwood, 2015). Highly impulsive patients also tend to 
experience symptoms of withdrawal more seriously than less impulsive patients, as they report 
higher scores of craving for substances than patients with lower impulsivity scores (Joos et al., 
2013), making them even more prone for relapse. Addictive substances may increase impulsivity 
levels, as a structural state of reduced inhibitory control due to substance abuse leads to long-
lasting neurocognitive and neurophysiological changes (Perry & Carroll, 2008). 
Yet, the exact nature of the causal association between heightened levels of impulsivity and SUD 
is still highly debated in scientific literature (Jentsch et al., 2014). Most likely, a predisposition for 
developing substance abuse problems, heightened levels of impulsivity, and further detrimental 
effects of addictive substances on response inhibition are strongly interconnected and cannot be 
viewed separately (Jentsch & Taylor, 1999; Lyvers, 2000). See Figure 1 for a graphical display. 
In recent years, studies have explored the common characteristics between impulsivity and SUD, 
and it is proposed that these two concepts stem from the same imbalance between neurocognitive 
bottom-up and top-down systems as already explained above (Bechara, 2005; Heatherton & 
Wagner, 2011; Tomko, Bountress, & Gray, 2016). In SUD, symptoms of dependency usually stem 
from bottom-up systems, with craving for substances - the urge to administer a drug - signaling 
the need for immediate reinforcement (Franken, 2003). Failure to suppress impulsive behavior 
can be seen as deriving from dysfunctional bottom-up systems, which overrule more reflective 
top-down systems in favor of immediate reward (Bechara, 2005; Stevens et al., 2014; Volkow 
et al., 2003). The interaction between these two neurocognitive processes resembles the dual-
processing model mentioned above, which views impulsive behavior as the outcome between 
impulsive and more reflective processes (Wiers et al., 2010). 
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Treatment for forensic psychiatric patients with SUD 
Once individuals seek treatment for substance abuse problems, treatment success is seriously 
hampered by high level of impulsivity (e.g., Charney, Zikos, & Gill, 2010; Van der Veeken, Lucieer, 
& Bogaerts, 2016). For forensic psychiatric patients especially, the maintenance of substance 
abuse poses risk for treatment failure. Drug abuse is a strong predictor of violent behavior, and 
subsequent violent criminal recidivism (Duke, Smith, Oberleitner, Westphal, & McKee, 2018; 
MacDonald, Erickson, Wells, Hathaway, & Pakula, 2008). The relationship between substance 
abuse, crime and violence has been established across a wide range of addictive substances, as 
well as types of mental disorder, such as psychotic disorders (Swanson et al., 2002) or personality 
disorders (e.g., Paim Kessler et al., 2012). High levels of impulsivity predict early relapse and 
increase chances of premature termination of substance abuse treatment (Charney et al., 2010). 
Poor treatment outcomes in these patients have been found across the literature, regardless of 
type of substance abuse (Van der Veeken et al., 2016). Given that the primary aim of treatment 
of forensic psychiatric patients is the prevention of violent criminal recidivism, substance abuse 
poses a substantial threat to achieve this aim. Hence, adequate treatment modalities for these 
highly impulsive individuals with substance abuse are much needed. 
Treatment of forensic psychiatric patients faces many challenges. Patients with low treatment 
compliance, lack of problem insight, and risk for aggressive outbursts provide challenges 
for successful treatment of these patients residing in forensic facilities. Common methods of 
evidence-based therapy consist of Cognitive Behavioral Therapy (CBT), Schema Focus Therapy 
(SFT), medication, and participation in a therapeutic environment with well-specified rewards 
Impaired response inhibition 
due to chemical effects of 
addictive substances
Compulsive drug taking, 
resulting in SUD
Predisposition for heightened 
levels of impulsivity 
Drug abuse
Figure 1. High levels of impulsivity are linked to the development and maintenance of substance abuse 
problems. 
and sanctions, which intent to help promote self-control, responsibility and thereby behavioral 
change (Welsh, Zajac, & Bucklen, 2013). Teaching patients to increase the use of attention to 
actions and goal-directed behavior is thought to reduce impulsivity and prevent relapse into 
drug abuse (Crews & Boettiger, 2009). However, effect sizes for prison-based substance abuse 
programs are usually small (e.g., Pearson & Lipton 1999; Magill & Ray, 2009). Therefore, 
additional treatment methods are needed in order to increase the chances for successful treatment 
outcomes. Neurofeedback could be a suitable intervention for forensic psychiatric patients. 
Neurofeedback is in its basics non-verbal and relies on the principles of operant condition, 
making it a suitable treatment intervention for a wide range of patient populations. Some studies 
have shown promising results for the reduction of impulsivity through means of neurofeedback 
(e.g., Fuchs, Birbaumer, Lutzenberger, Gruzelier, & Kaiser, 2003). 
EEG-Neurofeedback: Historical overview 
In the 1920’s, Hans Berger was the first to measure electroencephalographic (EEG-)activity 
on the human scalp (Demos, 2005). He discovered that different mental states coincide with 
distinct EEG-activity that are distinguishable from one another. For example, Berger found that 
bursts in the alpha frequency band (7.5-12 Hz) were related to wakeful relaxation whereas EEG-
activity in the beta frequency band (12-20 Hz) was related to the process of focusing attention and 
mental alertness (Demos, 2005). Correspondingly, Berger also believed that abnormalities in the 
EEG reflected clinical disorders (Criswell, 1995; Cantor, 1999; as cited in Demos, 2005). Since 
then, this notion has accumulated much evidence, and it is now widely accepted that deviant 
brain frequencies underlie mental disorders as well as their link to harmful behavior. Nowadays, 
electroencephalographic spectral analysis is frequently used to distinguish healthy controls from 
individuals with mental illness. For example, in ADHD, magnitude deviations in the theta (3.5-
7.5 Hz) and beta frequency bands are thought to underlie symptoms of hyperactivity and/or 
impulsivity (Arns, Heinrich, & Strehl, 2014). The so-called theta/beta ratio, where theta activity 
is increased and beta activity is decreased as compared to healthy controls, has shown to have a 
sensitivity (the proportion of patients that are correctly identified as having the disorder) of 86%, 
and a specificity (the proportion of healthy individuals that are correctly identified as such) of 98% 
for identifying someone with ADHD (Monastra et al., 1999). In SUD, alterations in magnitude of 
specific EEG-frequencies vary by type of substance-dependency, but can resemble the alterations 
found in ADHD, with deviations often found in the theta, alpha, and beta frequencies (Sokhadze 
et al., 2011). In SUD, neurophysiological alterations are hypothesized to contribute to symptoms 
of substance dependency such as over-attention to drug-cues, lack of inhibitory control, loss 
of control over drug intake and drug craving (Dackis & O’Brien, 2001; Volkow et al., 2003). 
EEG-alterations are also found in cluster B personality disorders such as antisocial or borderline 
personality disorder, where an increase of slow wave activity, specifically within the delta (0.5-
3.5 Hz) and theta frequency bands has been observed (De la Fuente, Tugendhaft, & Mavroudakis, 
1998; Reyes & Amador, 2009). The increase in slow waves has been linked to violent and 
aggressive behavior in male psychiatric inpatients, independent of patients’ current medication or 
treatment duration (Convit, Czobor, & Volavko, 1991). 
Since Berger’s discovery of coinciding mental states and distinct EEG-activity, it has also been 
established that humans are able to willingly control brain frequencies through reinforcement 
(e.g., research by Joseph Kamiya (1963) on alpha enhancement; or the work of Budzynski 
14
(1999), as cited in Demos, 2005) on theta enhancement. See for an overview Demos, 2005). Even 
more so, willingly controlling EEG-frequencies has been shown to also affect behavior. As with 
many scientific discoveries, the discovery of clinical implications of altering EEG-frequencies 
was done partly by accident. In 1968, Barry Sterman conducted experiments on the trainability 
of the sensorimotor rhythm (SMR, 12-15 Hz) in cats (Wyricka & Sterman, 1968). Ten cats were 
rewarded every time they increased their SMR activity. However, as financial means for scientific 
research were scarce, these cats were also used for another experiment for NASA, where rocket 
fuel was injected in cats to study its effect on the development of seizures. Surprisingly, the cats 
that had previously been trained to increase SMR activity were not developing any seizures, as 
opposed to the cats that were not trained to increase SMR activity. With that, the notion of what 
was then called biofeedback was born. This technique applies means of operant conditioning to 
teach patients to change cortical neuronal activity over time (Sokhadze et al., 2011). EEG-activity 
is measured and information about these measurements is fed back to the patient through simple 
video-games. The video-games display changes in EEG-parameters, and the patient learns to 
control the video-games by employing mental strategies. Thereby, patients learn to inhibit or 
reinforce these EEG-parameters, which can lead to the normalization of abnormal EEG-activity 
(Scott, Kaiser, Othmer, & Sideroff, 2005). 
Since then, thousands of studies have investigated the effects of neurofeedback on clinical 
symptoms and behavior (Rogala et al., 2016). One of the earliest clinical effects in humans 
with neurofeedback therapy was found in participants with ADHD. Lubar and Shouse (1976) 
applied SMR neurofeedback training in a child with (what is now known as) ADHD, and found 
that an increased activity of SMR was associated with reduced motor impulsivity, as well as 
improvements on behavioral measures such as hyperactivity and distractibility. Other landmark 
studies include the study on the effects of neurofeedback training in Vietnam veterans who had 
a dual diagnosis of alcohol dependency and posttraumatic stress disorder (PTSD; Peniston & 
Kulkosky, 1991). Peniston and Kulkosky (1991) employed neurofeedback training (known now 
as the ‘Peniston Protocol) in these patients and found clinical symptom improvements that were 
superior to traditional medication treatment. 
Neurofeedback in forensic psychiatric patients with substance abuse
Since these early studies, different neurofeedback training protocols have been established, where 
specific EEG-frequencies are enhanced (or ‘up-trained’), while others are inhibited (or ‘down-
trained’), based on Berger’s notion that normalization of aberrant EEG-activity can change 
abnormal psychological states. These training protocols are used for many different clinical 
symptoms, as well as in many different patient populations. For the reduction of high levels of 
impulsivity, neurofeedback protocols typically focus on the reduction of slow wave activity such 
as theta, and enhancement of faster activity such as beta or SMR. Elevated theta activity has been 
consistently linked with higher levels of impulsivity across various subject populations (e.g., 
Bresnahan & Barry, 2002; Hermens, Kohn, Clarke, Gordon, & Williams, 2005; Stenberg, 1992). 
Increased SMR activity is seen when humans try to inhibit a motor response, and neurofeedback 
training where the SMR activity has been up-trained has been found to facilitate thalamic 
inhibitory mechanisms (Sterman, 1996). In ADHD, neurofeedback protocols therefore usually 
aim at targeting the overrepresentation of slow wave activity such as delta (0.5-3.5 Hz) and 
theta (3.5-7.5 Hz), and the underrepresentation of faster waves like beta (12-20 Hz) or the SMR 
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frequency (12-15 Hz) (Arns et al., 2014; Fuchs et al., 2003). The alterations in theta, beta and 
SMR frequency bands have also been observed in patients with substance abuse (Sokhadze et al., 
2011). However, typical neurofeedback protocols for the treatment of addiction employ an alpha/
theta neurofeedback first, which is then followed by the same theta/SMR protocol that is also 
used in ADHD (also known as the Scott-Kaiser modification of the Peniston Protocol; Scott et al., 
2005). Although this protocol has shown promising results in reducing symptoms of substance 
abuse in patients with SUD, such as craving (e.g., Arani, Rostami, & Nostrabadi, 2010; Sokhadze 
et al., 2014), it can be argued that for any substance abuse treatment to be successful, dysregulation 
of impulse control should be a prime candidate, as this dysregulation places individuals at risk 
for poor response to SUD treatment (Loree et al., 2015; Tomko et al., 2016; Stevens et al., 2014). 
Usually, patients in substance abuse treatment are well aware that continuing to abuse substance 
has negative consequences, but they are nevertheless unable to control drug intake due to reduced 
inhibitory control. A theta/SMR neurofeedback training protocol aimed at reducing impulsivity 
might help these patients to inhibit dysfunctional responses to drug cues and therefore they may 
be more able to resist drug intake, resulting in beneficial effects on symptoms of substance abuse. 
Also, given that impulsivity has been shown to be related to severity of experienced drug craving, 
a theta/SMR neurofeedback training could also help patients deal with this key symptom of SUD 
(Moeller et al., 2001).
Assessing the efficacy of neurofeedback training
Still, neurofeedback training is not commonly applied in forensic inpatient treatment facilities. 
Treatment supervisors are hesitant to apply this treatment modality into common practice (Van 
Outsem, 2011). Specifically, there are only a limited number of studies describing effects of 
neurofeedback training in criminal populations (e.g., Konicar et al., 2015; Martin & Johnson, 
2005; Smith & Sams, 2005; Quirk, 1995; see for overview Fielenbach, Donkers, Spreen, 
Visser, & Bogaerts, 2018b). The hesitancy of treatment supervisors to integrate neurofeedback 
training into standard treatment programs may be partially due to the fact that, even decades of 
neurofeedback research and the promising results some studies have shown, there is an ongoing 
debate about which factors exactly are associated with beneficial outcomes after training. There 
is great variation between studies when it comes to applied neurofeedback training protocols, 
number of sessions applied, and time intervals in which the training sessions are scheduled. 
In studies with ADHD, neurofeedback training often includes up to 40 sessions (Carmody, 
Radvanski, Wadhwani, Sabo, & Vergara, 2001; Monastra, Monastra, & George, 2002). In 
substance dependent patients, promising results have been found after only 12 sessions (Horrell 
et al., 2010), whereas others have employed 30 sessions (Arani et al., 2010). 
The efficacy of neurofeedback training can be measured in two complementary ways: 1) Through 
changes at the neurophysiological level, i.e., normalization of deviant brain wave patterns, or 
increase/decrease of EEG-activity in particular frequency bands post-training, and 2) through 
improvements in behavior, i.e., clinical symptoms (Rogala et al., 2016). It can be argued that, for 
the training to be efficient, one cannot occur without the other. 
The first way of assessing the effectiveness of neurofeedback training can be described with 
the term ‘EEG-learning’. EEG-learning indicates whether patients have been able to learn how 
to influence the targeted EEG-activity. Zoefel, Huster and Herrmann (2011) describe this as 
‘trainability’, where participants show “spectral effects within the trained frequency bands caused 
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by the training.” In recent years, studies have focused more and more on the different ways 
patients learn to control EEG-activity, and different patterns of learning have been observed. In 
studies with healthy participants, learning performance showed to be highest in the beginning 
of training sessions, but then stabilized and did not increase any further (e.g., Ros et al., 2009; 
Dekker, Sitskoorn, Denissen, & Van Boxtel, 2014). In patient populations, ADHD patients for 
instance showed good neurofeedback performance during the first phase of training as indicated 
by an improvement in theta/beta ratio, but then stagnated in performance before increasing 
performance again by the end of the training (Bakhshayesh, Hänsch, Wyschkon, Rezai, & Esser, 
2011). Contradictory, Bink, van Nieuwenhuizen, Popma, Bongers, and van Boxtel (2015) found 
that adolescents with ADHD needed more time to learn to control theta activity and were better 
able to suppress this activity by the end of the training than during the first sessions. 
Interindividual differences with regard to EEG-learning have also been observed when it comes 
to different EEG-frequencies. Several studies suggest that patients find certain EEG-frequencies 
easier to control than others. For instance, in a study by Janssen et al. (2017), beta frequency 
increased linearly over the course of training, whereas participants failed to change theta activity. 
In a study by Doppelmayr and Weber (2011), participants succeeded in regulating SMR activity, 
but failed to regulate the theta/beta ratio. 
When adhering to the criteria for evaluating the efficacy of neurofeedback training as stated 
above, improvements on a neurophysiological level should be related to improvements on a 
behavioral level. Some studies suggest that better performance during neurofeedback training 
also results in more improvements in clinical symptoms. DeBeus and Kaiser (2011) report a 
significant positive correlation between participants’ ability to improve EEG-regulation and 
the degree of improvements in ADHD symptoms. In a study by Drechsler et al. (2007), good 
neurofeedback training performance was related to greater improvements on hyperactivity and 
impulsivity in ADHD children. In the only study known so far that applied neurofeedback in 
a group of criminal offenders and also assessed results on a neurophysiological level, larger 
improvements on behavioral measures such as physical aggression and aggression inhibition 
were linked with better neurofeedback training performance (Konicar et al., 2015). 
However, there is also a group of participants that fail to learn the principles of EEG-regulation 
altogether, and therefore show no changes on a neurophysiological level immediately after the 
last training session or at a later follow-up. These patients have been named ‘non-responders’ 
(Enriquez-Geppert et al., 2013; Zoefel et al., 2011). Investigations into neurofeedback learning 
have shown that in some studies as many as 50% of participants can be classified as non-responders 
(e.g., Doehnert, Brandeis, Staub, Steinhausen, & Drechsler, 2008). Even in studies with healthy 
participants, non-responders are still found (e.g., Hanslmayer, Sauseng, Doppelmayr, Schabus, 
& Klimesch, 2005; Weber, Köberl, Frank, & Doppelmayr 2011). In recent years, the term ‘brain-
computer illiteracy’ has been termed for the failure to gain control over cortical activity (Zuberer, 
Brandeis, & Drechsler, 2015). To date, it is still unclear which mechanisms are responsible for 
differences in participants’ ability to learn EEG-regulation. Apart from some methodological 
and technical aspects of EEG-research, it has also been proposed that variables such as mood, 
motivation or the distraction of the participant may play a role in participants’ performance 
(Zuberer et al., 2015). 
Adhering to the criteria stated above, non-responders should not show any improvements in clinical 
symptom post-training. However, there are studies that report improvements on a behavioral level 
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even though no significant changes were observed in EEG-activity post-neurofeedback training 
(e.g., Arns, Drinkenburg, & Kenemans, 2012; Schönenberg et al., 2017). The presence of clinical 
symptom improvements without any significant changes at the neurophysiological level post-
training raises the notion of possible placebo effects of neurofeedback training. Other mechanisms 
must be in place when it comes to clinical symptom improvement. A necessary first step to show 
that clinical improvements can be attributed to successful regulation of cortical activity therefore 
is to demonstrate that learning of EEG-regulation has occurred during neurofeedback training 
(Gruzelier, Egner, & Vernon, 2006; Zuberer et al., 2015). 
To date, it remains unclear what the effects of a theta/SMR neurofeedback training protocol are 
not only on levels of impulsivity, but also on symptoms of SUD such as levels of drug craving 
and actual drug use in forensic psychiatric patients. There are basically no studies that have 
investigated the effects of such a training protocol in forensic populations in which heterogeneity 
of clinical diagnoses and symptoms is especially pronounced. Treatment of forensic psychiatric 
patients with dual-diagnosis should integrate different multidisciplinary treatment approaches, 
which focus on the interactive nature of SUD and other mental disorders (Horsfall, Cleary, Hunt, 
& Walter, 2009). If efficient, a neurofeedback training protocol aimed at reducing high levels of 
impulsivity could be a valuable addition to standard treatment modalities.
The current study
This study is set in the FPC Dr. S. van Mesdag, a forensic psychiatric center (FPC) in Groningen, 
The Netherlands. Patients in this maximum security treatment facility are male forensic 
psychiatric patients with at least one mental disorder according to DMS-IV-TR (APA, 2000). 
Next to other mental disorders, about 70% of patients are diagnosed with substance abuse 
problems. Patients are considered high-risk for reoffending, and are treated on behalf of the state 
in a multidisciplinary environment. The aim of the treatment is to reduce clinical symptoms that 
are considered high-risk for reoffending, and to integrate patients back into society by the means 
of stepwise furlough and expansion of liberties. 
The study investigates the effects of a theta/SMR neurofeedback training protocol in addition to 
treatment as usual in participants from the treatment facility described above. More specifically, 
it investigates to what extent a theta/SMR neurofeedback training intervention reduces levels of 
impulsivity and symptoms of substance dependency, such as drug craving and drug use. It will 
focus on two main components for the application of neurofeedback training in forensic psychiatric 
patients: 1) Whether these patients are able to learn the regulation of EEG-activity, and 2) whether 
EEG-activity regulation through a theta/SMR neurofeedback training leads to a decrease in levels 
of impulsivity and symptoms of drug addiction. Effects of a theta/SMR neurofeedback training 
protocol on a group level will be investigated with a randomized controlled trial (RCT). 
To investigate the clinical effects of this intervention more closely, a sham-controlled clinical 
case series will also be applied. In clinical case studies, more information can be gathered about 
the timeframe in which clinical significant changes can be achieved by monitoring individual 
patient(s) more closely. This approach also allows for the detection of interpersonal differences 
in response to the intervention, which are not revealed with between-group comparisons typically 
assessed with RCT designs. By definition, SUD treatment that matches an individual’s maintaining 
factors for dependency should be more effective than a treatment that does not consider these 
factors (Tomko et al., 2016).
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Outline of this thesis
Chapter 2 provides a systematic review of previous studies on neurofeedback training for mental 
disorders commonly found in forensic psychiatric patients. The article discusses the implications 
of these studies for the applicability of neurofeedback training in forensic psychiatric patient 
populations. 
Chapter 3 presents the research protocol for the current study, where neurofeedback training is 
applied in male forensic psychiatric patients with SUD. 
Chapter 4 reports the results for a subset of the patients who participated in neurofeedback 
training. It was investigated whether forensic psychiatric patients diagnosed with SUD were able 
to learn to regulate neurophysiological activity through a theta/SMR neurofeedback and to what 
extent magnitude changes in these frequency bands are related to changes in levels of impulsivity. 
Criteria for qualifying patients as responders were established and scores on impulsivity measures 
and changes in level of craving over time were assessed.
Chapter 5 presents the results of the first RCT investigating the effects of theta/SMR neuro-
feedback training in forensic psychiatric patients. Main outcome measurements reported are 
levels of impulsivity, craving, and actual drug intake.
Chapter 6 describes the results of a sham-controlled series of clinical case studies, where two cases 
employed a theta/SMR neurofeedback protocol  and two cases employed sham neurofeedback. 
Self-report level of impulsivity and craving were assessed.
The final chapter will provide a general discussion of the main findings of this thesis. Limita-
tions of the current study will be discussed, as well as recommendations for future studies. 
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Chapter 2
Neurofeedback training for psychiatric disorders associated 
with criminal offending: a review
Abstract
Effective treatment interventions for criminal offenders are necessary to reduce risk of 
criminal recidivism. Evidence about deviant EEG-frequencies underlying disorders found 
in criminal offenders is accumulating. Yet, treatment modalities such as neurofeedback are 
rarely applied in the forensic psychiatric domain. Since offenders usually have multiple 
disorders, difficulties adhering to long-term treatment modalities, and are highly vulnerable 
for psychiatric decompensation, more information about neurofeedback training protocols, 
number of sessions, and expected symptom reduction is necessary before it can be successfully 
used in offender populations. Studies were analyzed that used neurofeedback in adult criminal 
offenders, and in disorders these patients present with. Specifically aggression, violence, 
recidivism, offending, psychopathy, schizophrenia, ADHD, substance use disorder, and cluster 
B personality disorders were included. Only studies that reported changes in EEG-frequencies 
post-treatment (increase/decrease/no change in EEG amplitude/power) were included. Databases 
PsychInfo en Pubmed were searched for the period 1990-2017 according to the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), resulting in a total 
of 10 studies. Studies in which neurofeedback was applied in ADHD (N=3), substance use 
disorder (N=3), schizophrenia (N=3) and psychopathy (N=1) could be identified. No studies 
could be identified for neurofeedback applied in cluster B personality disorders, aggression, 
violence or recidivism in criminal offenders. For all treatment populations and neurofeedback 
protocols, number of sessions varied greatly. Changes in behavioral levels ranged from no 
improvements to significant symptom reduction after neurofeedback training. The results are 
also mixed concerning post-treatment changes in targeted EEG-frequency bands. Only three 
studies established criteria for EEG-learning. Implications of the results for the applicability of 
neurofeedback training in criminal offender populations are discussed. More research focusing 
on neurofeedback and learning of cortical activity regulation is needed in populations with 
externalizing behaviors associated with violence and criminal behavior, as well as multiple 
comorbidities. At this point, it is unclear whether standard neurofeedback training protocols 
can be applied in offender populations, or whether QEEG-guided neurofeedback is a better 
choice. Given the special context in which the studies are executed, clinical trials, as well as 





Criminal offenders are a challenging patient group when it comes to adequate treatment 
interventions. This patient group exhibits externalizing behavior and usually suffers from 
schizophrenia, attention-deficit hyperactivity disorder (ADHD), substance use disorder (SUD), 
and cluster B personality disorders, with high comorbidity rates (Van Nieuwenhuizen, Bogaerts, 
Ruijter, Bonges, Coppens, 2011; Woicik, Van der Lem, Sijtsema, & Bogaerts, 2017). In order to 
prevent the risk of criminal recidivism and the suffering for potential victims, effective treatment 
interventions are necessary. 
In the last three decades, electroencephalographic (EEG) based neurofeedback training has been 
increasingly used in the treatment for various psychiatric disorders. Neurofeedback is an operant 
conditioning training aiming to improve brain activity, as well as to improve cognitive, behavioral, 
and emotional self-regulatory skills by learning patients how to control abnormal psychological 
states such as inattention and stress (Gunkelman, & Johnstone, 2005; Hammond et al., 2011). 
Previous studies have accumulated much evidence about deviant EEG-frequencies underlying 
disorders commonly found in criminal offenders that could be a target for neurofeedback training. 
Still, to date neurofeedback is hardly used in the forensic psychiatric domain (e.g., Van Outsem, 
2011).
In ADHD, common EEG-deviations reported in the literature concern the overrepresentation 
of slow frequencies like delta (0.5-3.5 Hz) and theta (3.5-7.5 Hz), with reduced amplitudes of 
faster waves like beta (12-20 Hz) or the sensorimotor rhythm (SMR, 12-15 Hz). The cortical 
slowing is hypothesized to underlie symptoms such as inattention, impulsivity, and inhibitory 
control (Van Doren et al., 2017). There is an ongoing debate in the EEG-based ADHD literature 
about whether these deviations are more common in children presenting with ADHD rather than 
adults, or whether there is a natural remission with aging of ADHD patients of their immature 
EEG-activity (Mann, Lubar, Zimmerman, Miller, & Muenchen, 1992). Other deviations reported 
include the Event-Related Potential (ERP) markers of response preparation, specifically the 
Contingent Negative Variation (CNV) component of the Slow Cortical Potential (SCP). Aberrant 
CNV patterns have been related to a reduction of attention, inhibition, and cognitive control 
(Barry, Johnstone, & Clarke, 2003).
While ADHD is overrepresented in forensic psychiatric patients (Woicik et al., 2017), deviant 
EEG-frequencies have been less studied in other psychiatric disorders commonly found in 
criminal offenders. In schizophrenia, EEG-deviations have been observed in as many as 
60% of patients (Small et al., 1984; Ellingson, 1954). Abnormal EEG-activity reported 
include decreased alpha activity, increased beta activity (Fenton, Fenwick, Dollimore, Dunn, 
& Hirsch, 1980; Merrin, & Floyd, 1992; Surmeli, Ertem, Eralp, & Kos, 2012), and reduced 
amplitudes of the CNV, reflecting disturbed information processing (Schneider et al., 1992). 
In substance-use disorder, chronic substance abuse has been hypothesized to produce neural 
changes leading to a structural state of disinhibition and impulsivity (Bates, Bowden, & 
Barry, 2002; Jentsch, & Taylor, 1999; Lyvers, 2000). EEG-deviations found in subjects with 
a history of prolonged substance abuse include alterations in theta, alpha and beta frequency 
bands (Arani, Rostami, & Nostrabadi, 2010; Sokhadze, Stewart, Tasman, Daniels, & Trudeau, 
2014). These deviations in EEG-frequencies are hypothesized to underlie classic symptoms of 
SUD, such as craving, over-attention to drug-cues, feelings of restlessness, and loss of impulse 
control (Charney, Zikos, & Gill, 2010; Dackis, & O’Brian, 2001; Volkow, Fowler, & Wang, 
2003). In antisocial personality disorder, increased slow wave activity has been observed 
(Reyes, & Amador, 2009), this has also been reported in borderline personality disorder (De 
la Fuente, Tugendhaft, & Mavroudakis, 1998; Tanahashi, 1988). This increase in slow wave 
activity has been linked to violence and aggressive behavior (Convit, Czobor, Volovka, 1991). 
In psychopathy, a personality construct which has many similarities with antisocial personality 
disorder (Konicar et al., 2015), dysregulation of SCP has been linked to poor anticipatory 
planning, self-regulation, and formation of stable expectancies (Flor, Birbaumer, Hermann, 
Ziegler, & Patrick, 2002; Birbaumer, Elbert, Canavan, & Rockstroh, 1990; Forth, & Hare, 
1989; Jutai, & Hare 1983). 
Although neurofeedback has been considered as a possible treatment intervention for antisocial 
and violent behavior (e.g., Van Outsem, 2011; Raine, 1996), not many studies have been 
conduc-ted in offender populations, although several studies indicate that improvements were 
found after neurofeedback training (e.g., Martin & Johnson, 2005; Smith & Sams, 2005; 
Quirk, 1995), as for instance, in aggressive behavior and attention (Martin & Johnson, 2005), 
or even in recidivism rates (Quirk, 1995). However, these studies did not report EEG-changes 
in training parameters post-treatment, so no conclusions can be drawn about how these findings 
are related to changes at a neurophysiological level.
Some studies suggest that greater response to neurofeedback training in terms of more 
successful cortical regulation will result in higher clinical improvements (Van Doren et al., 
2017). Surprisingly, many neurofeedback studies determine the effectiveness of the training by 
reporting improvements in behavioral symptoms only. Whether these behavioral changes are 
associated with changes in cortical brain activity is not examined (e.g., Duric, Aßmus, & Elgen, 
2014; Fuchs, Birbaumer, Lutzenberger, Gruzelier, & Kaiser, 2003). Therefore, it remains 
unclear how many patients actually responded to the training in terms of changes in EEG- 
activity. In addition, few studies report within-session and/or cross-session learning effects, and 
only focus on the pre- and post-intervention change, making it difficult to determine how many 
sessions were in fact necessary to reach the desired effects. Common neurofeedback protocols 
can range up to 50 sessions (e.g., Heinrich, Gevensleben, Freisleder, Moll, & Rothenberger, 
2004; Scott, Kaiser, Othmer, & Sideroff, 2005), while there is also evidence suggesting that 
significant improvements can be achieved within as few as 15 sessions (Schönenberg et al., 
2017). The number of neurofeedback sessions required to reach optimal training success is 
unclear, and whether more training sessions will actually lead to higher clinical improvements 
is still up for debate. Reporting changes in EEG-frequency bands after neurofeedback training 
seems a necessary first step in determining whether treatment success was related to the applied 
neurofeedback protocol. Zuberer, Brandeis, and Drechsler (2015) provide a useful review of 
studies that investigate learning of cortical activity in participants with ADHD, and also report 
some studies that show non-learning, in what they call ‘brain-computer illiteracy’ (Zuberer 
et al., 2015). Given that even studies with healthy participants have shown that about half 
of the participants were not able to learn cortical regulation through neurofeedback (Weber, 
Köberl, Frank, & Doppelmayer, 2011), it is to be expected that forensic patients with various 
comorbidities have more difficulties to actually learn the principles of neurofeedback. This 
may reduce chances to achieve beneficial clinical effects. 
As forensic psychiatric patients usually present with multiple disorders (Woicik et al., 2017), 
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have difficulties adhering to long-term treatment modalities due to low levels of treatment 
motivation, and are highly vulnerability for psychiatric decompensation, it is important to 
investigate the feasibility of this intervention, before forcing a large number of sessions upon 
patients. More information about the type of neurofeedback training protocols, number of 
sessions, and expected symptom reduction is necessary. 
Research question 
This study aims to review studies that applied neurofeedback training in criminal offenders, 
taking into account the multiple disorders of these patients. As such, this review focusses 
on neurofeedback as an intervention for criminal offending, recidivism, reoffending, 
aggression, violence, and the following disorders associated with criminal offending: ADHD, 
schizophrenia, psychosis, all Cluster B personality disorders, psychopathy and substance use 
disorder. Only studies that examined whether or not neurofeedback led to changes in the trained 
EEG-treatment parameters were considered. Three factors contributing to the evaluation of 
neurofeedback training were assessed: 1) the type of neurofeedback protocol applied, 2) the 
number of sessions during which the neurofeedback protocol was applied, and 3) the change in 
neurofeedback training parameters. 
Method
Study design 
This review focused on single-electrode EEG-neurofeedback, and therefore excluded neuro-
feedback modalities such as inter-hemispheric bipolar EEG-neurofeedback, near-infrared 
spectroscopy (NIRS) neurofeedback or functional Magnetic Resonance Imaging (fMRI) 
neurofeedback. Studies in which EEG-neurofeedback was combined with other feedback 
modalities, such as EMG-biofeedback in the experimental condition were also excluded. Up 
until the end of the 1990’s, EEG-biofeedback was the most common search term regarding 
neurofeedback (Arns, Heinrich, & Strehl, 2014). Therefore, EEG-biofeedback was included in 
the search terms. The following search terms were entered into the databases: neurofeedback 
or EEG-neurofeedback or EEG-biofeedback AND criminal offending, recidivism, reoffending, 
aggression, violence, psychopathy, schizo* or psycho* or psychosis or ADHD or attention-
deficit or ADD or personality disorder or antisocial or narcissistic or borderline or addict* or 
substance use or substance abuse or substance dependen*. Only studies using adult participants 
(mean age >18) were included. As the major mental disorders most commonly associated 
with criminal recidivism are associated with problems in impulse control and aggression, 
neurofeedback or EEG-neurofeedback or EEG-biofeedback AND impulsivity or aggression 
were included. Change in EEG-parameters was defined as whether neurofeedback resulted in 
a change in EEG-frequency bands (increase or decrease in mean amplitude/power). Studies in 
which changes in EEG-training parameters were observed without highlighting the direction 
of the effect were excluded, as well as studies where the dependent variable was ‘cortical 




1. The applied treatment was EEG-neurofeedback. 
2. The study contained detailed information about number of sessions applied, neurofeedback 
protocol applied, and electrode position used.
3. The study provided detailed information about change in EEG-training parameters due to 
neurofeedback training. 
Search Strategy
The search strategy consisted of two steps: First, databases were searched with the aforementioned 
terms. Electronic databases searched were PsychInfo and PubMed. Only English articles 
published from 1990 up until November 3rd of 2017 were taken into account. Book chapters, 
dissertations, letters to the editor and anecdotal case reports were not included. Studies in 
which neurofeedback protocols were tested on healthy individuals were also excluded, 
as well as articles describing training-effects on non-psychopathological features such as 
music performance. Articles resulting from the search strategy were scanned for relevance 
by screening titles and abstracts. Next, articles that seemed to meet inclusion criteria were 
examined more closely for fulfillment of all criteria. This step was done independently by 
two researchers (SF and HAV). If no agreement could be reached, an independent third party 
(FCLD) was asked in deciding whether or not the study had to be included. See Figure 1 for a 
flow diagram of selection of studies. 
Results 
The initial search resulted in 224 articles that were screened. Of these, 10 studies met the 
inclusion criteria. Table 1 lists all studies that meet the inclusion criteria and gives an overview 
of the employed neurofeedback protocol, characteristics of the control group, moments of 
measurement, targeted neuropsychological and behavioral effects, whether the study stated a 
criterion for defining learners and non-learners, as well as the reported results. 
Although the search concentrated on studies concerning neurofeedback training for aggression, 
violence, recidivism, offending, psychopathy, schizophrenia, psychosis, Cluster B personality 
disorders, substance use disorder and attention-deficit disorder, only studies for schizophrenia, 
attention-deficit/hyperactivity disorder, and substance use disorder could be detected that met 
the inclusion criteria. 
Attention deficit/ Hyperactivity Disorder
Three studies on ADHD were found that met the inclusion criteria (Arns et al., 2012; Mayer, 
Blume, Wyckoff, Brokmeier, & Strehl, 2016; Schönenberg et al., 2017). All studies used 
different neurofeedback protocols: Arns et al. (2012) employed a QEEG-guided feedback 
protocol, where enhancement/decrease in frequencies was based on deviations found in the 
QEEG at pre-treatment assessment. Mayer et al. (2016) employed a SCP-protocol, whereas 
Schönenberg et al. (2017) employed a theta/beta protocol. Applied number of sessions was 
approximately 30. All three studies reported significant clinical changes concerning ADHD 
symptoms, such as inattention, hyperactivity, impulsivity, and depressive symptoms, while 
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Figure 1: Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram of selection 
of studies. Two articles included in the search results refer to the same study, so the flow chart does not count 
them twice.
changes in trained EEG-frequencies post-treatment were not significant or only by trend. In 
Schönenberg et al. (2017), no significant effect of time/treatment was found, whereas Mayer 
et al. (2016) report a trend towards significance concerning the desired increase of CNV 
amplitude. In Arns et al. (2012), a significantly decreased SMR power was found post-treatment 
in patients who underwent a SMR-training protocol, while the training was actually aimed 
at enhancing this frequency band. Only one of the studies actually linked the results found 
on a neurophysiological level to behavioral outcome measures. Arns et al. (2012) reported a 
significant correlation between anterior individual alpha peak frequency and the percentage 
of improvement on depressive symptoms post-treatment, suggesting that participants with a 
slower anterior alpha peak frequency improved less on comorbid depressive symptoms. Only 
the study by Schönenberg et al. (2017) employed a control group (sham neurofeedback and 
meta-cognitive therapy), and effects of neurofeedback training were not superior to effects 
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For SUD, three studies met the inclusion criteria (Arani et al., 2010; Horrell et al., 2010; Lackner 
et al., 2016). The studies employed three different types of protocols: A classic Peniston Protocol 
(alpha-theta neurofeedback) in alcohol dependent patients (Lackner et al., 2016), a Scott-Kaiser 
modification of the Peniston Protocol (alpha-theta training followed by a SMR-protocol) in opiate 
dependent patients (Arani et al., 2010), and a SMR-based protocol in cocaine abusers (Horrell 
et al., 2010). Number of sessions ranged from 12 to 30 sessions. In all studies, the investigated 
behavioral outcome measures did not only concern substance use itself, but also concerned 
related clinical symptoms such as broader psychopathology (e.g., the Symptom Checklist-90 
(SCL-90) in the study by Arani et al., (2010) and the Brief Symptom Inventory (BSI) in the study 
by Lackner et al. (2016)), posttraumatic-stress syndrome related symptoms and depression scores 
(e.g., BDI in the study by Lackner et al., 2016 and Horrell et al., 2010). Post-treatment, positive 
effects were reported for some of the subscales of the SCL-90 (Arani et al., 2010) and depressive 
symptoms and level of stress (Horrell et al., 2010), whereas Lackner et al. (2016) found no 
significant behavioral changes except for an effect by trend in the sense of coherence, a concept 
strongly related to perceived mental health. Concerning primary symptoms of SUD, Arani et al., 
(2010) found a significant decrease of a number of subscales of a craving questionnaire (desire to 
use addictive substances, relief from withdrawal symptoms and anticipation of positive outcome), 
and Horrell et al. (2010) found a decrease in number of positive drug testing after neurofeedback 
training. Arani et al., (2010) and Horrell et al. (2010) also found significant effects in at least some 
of the EEG-frequency bands trained (delta, theta, alpha and SMR). Lackner et al. (2016) found a 
trend towards an increase in theta and alpha in absolute power bands, but the effects could not be 
found at six months follow-up assessment. However, participants’ perceived control over EEG-
activity, as well as anticipation of positive outcomes of training significantly, increased over the 
course of training. 
Schizophrenia
Three studies could be identified that met the inclusion criteria for neurofeedback studies in patients 
with schizophrenia (Gruzelier, Hardman, Wild, & Zaman, 1999; Nan et al., 2017; Schneider et 
al., 1992). The studies by Gruzelier et al. (1999) and Schneider et al. (1992) employed SCP-
neurofeedback at central electrode positions, whereas Nan et al. (2017) trained the individual 
alpha peak frequency in a single-subject design. Number of sessions ranged from 10 to 20, with 
the exception for Nan et al. (2017) who employed 12.5 hours of neurofeedback training within 
four consecutive days. Gruzelier et al. (1999) and Schneider et al. (1992) investigated whether 
patients were able to learn to control SCP. Gruzelier et al. (1999) found patients able to learn 
to control interhemispheric asymmetry, whereas Schneider et al. (1992) found schizophrenic 
patients to only achieve differentiation of feedback trials comparable to controls in the last three 
sessions of training. Only Nan et al. (2017) investigated effects on a behavioral level through 
a short-term memory test, which improved post-treatment, while results concerning change in 
EEG-frequencies post-treatment were only significant by trend. 
Offending/Psychopathy
Only one study was found regarding neurofeedback training in a population of criminal offenders 
and adhered to our inclusion criteria. The study by Konicar et al. (2015) employed a 25-session 
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SCP-training protocol in a population of offenders with high scores on the Psychopathy Checklist- 
Revised (Hare, 2003). Behavioral outcome measures concerned clinical symptoms, such as 
aggression as well as behavioral approach/avoidance constructs. Post-treatment, there was a 
significant reduction in physical aggression measurements as well as in behavioral approach, 
while reactive aggression and aggression inhibition did not improve significantly.
EEG-learning
Only three out of ten studies established criteria for EEG-learning (Gruzelier et al., 1999; Mayer 
et al., 2016; Schneider et al., 1992). Gruzelier et al. (1999) differentiated between good and bad 
performers based on visual inspection of performance of training sessions when comparing the 
first five sessions with the last five sessions, and reported that good performers had lateral shifts 
about twice as large as average performers. In Schneider et al. (1992), learning success was 
defined as mean difference between required negativity increase and negative suppression and 
found that for patients, learning success took longer in time to manifest as compared to controls. 
Learning success correlated negatively with symptomatology at the beginning of the study, 
history of illness, and number of hospitalizations, implying that patients with a worse history of 
schizophrenic symptoms were less able to learn principals of neurofeedback training. The study 
by Mayer et al. (2016) was the only study that established criteria for EEG-learning and also 
investigated whether EEG-learning was related to changes in clinical symptoms. They reported 
a trend towards significance for higher ADHD symptom improvement in patients who could be 
classified as a ‘neurofeedback-learner’ (based on a participants’ ability to differentiate between 
negativation and positivation in neurofeedback transfer conditions). The study by Arns et al., 
(2012) did not establish criteria for EEG-learning, but classified responders to neurofeedback 
training based on clinical symptom reduction. They found a response rate of 76% based on 
behavioral measures, with significant improvements on attention, impulsivity and comorbid 
depressive symptoms, but post-treatment EEG measurements were only available for six out 
of 21 patients. The results of the available EEG measurements indicated changes in training 
parameters in an opposite direction as expected, as shown by a decrease in SMR power post-
treatment when actually SMR was up-trained. In the study by Konicar et al. (2015), the level 
of participants’ SCP-differentiation was correlated with improvements on behavioral measures, 
indicating larger reductions in physical aggression, behavioral approach, reactive aggression and 
aggression inhibition, with greater SCP-differentiation indicating higher clinical improvements. 
Risk for bias
Risk for bias in the selected studies was analyzed according to Cochrane standards of practice 
(Higgings & Green, 2017). Two reviewers (SF and HAV) independently scored the risk for bias 
and then reached consensus. See Figure 2 and 3 for an assessment of bias in the included studies. 




Figure 2: Risk of bias graph according to Cochrane Handbook for Systematic Review Intervention (Higgins, 
& Green, 2017).
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Figure 3. Risk of bias table according to Cochrane Handbook for Systematic Review Intervention (Higgins, & 
Green, 2017).
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This study set out to review studies that applied neurofeedback in criminal offending and 
the disorders these patients usually present with. Only studies that described whether or not 
neurofeedback led to changes in trained EEG treatment parameters were considered. To the 
best of our knowledge, this is the first review that investigates neurofeedback training for the 
purpose of applying it in the treatment of criminal offenders. The review identified 10 studies, 
of which three studies concentrated on neurofeedback training in patients with ADHD, three 
on patients with substance use disorder, three on schizophrenia, and one on offenders with 
psychopathic traits. No studies fitting the inclusion criteria could be identified for neurofeedback 
applied in patients with cluster B personality disorders, or for reducing violence or recidivism 
in criminal offenders. For all treatment populations and applied neurofeedback protocols taken 
into account, the number of neurofeedback sessions varied greatly, ranging anywhere from 10 
to 30 sessions. Most sessions were applied in patients with ADHD (about 30 sessions), whereas 
number of sessions was smaller in patients with schizophrenia (10-20 sessions). Possibly, patients 
with ADHD are more able to undergo a large number of treatment sessions than patients with 
schizophrenia, which are more disabled when it comes to adhering treatment due to their negative 
symptoms (Lyne, et al., 2016). In the study by Nan et al. (2017), an intense four day neurofeedback 
training protocol was applied. Unfortunately, level of negative symptoms was not assessed and 
no indication about patient motivation for treatment was given, so it remains unclear whether 
individual characteristics of the patient (such as the high degree of education) contributed to the 
patients ability to follow such an intense training protocol.
With regard to the behavioral results of the studies in this review, neurofeedback research for 
criminal offenders might benefit most from studies where improvements were found for levels 
of impulsivity (Arns et al., 2012; Mayer et al., 2016; Schönenberg et al., 2017), psychopathy 
(Konicar et al., 2015), hostility (Arani et al., 2010), and drug use (Arani et al., 2010; Horrell et 
al., 2010), which are all very often present among forensic psychiatric patients. Impulsiveness 
is a strong predictor of criminal offending, and the difficulties with inhibitory control make 
these patients more prone to aggressive outbursts and violent behavior (e.g., Reddy et al., 2014; 
Swann, Bjork, Moeller, & Dougherty, 2002). Substance use is associated with higher rates of 
violence (Dugré, Dellazizzo, Giguère, Potvin, & Dumais, 2017). Reducing these symptoms by 
neurofeedback might be promising with regard to the reduction of recidivism. The results of these 
studies are mixed with regard to post-treatment changes in the targeted EEG-frequency bands, 
with results ranging from no significant changes, trends towards significance, to significant 
changes in the desired direction. 
A central hypothesis in neurofeedback research is that the positive effects of the training are due 
to a feedback-driven training of specifically targeted frequency bands (Schönenberg et al., 2017). 
However, even in studies where EEG-frequencies did not significantly change post-treatment 
(Schönenberg et al., 2017), or even changed in the opposite direction as intended with the training 
protocol (Arns et al., 2012), clinical improvements could still be observed. Also, in the study by 
Lackner et al. (2016), no behavioral improvements could be observed, while changes in theta and 
alpha power were significant by trend post-treatment (however, patients’ belief in the efficacy 
of training and the perceived control of EEG-activity increased over the course of training). It is 
to be expected that a patients’ ability to learn principles of neurofeedback should be correlated 
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with changes in clinical symptoms. In the study by Konicar et al. (2015), level of participants’ 
SCP-differentiation was positively correlated with improvements on behavioral measures. In 
Mayer et al. (2016), a trend towards higher improvements of ADHD symptoms for EEG-learners 
could be observed. In the study by Schneider et al. (1992), EEG-learning success correlated 
negatively with symptomatology at the beginning of the study, history of illness, and number 
of hospitalizations, so possibly, neurofeedback is easier for patients with less severe courses of 
illness. Based on the studies in this review, no final conclusion can be drawn about whether 
positive effects of neurofeedback are due to specific neurophysiological changes. 
There is still an ongoing debate about whether improvements in clinical symptoms post-
neurofeedback training are due to other, non-specific effects, such as perceived self-efficacy 
(Barth, Mayer, Strehl, Fallgatter, & Ehlis, 2017), therapist-patient interaction and/or increased 
ability to focus on the neurofeedback training at hand. Only four studies in this review compared 
the effects of neurofeedback to a control group (Arani et al., 2010; Lackner et al., 2106; Schneider 
et al., 1992; Schönenberg et al., 2017). While some of the unblinded trials in this review revealed 
improvements in clinical symptoms after neurofeedback training, the triple-blind, randomized 
controlled trial by Schönenberg et al. (2017) showed no superiority of neurofeedback training 
over sham-neurofeedback and meta-cognitive group therapy. Most of the studies included in 
our review also had a high risk of bias, which was mostly due to the lack of a control group and 
blinding of participants and therapists. The use of adequate control groups is an ongoing debate in 
the literature. Sham-neurofeedback training often times contains of training seemingly irrelevant 
frequency bands that are typically in the higher beta or gamma bands. However, some studies 
show that alterations in EEG-frequency bands post-treatment can still be observed, even though 
these frequency bands were not up- or down-trained during the intervention (e.g., Doehnert et 
al., 2008). It is therefore possible that effects found in sham-neurofeedback conditions are due to 
training of seemingly irrelevant frequency bands. The use of an EMG-biofeedback as an adequate 
control group is also highly questionable, as a recent study by Barth et al. (2017) showed that 
even EMG-biofeedback resulted in an increase of alpha power post-treatment. It is clear that 
more research on adequate control groups is needed.
For forensic psychiatric patients with multiple comorbidities, QEEG-deviations might not match 
with the frequency bands that are up- or down-trained in standard neurofeedback protocols. In 
this review, most studies only investigated differences between groups pre-treatment, but did not 
investigate whether QEEG deviations at baseline actually matched the employed neurofeedback 
protocol. Clarke et al. (2011) for example, identified three different EEG-frequency clusters 
in children with ADHD, who also presented with significantly different behavioral complaints 
between groups. They identified a subgroup who presented with increased delinquent behavior, 
but who showed an increased beta activity and a decreased theta activity instead of the cortical 
underarousal often used as an indicator for lack of inhibitory control. More research is still 
needed about how these EEG-deviations manifest in ADHD adults, but it can be argued that these 
patients will most likely not profit from a standard theta/beta neurofeedback protocol.
The success of neurofeedback training for complex combinations of disorders might also 
be found in secondary factors such as treatment retention and teaching patients to cope with 
stress, rather than successfully normalizing (all) QEEG-deviations. Individuals with high levels 
of impulsivity (such as often seen in ADHD and/or SUD) more often fail to complete treatment 
programs (Moeller et al., 2001; Wilens, 2004), which in turn increases risk for recidivism. 
In a study by Scott et al. (2005), the Scott-Kaiser modification of the Peniston Protocol was 
employed in subjects presenting with SUD and attention-deficits, and while the study does not 
report outcomes on a neurophysiological level, participants remained in treatment significantly 
longer than controls. For criminal offenders, risk for criminal recidivism will almost certainly 
benefit from keeping patients in treatment. Furthermore, studies have shown that neurofeedback 
(especially alpha-theta protocols) can be effective in improving mentalization (Imperatori et al., 
2017). Poor mentalization skills are believed to at least partially underlie aggressive behavior in 
antisocial personality disorder (Velotti et al., 2016). Improving mentalization skills could serve 
as a protective factor toward preventing aggression among criminal offender populations (Velotti 
et al., 2016). 
None of the studies investigated in this review report serious side effects of neurofeedback training. 
With medication for disorder such as ADHD and schizophrenia, side effects tend to be quite 
stressing and uncomfortable for patients. Also, positive effects of medication tend to diminish 
once medication use is terminated. Often times, the efficacy of neurofeedback is questioned as it 
has not been shown to be superior to medication. Yet, some studies do show comparable effects 
of medication and neurofeedback (e.g., Fuchs et al., 2003; Janssen et al., 2017). If similar results 
can be achieved with neurofeedback as with medication, neurofeedback could be seen as the less 
invasive treatment with less possible side effects. This would especially be the case when applied 
in vulnerable patients populations. 
Conclusion
More research focusing on neurofeedback and actual learning of cortical activity regulation is 
needed in populations with externalizing behaviors associated with violence, criminal behavior, 
and oftentimes multiple comorbidities. Although large randomized controlled trials are considered 
the gold standard in scientific research, it is questionable whether studies with criminal offenders 
can adhere to these strict standards, due to low levels of treatment compliance of criminal 
offenders making it difficult to engage these patients in scientific research (Van Outsem, 2011). 
Clinical trials, as well as single-case experimental designs (e.g., Fielenbach, Donkers, Spreen, & 
Bogaerts, 2017), where some compromises in research methodology and experimental controls 
have to be made, but where treatment is tailored to the individual and his/her clinical complaints 
(Rossiter, & LaVaque, 1995) might be more feasible than large double-blind randomized controls. 
The study by Nan et al. (2017) explored the effects of neurofeedback training in a single subject 
design, but unfortunately, improvement in clinical symptoms was not investigated systematically. 
However, the methods used in clinical trials can provide the same level of experimental rigor 
and internal validity (Rizvi, & Nock, 2008) if executed correctly, and might help shed light on 
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Abstract
Impulsivity and substance use disorder (SUD) are strongly interconnected, with persons scoring 
high on impulsivity being more vulnerable to develop substance abuse, facing more challenges 
for successful treatment, and being more prone to engage in criminal behavior. Studies have 
shown that impulsivity and craving for substances are strongly correlated. Neurofeedback is an 
effective treatment to reduce impulsive behavior. This study intends to determine to what extent a 
neurofeedback intervention that is aimed at reducing impulsivity can also reduce levels of craving 
in forensic patients with SUD and comorbid Axis I and/or II diagnoses. The main objective of 
this study is to investigate to what extent a reduction in impulsivity by a sensorimotor rhythm 
(SMR) neurofeedback intervention will lead to a reduction in craving in a population of forensic 
psychiatric patients with a diagnosis of SUD. Participants will be male SUD patients with various 
comorbidities residing in an inpatient forensic treatment facility approached through treatment 
supervisors for participation. Participants have tested positive for drug use in the past 24 months.
The study consists of 2 parts: a randomized controlled trial (RCT) and a n-of-1 clinical series. 
In the RCT, 50 patients will be randomly assigned to an intervention (n=25) or a control (n=25) 
condition. Patients in the intervention group will receive 20 SMR neurofeedback sessions 
aimed at reducing impulsivity; participants in the control group receive treatment as usual 
(TAU). Additionally, 4 in depth n-of-1 clinical trials will be conducted where effects of an SMR 
neurofeedback intervention will be compared to effects of sham neurofeedback.
Results of this study are expected by the end of 2017. This protocol describes the design of a 
study testing the effects of an impulsivity-based neurofeedback protocol among forensic patients 
with SUD and various comorbidities. We expect a significant reduction in impulsive behavior, 
level of craving, and actual drug-use for participants receiving the SMR neurofeedback protocol. 
The n-of-1 approach might help to explain effects possibly found in the RCT study since it 
allows for a more direct focus on treatment effects by following participants more closely and 




Impulsivity has been defined as a dysfunctional trait, leading to a tendency for an individual to 
display behavior that is performed with little or inadequate forethought (Evenden, 1999) and 
might be criminal and possibly harmful to oneself or to others (Verdejo-Garcia, Lawrence, & 
Clark, 2008). Impulsivity has been operationalized in different ways with inadequate behavioral 
inhibition being conceived as one of the key factors (Loree, Lundahl, Ledgerwood, 2015). 
Impulsive behavior is hypothesized to involve a disinhibition of cognitive control that occurs 
without conscious deliberation (Nielsen et al., 2012). 
Several studies have demonstrated that substance use disorder (SUD) is strongly associated 
with elevated impulsivity scores on various measures (Loree et al., 2015). In SUD, the use of a 
substance is continued even though a person is aware of the negative consequences of prolonged 
drug use. This can be explained by deficient inhibitory control over drug-taking which provides 
immediate (positive) reinforcement (Verdejo-Garcia et al., 2008). Higher levels of impulsivity 
were found in individuals scoring high on alcohol, stimulant, and opiate use (Loree et al., 2015), 
as measured by self-report instruments, such as the Barratt Impulsivity Scale (BIS-11) (Nielsen 
et al., 2012). Individuals with combined cocaine and alcohol abuse show impaired response 
inhibition as compared to controls on continuous performance tasks measuring impulse control 
such as the Cued Go/No-Go task (Fillmore & Rush, 2006). Furthermore, a strong relation between 
elevated impulsivity scores during childhood/early adulthood and substance abuse problems later 
in life has been observed, indicating that heightened levels of impulsivity might precede the 
development of substance abuse problems (in Hawkins, Catalano, & Miller, 1992, for example). 
In alcoholism for example, behavioral disinhibition as assessed with a novelty-seeking scale has 
been shown to predict early onset alcoholism (Howard, Kivlahan, & Walker, 1997). Individuals 
scoring high on impulsivity are therefore more prone to develop SUD than healthy controls and 
more often exhibit antisocial behavior (Howard et al., 1997).
The concept of impulsivity has been of particular interest in studies involving criminal offenders, 
as these individuals often suffer from major mental disorders and are therefore more likely to be 
involved in criminal acts than persons without major mental disorders (Kamperman et al., 2014). 
In criminal offenders, cluster B personality disorders and schizophrenia are frequently diagnosed 
(Van Nieuwenhuizen, Bogaerts, Ruijter, Bonges, & Coppens, 2011). Comorbidity rates between 
these disorders and SUD are as high as 70% (Van Nieuwenhuizen et al., 2011). Generally, 
treatment of SUD has proven to be difficult, with relapse rates as high as 60% after treatment 
in opiate abusers (Marissen, Franken, Blanken, Van den Brink, & Hendriks, 2005). For patients 
with a criminal history and a combination of SUD and comorbid disorders characterized by high 
levels of impulsivity, long-term treatment outcomes are worse (Van Nieuwenhuizen et al., 2011). 
High impulsivity levels predict both early relapse and increase chances of premature termination 
of treatment (Charney, Zikos, & Gill, 2010). This, in turn, increases the risk of recidivism in 
criminal behavior (Trimbos, 2008). Adequate treatment for this vulnerable patient population is 
therefore extremely important, as impulsivity can be understood as an important risk factor in 
both the onset of SUD as well as post-treatment relapse (Bozkurt et al., 2014). 
Neurofeedback Treatment for Impulsivity and Substance Use Disorder
Electroencephalographic (EEG) spectral analysis is a frequently used method to compare healthy 
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controls with prolonged drug users by focusing on differences in the (relative) strength of 
naturally occurring rhythms in the EEG (in Alper, Prichep, Kowalik, Rosenthal, & John, 1998), 
for example). EEG alterations most commonly found in individuals with SUD are characterized 
mainly by alterations in the strength of theta (4-8 Hz), alpha (8-12 Hz), and beta (12-20 Hz) 
frequency bands (Dehghani-Arani, Rostami, & Nadali, 2013) and are hypothesized to be related 
to symptoms of drug use disorder, such as over attention to drug cues, feelings of restlessness, 
and loss of impulse control. Although alterations in several EEG spectral measures have been 
observed that vary by type of addiction, they persist even after drug abuse is in remission (Alper 
et al., 1998).
Neurofeedback is an intervention that uses real-time EEG measurements and displays information 
about these EEG measurements back to the participant, allowing them to not only see but also 
change their brain electrical activity over time (Sokhadze, Stewart, Tasman, Daniels, & Trudeau, 
2011). By principles of operant conditioning, participants learn to reinforce or inhibit specific 
frequencies of the EEG activity (Scott, Kaiser, Othmer, & Sideroff, 2005) and thereby normalize 
abnormal EEG states, which in turn aims at changing abnormal psychological states (Gunckelman 
& Johnstone, 2005). Sensors are placed on the scalp and moment-to-moment information about 
brain activity is fed back to the participant (Hammond et al., 2011).
Several studies have shown neurofeedback to be a promising intervention for various disorders, 
ranging from SUD to attention deficit hyperactivity disorder (ADHD) (Sokhadze et al., 2011). 
In SUD, a widely used neurofeedback protocol is the Scott-Kaiser modification of the Peniston 
Protocol, consisting of a combination of sensorimotor rhythm feedback (SMR, 12-15 Hz) followed 
by alpha-theta based feedback (Scott et al., 2005). With this type of protocol, patients first receive 
neurofeedback that focuses on reinforcing SMR (12-15 Hz) while inhibiting slower frequencies 
such as delta (2-5 Hz) and theta (5-8 Hz) and also inhibiting high beta (ranging from 18-30 Hz) 
(Dehghani-Arani et al., 2013; Scott et al., 2005). This type of feedback is first employed for 10 to 
20 sessions before the neurofeedback protocol is switched to an alpha-theta based protocol, where 
alpha (ranging from 8-12 Hz) is decreased while theta (5-8 Hz) is augmented until the amplitude 
of alpha drops below the level of theta (Dehghani-Arani et al., 2013; Scott et al., 2005). The 
Scott-Kaiser modification of the Peniston Protocol has shown to be effective in opiate dependent 
patients as well as in patients with a mixed substance dependency, as it led to the reduction of 
feelings of craving (Scott et al., 2005), a powerful predictor of relapse in drug-taking (Paliwal, 
Hyman, & Sinha, 2008; Weiss et al., 2003), and therefore promoted treatment attendance and 
abstinence rates of participants (Scott et al., 2005). As most criminal offenders with SUD also 
suffer from comorbid psychiatric conditions however, treatment with neurofeedback may become 
more complicated (Sokhadze et al., 2011). For patients having a combination of impulsivity 
issues due to comorbidity with other psychiatric disorders, as well as substance abuse problems, it 
is suggested that a SMR-enhancing neurofeedback protocol should be applied to address the issue 
of impulsivity first (Trudeau, 2005). Studies performing a neurofeedback protocol consisting of 
suppressing slow waves such as theta (4-7 Hz) and enhancing faster waves such as SMR (12-
15 Hz) have demonstrated an improvement of impulse control in a population of students (in 
Egner & Gruzelier 2004, for example) and have shown to positively affect motor control and 
cortical inhibitory function (in Sokhadze et al., 2011, for example). This type of neurofeedback 
protocol is also commonly applied with patients suffering from the hyperactive-impulsive 
ADHD subtype and there are many studies reporting reduction in impulsivity after treatment 
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(in Fuchs, Birbaumer, Lutzenberger, Gruzelier, & Kaiser, 2003). Several studies have shown 
that impulsivity and craving for substances are strongly correlated no matter the administered 
drug of choice. For example, in a study by Tziotzis, Mahoney, Kalechstein, Newton, and De 
la Garza (2011) with methamphetamine users, individuals with higher levels of impulsivity 
reported significantly more craving than individuals scoring lower on impulsivity. In alcohol 
dependent patients, higher scores of craving were correlated with higher self-reported impulsivity 
on the BIS-11 (Joos et al., 2013). Moeller et al. (2001) found a significant correlation between 
the motor impulsivity subscale of the BIS-11 and craving in a population of cocaine dependent 
subjects. Also for cocaine dependent patients, higher impulsivity was associated with greater 
severity of addiction symptoms such as craving (Bornovalova, Levy, Gratz, & Lejuez, 2010; 
Ledgerwood & Petry, 2010). Also, contemporary neuropsychological models stress impulsivity 
and SUD to be the result of the same imbalance between bottom-up and top-down neural systems 
(Bechara, 2005; Heatherton & Wagner, 2011). Bottom-up systems concern subcortical brain 
circuitry promoting impulsive reward behavior (regardless of long-term outcomes), whereas top-
down processes concern reflective and self-control functions driven by prefrontal brain circuitry 
(Stevens et al., 2014). Within SUD, chronic substance abuse may produce neural changes leading 
to a structural state of disinhibition and impulsivity (Bates, Bowden, & Barry, 2002; Jentsch & 
Taylor, 1999), causing immediate reaction to substance-related cues that elicit craving (Lyvers, 
2000). Not only acute but also prolonged effects of substance abuse have proven to be of great 
influence in disrupting these neuropsychological mechanisms, therefore maintaining problems 
with inhibitory control even after drug use is terminated (Roozen, van der Kroft, van Marle, 
& Franken, 2011). Although impulsivity and craving are both independently identified as key 
elements in SUD, to date, there has been no study investigating whether a reduction in one will 
also lead to a reduction of the other.
This Study
Although the relationship between impulsivity and symptoms of SUD such as craving and actual 
drug use has been established, to date there is no evidence about the effects of an impulsivity 
based neurofeedback protocol and its effectiveness on impulsivity and on symptoms of SUD. This 
study aims to examine the treatability of impulsivity with an SMR neurofeedback intervention in 
a population of forensic psychiatric patients with SUD and comorbid Axis I and/or II disorders. It 
also aims to investigate whether a reduction of impulsivity through an SMR-based neurofeedback 
protocol will also result in a reduction of SUD symptoms such as craving and actual drug use.
The study will combine a randomized controlled trial (RCT) design with an n-of-1 clinical trial. 
The RCT allows for investigating to what extent a SMR neurofeedback protocol can reduce 
craving and actual drug use by augmenting levels of impulsivity for forensic psychiatric patients 
at a group level. However, RCTs have several disadvantages. First, they focus on between-group 
differences, making it difficult to determine the exact working mechanisms of neurofeedback at 
the single patient level. Despite the fact that the number of studies employing neurofeedback has 
increased over the past 2 decades, to date the underlying working mechanisms of neurofeedback 
remain unclear. Success of treatment is usually determined by a reduction in subjective complaints 
or based on other behavioral measures, independent of patients’ responses to neurofeedback on 
a neurophysiological level (e.g., change in mean amplitude of brain frequencies). Second, most 
RCTs focus on participants with single, well-defined disorders or diagnoses, making it difficult 
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to apply previous findings to patients who have a more complex psychopathology as is usually 
the case in forensic patients. Third, finding a reduction in subjective complaints could partially be 
explained by the interaction with the person giving the treatment, as this occurs with almost all 
frequently given types of therapy in the psychological field (Horvath & Symonds, 1991). To rule 
this out, large RCTs with a treatment and a sham arm are necessary. Unfortunately, these studies 
are very difficult to conduct in a forensic psychiatric setting due to the fact that forensic patients 
generally have low levels of treatment compliance (van Outsem, 2011). As the current study 
concerns a single-site study with only a limited number of patients who fit the inclusion criteria 
to begin with (but on forehand sufficient according to power analysis), adding a sham arm to the 
RCT would most likely further reduce the motivation of patients to participate and hence increase 
nonresponse. However, insight in possible sham effects is needed to differentiate between specific 
and nonspecific treatment effects which are independent of the neurofeedback trainer. Finally, 
RCT studies showing treatment effects of neurofeedback often vary in the applied protocols, 
number of sessions, and treatment intensity. To date, there have been no guidelines developed that 
specify these neurofeedback parameters. Especially for forensic patients, developing a treatment 
that is well applicable and helps to reduce symptoms of SUD is of great importance, as forensic 
treatment is aimed at protecting society and reducing the risk of reoffending. By adding several 
n-of-1 clinical trials we attempt to cope with these disadvantages. A well conducted n-of-1 trial 
allows testing of the specific working mechanisms of neurofeedback in a single patient and is 
therefore able to detect detailed behavioral and neurophysiological changes that can then be 
attributed more definitely to neurofeedback treatment.
Objectives
Primary outcome variables are the degree of impulsivity as measured with the Dutch version of 
the Barratt Impulsivity Scale (BIS-11) (Lijffijt & Baratt, 2005); inhibitory control as measured 
with a cued Go/No-Go reaction time task (Fillmore, 2003); degree of drug craving as measured 
with an altered version of the Desire for Alcohol Questionnaire (DAQ) (Franken, Rosso, & 
Van Honk, 2003); actual drug use as measured with urine, saliva, or breathalyzer analysis; and 
changes in resting state EEG pattern.
Primary objective: To what extent does a reduction in impulsivity by using SMR neurofeedback 
result in a reduction of core symptoms of SUD such as craving and actual drug use in a population 
of forensic psychiatric patients with a diagnosis of SUD?
Secondary objectives:
1. To what extent can a SMR-based neurofeedback intervention reduce levels of impulsivity 
as measured by BIS-11 and a cued Go/No-Go task in a population of forensic psychiatric 
patients with a diagnosis of SUD?
2. To what extent can a SMR-based neurofeedback intervention reduce levels of craving as 
measured by self-report questionnaire DAQ-SF (short form) in a population of forensic 
psychiatric patients with a diagnosis of SUD?
3. To what extent can a SMR-based neurofeedback intervention reduce actual drug use as 
measured with urine, saliva, or breathalyzer analysis in a population of forensic psychiatric 




This study will be conducted according to the principles of the Declaration of Helsinki (version 
59, Seoul, October 2008) and in accordance with the Medical Research Involving Human 
Subjects Act. It has been approved by the medical ethical council of Brabant, the Netherlands 
(study number NL46390.008.13).
This study takes place in Forensic Psychiatric Centre (FPC) Dr S van Mesdag, a maximum security 
inpatient forensic treatment facility in Groningen, the Netherlands. Patients in this treatment 
facility are male criminal offenders with at least one Axis I or II diagnosis and considered to be 
at risk for criminal recidivism if not treated properly. About 70% of all patients treated in this 
facility have a comorbid diagnosis of SUD. About 70% of all patients treated in this facility have 
a comorbid diagnosis of SUD (Van Nieuwenhuizen et al., 2011).
Randomized Controlled Trial
A randomized controlled trial with N=50, where 25 participants are randomly assigned to treatment 
as usual (TAU) combined with 20 SMR-based neurofeedback sessions and 25 participants are 
randomly assigned to TAU only, without neurofeedback intervention. The 2 groups are compared 
pretreatment (T0) and posttreatment (T1) on variables linked to the research questions. Both 
groups will receive pre- and post-treatment measurements with an interval between T0 and 
T1 of approximately 10 weeks in which participants in the intervention group will receive 20 
neurofeedback treatment sessions and participants in the control condition will follow TAU.
The design of this part of the study is a 2×2 design with the condition (neurofeedback vs TAU) 
as a between-subjects factor and time as a within-subjects factor (pre- and post-intervention).
N-of-1 Clinical Trial
To zoom in on specific treatment effects, 4 single case studies with an A1B1A2B2 design (single time 
series) will be conducted, of which 2 single case studies will apply an actual SMR neurofeedback 
protocol and 2 single case studies will apply a sham neurofeedback training. The clinical trial 
will be single-blinded, indicating that participants do not know which part of the training they 
will receive. Participants are selected from the control group of the previously described RCT 
protocol who have already completed pre- (T0) and post-treatment (T1) measurements. Inclusion 
in the n-of-1 trial will be selective: participants with the highest scores on outcome measures on 
T1 of the RCT will be approached first as it is believed that these patients have the highest need 
for treatment. However, allocation to treatment (sham or real) will be random. 
For a detailed description of this design of n-of-1 studies, see Rizvi and Nock (2008). Basically, in 
this design, a baseline period (A1: no-treatment, lasting 3 weeks) is followed by a treatment period 
(B1: neurofeedback, sham or real, lasting 4 weeks and resulting in 8 neurofeedback sessions), 
which is followed by a period where treatment is withdrawn (A2: lasting 3 weeks). During all 
periods, outcome measures DAQ-SF and BIS-11 will be assessed 2 times a week. At the end of 
the A2 period, statistical analyses are applied to test for significant improvements in study end 
points. In cases of significant improvement during treatment, a second period of neurofeedback, 
B2 (sham or real), will be applied. This way, if neurofeedback does not prove to be effective 
within B1, participants will not be burdened with the requirement of completing more sessions. It 
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is expected that patients who have not shown any significant improvement during neurofeedback 
sessions in B1 will not show any further improvements when undergoing more sessions. After 
completion of the study, patients and treatment supervisors will be debriefed about whether the 
neurofeedback intervention was real or sham.
To test for transient effects of the neurofeedback intervention, a follow-up measurement of 
resting state EEG, BIS-11, DAQ-SF, and Cued Go/No-Go task will be performed 12 months 
after completing the post-treatment measures for both participants in the intervention group of the 
RCT and for participants in the n-of-1 clinical trial.
Participants
A power analysis calculation for the RCT using G*Power 3 (Faul, Erdfelder, Lang, & Buchner, 2007) 
based on a 1-tailed alpha value of .05, a power value of 0.80, and an effect size (f) of 0.80 yielded a 
recommended sample size of 21 participants each in the control and intervention conditions. Given 
the special research population we aim to select 25 participants for each condition.
Participants are male patients diagnosed with SUD (substance dependency or substance abuse) 
according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text 
Review (DSM-IV-TR, American Psychiatric Association, 2000) and currently staying at the 
treatment facility. Participants have tested positive for drug use in the past 24 months at time of 
inclusion. Drug use is operationalized as urine, saliva, or breathalyzer analysis testing positive 
for either marijuana and/or psychostimulant/opioid drugs and/or alcohol. Corresponding with 
treatment facility policy, nonprescribed medication that is used for recreational drug consumption 
such as inhaled methylphenidate will also be scored as positive drug testing, as will refusal to 
undergo drug testing.
Participants are allowed to continue using prescription medication (as prescribed by a psychiatrist or 
general physician of the treatment facility) but are required to inform researchers of any medication 
they are currently using or any change in medication during treatment with neurofeedback.
Recruitment
Recruitment will start with the selection of patients for the RCT part of the study. Participants 
are approached through treatment supervisors for participation. Treatment supervisors are 
informed about the general inclusion criteria for this study. Out of all participants that meet 
the requirements, a random sample of 50 will be drawn and randomly assigned to 1 of the 2 
conditions (intervention and control). Prior to participation in the trial all participants are asked 
to provide written consent. If at this point a participant chooses to not participate in the trial, 
this will be coded as a nonresponse. Missing numbers of participants will be complemented 
by randomized allocation of other suitable participants that are willing to participate in order to 
guarantee the sample size. Once all patients for the RCT have been recruited, recruitment for the 
n-of-1 clinical trial will begin. All participants will receive a financial reward after completing 
pre- and post-treatment measurements.
Measures
Electroencephalography. Participants will undergo a 21-channel EEG measurement with 
Nexus-32 hardware and Biotrace+ software (Mind Media BV). The EEG will be collected 
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from 19 standard 10/20 positions (Herbert & Jasper, 1958) and the right and left mastoid with a 
sampling rate of 512 samples per second. The left mastoid will serve as the online reference. Flat 
type electrodes will be placed above and below the left eye and at the outer canthi of each eye to 
correct for vertical and horizontal eye movements. Participants will be seated comfortably while 
5 minutes of eyes closed resting state EEG data is collected. EEG measures will be conducted 
at T0 and T1 as well as at 12 months follow-up for participants in the intervention group (T2). 
For participants in the neurofeedback group, a 1-minute baseline recording over 3 conditions 
will be conducted before start of the first neurofeedback session and after the last session. EEG 
signal will be recorded from electrode position Cz against a right ear mastoid reference across the 
conditions (1) eyes open, (2) eyes closed, and (3) cognitive task (where participants are instructed 
to solve simple mathematical calculations). These measurements will be used to determine 
neurofeedback threshold values and to assess change in mean magnitude of frequency bands 
before and after neurofeedback training.
Barratt Impulsivity Scale–11. The Dutch version of the BIS-11 (eleventh edition) (Patton, 
Stanford, & Barratt, 1995) is a self-report questionnaire designed to measure the behavioral 
and personality construct of impulsivity across 3 second-order factors: attentional, motor, and 
nonplanning. It consists of 30 items scored on a 4-point scale ranging from rarely/never to almost 
always/always. The BIS-11 has been proven to be an internally consistent measure of impulsivity 
among inmate populations (Patton et al., 1995).
Cued Go/No-Go Task. The cued Go/No-Go task is a continuous performance test measuring 
impulse control by the ability to inhibit prepotent responses (Fillmore, 2003). Participants are 
instructed to respond to a green square by pressing a button as quickly as possible while not 
responding to a blue square. A go or no-go cue is given before the actual target appears, providing 
information about the likelihood of an actual go or no-go target (Fillmore, 2003). The likelihood 
of a correct target after a cue is manipulated with a 80/20 ratio, with 80% being a correct cue 
and 20% being an incorrect cue. Cues are presented with 4 fixed stimulus onset asynchronies 
(100, 200, 300, and 400 ms), giving participants time to prepare for responding. The cued Go/
No-Go task has been proven to be a useful measurement of impulse control in substance abusing 
populations (Fillmore, 2003). It consists of 250 trials spread over 5 rounds with a 30-second break 
in between each round, taking approximately 20 minutes to complete. Outcome measurements 
are omission (the participant does not respond when he should respond) and commission errors 
(the participant responds when he should not respond) and reaction time.
Modified Desire for Alcohol Questionnaire. The DAQ-SF (Courtney et al., 2013) is a self-
report questionnaire assessing the desire to use drugs at the moment of assessment. It is derived 
from the original desire for alcohol questionnaire (DAQ) with 36 items. The short-form version 
of the DAQ consists of 14 item that can be scored on a scale from 1 to 7 ranging from strongly 
disagree to strongly agree. It consists of 3 factors: (1) strong desires/intention to drink, (2) negative 
reinforcement, and (3) ability to control drinking. The abbreviated version has been shown to be 
reliable in measuring alcohol craving (Courtney et al., 2013).
All questions of the original questionnaire are designed to measure craving purely for alcohol; 
however, within the treatment facility alcohol use is less common than other drug use (such 
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as marijuana and/or cocaine). Therefore, questions from the questionnaire have been altered 
so they can fit any type of drug dependency. An example of this is “My desire to drink seems 
overpowering” which has been altered to “My desire to use drugs seems overpowering.”
Instrument for Forensic Treatment Evaluation. The Instrument for Forensic Treatment 
Evaluation (IFTE) is an observational treatment evaluation instrument consisting of 22 items 
measuring 3 factors: Problematic behavior, protective behavior, and resocialization skills. It 
is scored on a 17-point Likert scale with 5 anchor points: none, rarely, sometimes, often, and 
always (Schuringa, Spreen, & Bogaerts, 2014). The IFTE assesses forensic risk behaviors such 
as impulsivity, hostility, and violating treatment conditions. These risk behaviors might be 
manifestations of impulsive behavior and could help assess engagement in impulsive behavior 
that is not assessed by the BIS-11 and the cued Go/No-Go task. Furthermore, the IFTE also 
assesses cooperation with treatment, which measures the amount of effort a patient puts in to 
make progress in his treatment, giving an indication of the degree of commitment (and thereby, 
motivation) of a patient to forensic treatment. The IFTE is scored twice a year by clinicians 
involved in patients’ treatment as part of routine outcome measurement within the treatment 
facility. Patients also score the IFTE on a self-report version of the original IFTE (IFTE-SR), 
where they can give an indication of treatment progress during the past 6 months. Scores of the 
IFTE and IFTE-SR are assessed from the moment a patient arrives at the treatment facility up 
until release. Therefore, scores on the IFTE are available throughout the research. Relevant scores 
included in this study will be assessments 6 months prior to inclusion up until 12 months after 
the last measurement.
Actual Drug Use. Drug testing is performed on a regular basis, usually once every 2 weeks. 
Whenever staff suspects illegal use of substances within 2 moments of drug testing, spontaneous 
and unexpected drug testing can be performed. Number of drug tests will be counted, as will be 
positive (meaning drug use in the period of time since last drug test) and negative (meaning no 
drug use since last testing) outcome scores. Drug testing is done in the form of urine, saliva, or 
breathalyzer (for alcohol use only) analysis.
Covariates. Covariates are sociodemographic characteristics; specific psychopathology; duration 
of forensic treatment; actual drug use during the past 24 months (or as long as patients reside in 
the treatment facility); medication use; clinical risk assessment score (Historical/Clinical/Future-
Revised, HKT-R) (Spreen, Brand, Ter Horst, & Bogaerts, 2014); actual drug use; and mean score 
of delta, theta, alpha, beta, and gamma resting state EEG-frequency band power. Covariates will 
be collected through case file information. Medication and medication change will be categorized 
according to class of medication (e.g., benzodiazepines, antipsychotic medication).
Intervention
All participants already receive TAU at the moment of inclusion. They will continue to do so 
during the course of this trial. Type of TAU is dependent on disorder and behavior but can range 
from cognitive behavioral therapy, psychotherapy, and psychomotor therapy to relapse prevention 
treatment and can be either individual treatment or in-group treatment. Treatment can also be 
supplemented by medication for psychotic symptoms or depressive symptoms, for example. In 
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some rare cases, aversion or craving reducing medication is prescribed.
Participants in the intervention condition of the RCT will receive 20 neurofeedback sessions, 
each lasting approximately 40 minutes. EEG magnitude is measured across delta (0.5-3.5 Hz), 
theta (3.5-7.5 Hz), alpha (7.5-12 Hz), beta (12-20 Hz), SMR (12-15 Hz), high beta (20-32 Hz), 
and gamma (32-49 Hz) frequency bands. To reduce inattention and impulsivity, a conventional 
neurofeedback protocol will be used that consists of suppressing theta magnitude and enhancing 
SMR magnitude (Lubar, Swartwood, Swartwood, & Timmermann, 1995; Linden, Habib, & 
Radojevic, 1996). The aims of the neurofeedback sessions are therefore to reduce slow waves 
(specifically theta, 3.5-7.5 Hz, and if necessary delta, 0.5-3.5 Hz) and increase faster waves 
(SMR, 12-15 Hz). A maximum of 3 different frequency bands will be trained during each session. 
Neurofeedback training will be performed on the EEG signal recorded from electrode position Cz 
against a right ear mastoid reference.
For the n-of-1 design of the trial, 2 participants will receive the SMR neurofeedback intervention 
and 2 participants will receive sham neurofeedback. Real and sham neurofeedback procedures 
will be similar (e.g., electrode position, preparation, instructions given to participants) except that 
for the sham neurofeedback training group, participants are instructed to enhance an irrelevant 
frequency band that is randomly chosen from higher beta bands (20-23 Hz, 23-26 Hz, 26-29 
Hz, and 29-32 Hz). Therefore, no specific frequency band is systematically modulated and 
thus should not result in desired treatment outcomes. Participants will still be given positive 
feedback and be able to influence the video games in order to minimize possible irritation of 
participants. Neurofeedback will be applied as implemented within the BrainMarker software 
engine (BrainMarker Device, Brainmarker BV Gulpen). Participants will be shown simple video 
games implemented in the software that will provide feedback about their brain activity. During 
the video games, they are instructed to be attentive to the feedback (no movement/movement of 
objects) in the video game and to find the most successful strategy to reach the goal of the game. 
Example of such video games are a car moving on a road, where participants are instructed to 
keep the car in the right lane of the road, or a basketball court where participants are instructed to 
try to throw the ball in the basket. The video game-based neurofeedback rounds will last 1 minute 
at a time, with a short break in between rounds. Also, movie-based neurofeedback will be applied. 
During movie-based neurofeedback participants will watch a digital video disk of their own 
choice and be instructed to keep the monitor as free as possible from black curtains appearing 
on both sides of the monitor and keep the volume of the movie at an audible level. Movie-based 
training will last 90 seconds at a time with a short break when necessary. Participants will receive 
both game- and movie-based neurofeedback in each session.
Thresholds will be set manually in a way that if a participant maintains the reinforced frequency 
band above a threshold for 80% of time, positive feedback will be received. To determine 
threshold values, mean magnitude of the baseline measurement across the 3 conditions described 
above will be used to roughly assess threshold values for the neurofeedback training. For each 
training session, mean magnitude values will be calculated for all frequencies.
Statistical Analysis
All statistical analysis will be conducted using SPSS version 19 (IBM Corp). Summarizing 
descriptive statistics and frequency tables will be provided.
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Randomized Controlled Trial. Resting state EEG data will be analysed using custom-made 
Matlab R2012b scripts (version R2012b). A repeated measures multivariate analysis of variance 
with factors condition (neurofeedback vs control) and frequency band (delta, theta, alpha, beta, or 
gamma) will be conducted. If main or interaction effects are observed, post hoc tests will be used 
to determine which levels of the factors are explaining the observed effects.
Repeated measurement with time (pre- [T0] and postintervention [T1]) as the within-subject 
factor and group (control vs intervention) as the between-subject factor will be conducted for 
the DAQ-SF, BIS-11, IFTE, and IFTE-SR. If main or interaction effects are observed, post hoc 
test will be used to determine which levels of the factors are explaining the observed effects. An 
repeated measures analysis of covariance will be conducted to examine differences in actual drug 
use as dependent variables to test for a moderating effect of impulsivity on craving and actual 
drug use.
N-of-1 Trial. First, a time-plot will be inspected using the autocorrelation coefficient (i.e., 
correlogram) (Chatfield, 2004) . After inspection, time-series analysis will be applied to test for 
significant slope and level changes as well as a trend analysis. Analysis techniques will be based 
on the study by Solanas, Manolov, and Onghena, 2010.
Results
Results of all measurements will be expected by the end of 2017 and will be published in 
corresponding articles.
Discussion
This study aims to evaluate the efficacy of an SMR-based neurofeedback treatment on reducing 
impulsivity in a population of inpatient forensic patients. Possible effects of a reduction in 
impulsivity on substance abuse will be assessed as well. We expect a significant reduction in 
impulsive behavior, level of craving, and actual drug use for participants receiving the SMR 
neurofeedback protocol. The n-of-1 approach might help to explain effects possibly found in the 
RCT study since it allows for a more direct focus on treatment effects by following participants 
closely and thereby being able to directly attribute behavioral and neurophysiological change to 
the SMR neurofeedback protocol employed. The study aims to extend previous findings on the 
efficacy of neurofeedback treatment in reducing impulsivity, not only by linking possible findings 
regarding a reduction of impulsivity to substance abuse symptoms but also by examining effects 
in a forensic psychiatric population with various comorbid disorders.
Studies about the efficacy of neurofeedback in a psychiatric forensic setting, in which the 
population is characterized by various comorbidities and various kinds of medication, are lacking. 
In our study, exclusion criteria are kept to a minimum to include as many participants with SUD 
as possible and to be able to generalize effects of an SMR neurofeedback treatment over different 
types of comorbidities.
Although RCTs with a treatment and a sham treatment arm are considered the gold standard in 
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research, conducting large trials is often times difficult in forensic settings; treatment motivation 
might be low for the type of patients in the treatment facility because they are placed under 
compulsory inpatient custody and are not seeking treatment due to inner motivation for change. 
In RCTs, number of participants usually has to be quite high to reach the desired effect size 
(Cohen, 1988). Participating patients might be even less inclined to take part in the trial if they 
know that they might end up in a placebo condition. 
By employing an n-of-1 approach combined with an RCT, this study might help shed light on the 
underlying mechanisms of neurofeedback because an n-of-1 approach allows closer monitoring 
of treatment effects and provides valuable insight into an individual’s treatment progress that 
might otherwise be lost in a between-group design (Rizvi & Nock, 2008).
If effective, neurofeedback could be a noninvasive treatment option for the reduction of 
impulsivity, which may lead to a reduction in feelings of drug craving and in actual drug use. 
Both impulsivity and drug-seeking behavior are known to hamper treatment progress and are 
strongly linked to criminal behavior (Stevens et al., 2014). By reducing impulsivity, chances of 
successful treatment for SUD may increase, thereby decreasing the risk for relapse in drug use 
and reducing criminal behavior.
There are several important issues to consider that might influence the results. First of all, 
participants are not selected based on their level of impulsivity. Even though the most commonly 
observed disorders in the treatment facility are schizophrenia and personality disorder and both 
types of disorders are associated with increased impulsive behavior, not all suitable participants 
might show elevated levels of impulsivity. Studies have shown that although there is evidence 
that heightened impulsivity can be found across different types of substance use disorders, there 
is still substantial heterogeneity on impulsivity levels within these groups (Verdejo-Garcia et 
al., 2008). A recent study by Albein-Urios et al. (2014) found several subgroups of addicted 
individuals that exhibited different clinical presentation and most interesting, different severity 
levels of craving. In the study, a latent class analysis showed that greater impulsivity levels 
were associated with worse clinical outcomes, whereas conventional diagnostic groups showed 
no significant differences on outcome variables. Also, there have been studies that show that 
antisociality is actually associated with better impulse control, independent of extent of drug use 
(Vassileva, Gonzalez, Bechara, & Martin, 2007). To ensure a sufficient number of participants, 
inclusion criteria in this study are quite lenient, which may provide heterogeneity within this 
sample. Ideally, participants would have to present with the same diagnoses, same type of 
medication, etc, however, this would limit the number of available participants to such an extent 
that it will be hard to find any effects. The heterogeneity of the population makes it possible that 
an impulsivity-based neurofeedback protocol might not result in a reduction of craving and actual 
drug use.
Also, participants will be included who have tested positive for drug use in the past 24 months. 
This implies that there will also be participants whose substance use disorder is in early remission. 
Although substance abuse–related symptoms such as craving are known to persist even after drug 
use is terminated, this period of time might be too long for these participants to report any craving 
at the moment of the administered questionnaire.
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Chapter 4
The ability of forensic psychiatric patients with substance 
use disorder to learn neurofeedback
Abstract
Despite the increasing use of neurofeedback in clinical psychology, it is rarely used in forensic 
psychiatric settings. This study investigated whether forensic psychiatric patients (n=19) 
diagnosed with substance use disorder were able to learn to control EEG-activity based on a 
sensorimotor rhythm/theta neurofeedback protocol. Criteria for qualifying patients as responders 
were established and scores on impulsivity measures and changes in level of craving over time 
were assessed. Results indicated that one in five patients was able to consistently change the 
targeted frequency bands. All patients improved on self-reported impulsivity measures and 
levels of craving, but only levels of craving were associated with responding to neurofeedback 
treatment. Patients were more able to up-train the sensorimotor rhythm magnitude than to down-
train theta magnitude. Although these results are encouraging for some forensic patients, it is 
important to assess which patients will respond positively to the training and which will not. This 




Neurofeedback training is increasingly used in clinical psychology as a noninvasive treatment 
method. With neurofeedback training, patients learn to regulate aberrant electroencephalographic 
(EEG-)activity assumed to underlie the manifestation of clinical and behavioral symptoms of 
various disorders. Since neurofeedback training aims directly at changing basic neurophysiological 
brain functioning, it is less dependent on direct patient-therapist interaction than traditional 
psychotherapeutic interventions (Casher, 2013). Patients’ motivation and compliance for 
psychotherapy tends to be especially low in forensic psychiatric populations (O’Brien, & Daffern, 
2017; Ogloff, Wong, & Greenwood, 1990). Neurofeedback training might provide a promising 
alternative treatment option for this patient population. 
Forensic patients are often diagnosed with externalizing disorders characterized by lack of 
inhibitory control, such as Cluster B personality disorders, schizophrenia, and attention-deficit/ 
hyperactivity disorder (ADHD). In addition, about 70% of the forensic patients have a comorbid 
substance use disorder (Van Nieuwenhuizen, Bogaerts, Ruijter, Bonges, & Coppens, 2011). 
In substance use disorder (SUD), lack of inhibitory control is especially pronounced. Drug-
taking can be seen as a loss over control of drug-intake, despite the fact that people are usually 
aware of the negative consequences of their drug-use. Individuals with SUD show significantly 
higher score on various impulsivity measures, regardless of type of drug addiction (Fillmore 
& Rush, 2006; Nielsen et al., 2012). They show impaired response inhibition, which has often 
times already been observed in childhood and early adulthood (Hawkins, Catalano, & Miller, 
1992). Individuals who report higher levels of impulsivity also report more frequent and more 
severe symptoms of SUD, such as the level of experienced drug craving. Studies in patients 
with methamphetamine (Tziortzis, Mahoney, Kalechstein, Newton, & Garza, 2011) or cocaine 
addiction (Moeller et al., 2001), as well as alcohol dependency (Joos et al., 2013), have shown 
that patients who score higher on impulsivity report more severe levels of craving. 
For forensic psychiatric patients, the combination of SUD and comorbid major mental disorders 
also has a negative impact on treatment (Van Nieuwenhuizen et al., 2011), as high levels of 
impulsivity increase chances for relapse in substance abuse and treatment drop-out (Van der 
Veeken, Lucieer, & Bogaerts, 2016). Most likely, chronic substance abuse results in neurocognitive 
and neurophysiological changes, causing a structural state of reduced inhibitory control and high 
levels of impulsivity (Jentsch, & Taylor, 1999; Lyvers, 2000). Neurofeedback protocols aimed at 
enhancing the sensorimotor rhythm (SMR; 12-15 Hz) and reducing slower waves such as theta 
(3.5- 7.5 Hz) have shown promising results in reducing levels of impulsivity in (ADHD) (Fuchs 
et al., 2003). A reduction in levels of impulsivity through neurofeedback training could possibly 
also have a positive effect on SUD, as both impulsivity and SUD are characterized by a lack of 
inhibitory control (Tomko, Bountress, & Gray, 2016).
To our knowledge, neurofeedback training for forensic psychiatric patient populations with 
multiple externalizing disorders has not been performed so far. A possible explanation might be 
that comorbidity is often seen as a contra-indication to include patients in Randomized Controlled 
Trials (RCT’s) (Janssen et al., 2017; Mayer, Blume, Wyckoff, Brokmeier and Strehl, 2016; Mayer, 
Wyckoff, Schulz, & Strehl, 2012; Mohammadi, Malmir, Khaleghi, & Aminiorani, 2015; Moreno-
Garcia, Delgado-Pardo, Camacho-Vara de Rey, Meneres-Sancho, & Servera-Barcelo, 2015). 
Although neurofeedback training is increasingly applied in clinical populations, its effectiveness 
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is often solely described in terms of a reduction in behavioral and clinical symptoms (e.g., Bink, 
van Nieuwenhuizen, Popma, Bongers, & van Boxtel 2015). Results describing changes in deviant 
EEG-patterns due to neurofeedback training are often not reported. 
A necessary first step in showing that clinical improvements are actually linked to successful 
regulation of cortical activity, is to demonstrate that learning of EEG-regulation has occurred 
during neurofeedback training (Gruzelier, Egner, & Vernon, 2006; Zuberer, Brandeis, & Drechsler, 
2015). Previous research shows mixed results regarding the specific effects of neurofeedback 
training (e.g., Cortese et al., 2016; Zuberer et al., 2015), regardless of the applied neurofeedback 
protocol or the disorder for which the training was employed. Oftentimes, participants seem unable 
to learn to regulate the targeted cortical activity over the course of neurofeedback training. As an 
example, in a study among children diagnosed with ADHD, approximately 50% of participants 
were classified as so-called non-responders (Doehnert, Brandeis, Straub, Steinhausen, & 
Drechsler, 2008). Even in studies with non-clinical participants, responder rates tend to be quite 
low. Weber, Köberl, Frank and Doppelmayr (2011) trained non-clinical participants to increase 
SMR frequency through neurofeedback training. They found that only 43-54% of participants 
were able to consistently increase their SMR-frequency. 
Studies describing learning progress during neurofeedback training have also reported different 
patterns of participants regarding the adaptation of learning strategies, with large inter-individual 
variability in learning performance (Drechsler et al., 2007; Leins et al., 2007; Strehl et al., 
2006). Several studies (e.g., Bakhshayesh, Hänsch, Wyschkon, Rezai, & Esser, 2011; Lubar, 
Swartwood, Swartwood, & O’Donnell, 1995) report that participants showed positive learning 
curves at the beginning of a theta/beta neurofeedback training, followed by a stagnation in 
learning progress, again followed by a second learning curve at the end of the training sessions. 
This was similar to a Slow Cortical Potential (SCP) training protocol in a study by Mayer et al. 
(2016). The participants in this study showed a positive learning curve in the first few sessions, 
but then deteriorated and needed time to adapt strategies to deliberately control cortical activity. 
Inconsistent learning curves also add to the debate about the appropriate number of sessions 
required to see improvements, as studies vary significantly in the number of sessions (e.g., from 
10 in schizophrenic patients (Gruzelier, Hardman, Wild, & Zaman, 1999) to 35-50 in ADHD 
(Gevensleben et al., 2009; Heinrich, Gevensleben, Freisleder, Moll, & Rothenberger, 2004). It is 
plausible that the complexity of comorbidity can complicate the learning process to regulate and 
control cortical activity. 
This raises the question of (pre)conditions of neurofeedback training that must be met before 
starting an intervention among forensic psychiatric patients. Zoefel, Huster, and Herrmann 
(2010) have established three criteria that in their view any neurofeedback training should adhere 
to, in order to be valid: a) trainability: neurofeedback training should lead to effects in the trained 
frequency band b) independence: the training should not affect other frequency bands, and c) 
interpretability: frequency bands should be associated with certain cognitive functions to increase 
the probability of reliable behavioral effects. 
The current study focuses on the trainability and interpretability aspect of neurofeedback training 
in forensic psychiatric patients with SUD, and other comorbidities, such as personality disorders, 
ADHD and/or schizophrenia. It will investigate: a) to what extent this patient group is able to 
learn to regulate neurophysiological activity through a theta/SMR-neurofeedback training, b) to 
what extent changes in frequency bands are related to changes in their levels of impulsivity, and 
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c) to what extent a reduction in levels of impulsivity is related to a reduction in their SUD related 
behavior, such as reduced levels of craving for substances and actual drug intake. 
Methods 
This study is part of a RCT investigating the effects of neurofeedback training for impulsivity in 
a forensic psychiatric population with SUD (Fielenbach, Donkers, Spreen, & Bogaerts, 2017). 
Results of the RCT will be reported elsewhere. In this study, only outcomes for those patients 
who received neurofeedback training will be reported. The study was conducted according to the 
principles of the Declaration of Helsinki (version 59, Seoul, October 2008) and in accordance 
with the Medical Research Involving Human Subjects Act. It has been approved by the medical 
ethical council of Brabant, the Netherlands (study number NL46390.008.13). 
Participants 
Participants were 26 forensic psychiatric patients residing in a maximum-secured inpatient 
treatment facility situated in Groningen, the Netherlands. Patients in this treatment facility are 
convicted for a crime with a minimum penalty of at least four years according to Dutch jurisdiction. 
These patients are held to be only partially responsible for their behavior due to mental illness 
and are admitted to a forensic psychiatric center by order of the state (called Ter Beschikking 
Stelling (TBS), Van Nieuwenhuizen et al., 2011). All patients suffer from at least one DSM-IV-
TR disorder (American Psychiatric Association, 2000). Inclusion criteria for participants in this 
study consisted of at least one diagnosis of SUD according to DSM-IV-TR, and positive drug 
testing at the treatment facility in the past 24 months before the start of inclusion. Exclusion 
criteria were acute psychosis, acquired/congenital neurological brain disorders (e.g., epilepsy), 
and visual and/or auditory impairments, which would severely influence a patients’ ability to 
follow neurofeedback training. 
Patients were allowed to take medication during the study and clinical supervisors were asked 
to report pharmacological changes during the course of the training. Patients received 20 
neurofeedback sessions, lasting 40 minutes at a time, two times a week. Neurofeedback training 
was added to treatment as usual (TAU). TAU was different for every patient, but typically consisted 
of cognitive behavioral therapy, non-verbal therapy (such as music therapy or psychomotor 
therapy), and behavioral skills training. 
Before the start of the training, patients participated in pre-training measurements. After the last 
session, the same instruments were assessed again as post treatment-measurements. 
Sample characteristics
Descriptive statistics are given in Table 1. Out of 26 patients, 19 patients completed all sessions 
of neurofeedback training. Patients dropped out due to transfers to different treatment facilities 
(n=1) or lack of motivation for the training (n=6). Patients who did not complete the training were 
excluded from further analysis. Although neurofeedback sessions were originally planned to take 
place two times a week resulting in a duration of 10 weeks of training per patient, due to the 
special setting in which this study took place, the intervention lasted for an average of 16.8 weeks 
(range 11-25, SD=4.86). Interruptions were due to patients not feeling well enough to complete 
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a training session, aggressive incidents which resulted in temporary separation/placement on a 
specialized crisis unit, unplanned furlough of patients, and lack of motivation to attend training 
sessions. Mean number of months in treatment by the start of neurofeedback was 95.3 months 
(range 22-247, SD=61.32). The large standard deviation was due to one patient who had already 
spent 247 months in treatment. Patients had an average of 4.6 (range 2-8, SD=1.64) DSM-IV-TR 
axis I and axis II disorders. The most common diagnosis on axis I was schizophrenia (n=10), 
and Antisocial Personality Disorder (n=7) and Personality Disorder Not Otherwise specified 
(PDNOS) (n=7) on axis II. 
Measurements 
Electroencephalography. For pre- and post-training measurements, participants received a five-
minute resting state 21-channel eyes closed EEG measurement with Nexus-32 hardware and 
Biotrace+ software (Mind Media BV). The EEG was collected from 19 standard 10/20 positions 
(Herbert & Jasper, 1958), and the right and left mastoid with a sampling rate of 512 samples per 
second. The left mastoid served as the online reference. Flat type electrodes were placed above 
and below the left eye and at the outer canthi of each eye to be able to correct for vertical and 
horizontal eye movements. EEG magnitude across delta (0.5-3.5 Hz), theta (3.5-7.5 Hz), alpha 
(7.5-12 Hz), beta (12-20 Hz), SMR (12-15 Hz), high beta (20-32 Hz), and gamma (32-49 Hz) 
frequency bands was assessed. 
  
Barratt Impulsiveness Scale-11 (BIS-11). The Dutch version of the BIS-11 (Lijffijt, & Barratt, 
2005) is a self-report questionnaire designed to measure the behavioral and personality construct 
of impulsivity. It consists of 30 items and is scored on a four-point Likert scale ranging from 1 
(rarely/never) to 4 (almost always/ always). The total score can be subdivided in three second-
order factors: attentional, motor, and nonplanning. The BIS-11 has been shown to be an internally 
consistent measure of impulsivity among inmate populations (Cronbach’s α=.80) (Patton, 
Stanford, & Barratt, 1995).  
 
Modified Desire for Alcohol Questionnaire -Short Form (DAQ-SF). The Dutch version of the 
DAQ-SF (Franken, Rosso, & Honk, 2003) is a self-report questionnaire measuring the craving for 
alcohol at the moment of assessment. The short form of the DAQ consists of 14 items scored on a 
seven-point Likert scale, ranging from 1 (strongly disagree) to 7 (strongly agree). The DAQ-SF has 
shown to be a reliable measure to assess craving in a substance-dependent population (Cronbach’s 
α=.70) (Courtney et al., 2013). All questions in the original version are designed to measure craving 
for alcohol, however, as the aim of this study was to measure craving for drugs in general, the word 
alcohol has been replaced by the word drugs. Patients were instructed to focus on their preferred 
drug of choice and indicate the level of experienced craving on the questionnaire. An extra written 
instruction was given, indicating that ‘drugs’ can refer to alcohol as well as soft- and hard drugs.  
 
Substance abuse. To score substance abuse, the item ‘substance abuse’ on the risk assessment 
scale ‘Historische, Klinische, Toekomst- Revised (HKT-R) (Historical, Clinical, Future-Revised) 
was used (Spreen, Brand, Ter Horst, & Bogaerts, 2014). The HKT-R is a clinical risk assessment 
instrument which was validated in a nation-wide population of forensic psychiatric patients 
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(Bogaerts, Spreen, Ter Horst, & Gerlsma, 2018). This item is scored on a five-point scale ranging 
from 0 to 4. The items are scored as follows: 0- no drug use whatsoever, 1- the patient did not test 
positive for drug use, but did not cooperate with drug testing, 2- the patient had one positive drug 
testing, and might have also failed to cooperate with drug testing, 3- the patient tested positive for 
drug use at least twice, but did not refuse to cooperate with drug testing, and 4 – the patient tested 
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 Sample Index offenses
N
*1 Pervasive developmental disorder: Autism, Aspergers disorder, developmental disorder not otherwise 
specified; *2 ADHD: All types of attention-deficit disorder; Index offense: In case of more than one index 
offense, the most serious one is reported, based on Nieuwenhuizen et al. (2011).
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positive at least twice and also refused to undergo drug testing. The questionnaire differentiates 
between type of drug (‘Soft drugs’, ‘Hard drugs’, ‘Alcohol’ and ‘Other’ ), and the item is scored 
on a five-point scale for each type of drug. The highest score on any of the different type of drugs 
is considered the final score. To score this item, results of regular drug testing as part of treatment 
facility policy were used. Positive drug testing is operationalized as any analysis testing positive 
for either marijuana, and/or psychostimulant/opioid drugs, and/or alcohol. Corresponding with 
treatment facility policy, non-prescribed medication that is used as recreational drug consumption 
such as inhaled Methylphenidate (e.g., Ritalin or Concerta), was also scored as a positive drug 
test, as well as refusal to undergo drug-testing. This item was scored weekly for the ten weeks 
prior to pre-training measurements, and for ten weeks after post-training measurements. 
Cued Go/No-Go reaction time task. The cued Go/No-Go reaction time task is a measure of 
impulse control. It is a continuous performance task measuring the ability to inhibit a prepotent 
response (Fillmore, 2003). Participants sit in front of a computer, where blue and green squares 
are presented in five rounds with a short break in between. A total of 250 targets appear on the 
screen. Participants are asked to react as fast as possible to a green square but are instructed 
to inhibit a response when a blue square appears. A go or no-go cue appears before the target, 
indicating the likelihood of a green or blue target. The likelihood of a correct target is manipulated 
so that in 80% of the time the cue provides correct information and in 20% an incorrect cue is 
presented. Cues are presented with a fixed stimulus-onset interval (SOA) of 100, 200, 300 or 
400 ms. Outcome measures are the number of commission errors, reflecting the failure to inhibit 
responses to no-go targets. The cued Go/No-Go reaction time task has been shown to be a valid 
measure of impulse control in a substance abusing population (Fillmore, 2003). 
Intervention: Neurofeedback 
A standard SMR-enhancement protocol was used, where SMR (12-15 Hz) was up-trained and 
theta (3.5-7.5 Hz) was down-trained (i.e., inhibited). If excess high beta (20-32 Hz) or delta (0.5-
3.5 Hz) was detected, these frequency bands were inhibited as well, with a maximum of three 
frequency bands being trained in each session. Feedback training was performed on the EEG 
signal recorded from electrode position Cz against a right ear mastoid reference. Neurofeedback 
was applied as implemented in the Brainmarker software engine (BrainMarker Device, 
Brainmarker BV Gulpen). Every training session consisted of a number of feedback rounds, in 
which patients had to learn to control simple video-games by increasing and inhibiting the EEG 
signal in the desired frequency bands. Each round of video-game neurofeedback training lasted 
60 seconds at a time with a short break in between rounds. Besides video-game based feedback, 
movie-based feedback was also given. Here, participants had to keep the monitor screen free 
from black curtains appearing over the displayed movie, resembling training parameter activity. 
Movie-based feedback lasted 90 seconds per round. Patients received positive feedback once a 
frequency band was maintained above or below a threshold for 80% of the time, depending on 
the frequency band that was enhanced or inhibited. Feedback thresholds were adjusted manually, 
based on how successful a patient was in regulating EEG-activity. During treatment sessions, 
patients were continuously encouraged to try their best and engage in the training. Positive verbal 
reinforcement was used whenever patients met feedback thresholds. 
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Data processing
As for the analysis of neurofeedback sessions, the last session (session 20) was excluded from 
the analysis. This session was usually combined with post-training measurements and therefore 
shorter in duration than the other sessions. Hence, data from session 1-19 were used for final 
analysis. 
For each session of neurofeedback, standardized values for all frequency bands were calculated 
for every round of training. Absolute magnitude values at Cz were calculated per round of 
neurofeedback within the Brainmarker software and subsequently exported into SPSS. Magnitude 
values for frequency bands delta (0.5-3.5 Hz), theta (3.5-7.5 Hz), alpha (7.5-12 Hz), SMR (12-
15 Hz), beta1 (12-18 Hz), beta2 (18-22 Hz), and gamma (22-30 Hz) were calculated. As the 
neurofeedback protocol consisted of up-training SMR magnitude while down-training theta 
magnitude, subsequent analysis focused on SMR and theta magnitude changes across sessions. 
Training rounds in which magnitude values differed more than two standard deviations from the 
mean were excluded, as these rounds were most likely influenced by artifacts due to eye blinking 
and/or movement. The resulting artifact free data were averaged, resulting in a mean and median 
magnitude per frequency band for each session. 
Next, the total number of neurofeedback sessions was divided into time periods (TP). As Weber 
et al. (2011) argue, due to the high individual variability, no single session median value should 
be used for analysis, but median magnitudes across three consecutive sessions can be calculated 
as a so-called time period (e.g., TP2 is the median value of session two, three and four). As the 
analysis consisted of 19 sessions, 17 TP’s were created. The median of SMR and theta magnitude 
of each TP was calculated. Before beginning of the actual training, a one-minute baseline EEG 
measurement with eyes-closed and eyes-open was performed. However, as cognitive demands 
required by neurofeedback tasks are quite different from an eyes-open or eyes-closed resting 
state, it can be argued that these measures do not reflect patients’ baseline median frequency 
magnitudes adequately. Therefore, TP1 (consisting of the median value of sessions one, two and 
three) was chosen to serve as the baseline. 
Criteria for establishing neurofeedback responders vs non-responders
This study adapted part of the criteria set out in the study by Weber et al. (2011) for the definition 
of (non-) responders. They argued that, for responders, a) EEG magnitudes should change in 
the desired direction during all training sessions, resulting in a positive mean magnitude change 
across all sessions, and b) the increase of mean percentage of EEG magnitude during the training 
should exceed 8% by the end of training as compared to the baseline state. The increase of 8% or 
higher given by Weber et al. (2011) was based on their clinical experience, where less than half 
of the subjects were able to gain a 10% increase in the investigated frequency band. However, 
since Weber’s et al. developed these criteria based on non-clinical participants, it can be expected 
that forensic patients have more difficulties in learning to regulate cortical activity and may not 
achieve magnitude changes in the desired direction during every single session. Therefore, these 
criteria were somewhat adjusted to fit the population of this study. The definition of neurofeedback 
responders for this study was as follows: 
1. Mean magnitudes of theta and SMR should change in the desired direction for 60% of all 
training sessions. In this study, 19 sessions of neurofeedback training were used for analysis, 
resulting in a minimum of 11.4 sessions (we will use 11 sessions). As the neurofeedback protocol 
applied consisted of downtraining theta while simultaneously uptraining SMR frequency, in order 
to be qualified as neurofeedback responders, patients had to show a change in both frequency 
bands during at least eleven sessions. To test for possible differences between frequency bands 
(e.g., that patients find the regulation of one frequency band easier than regulation of the other), 
number of sessions in which only SMR magnitude increased were investigated separately, as 
were training sessions in which only theta magnitude decreased.
2. Overall, participants had to show an average change in EEG magnitude of 8% in the desired 
direction (increase of SMR/decrease of theta) by the end of the training as compared to baseline. 
This criterion proposed by Weber et al. (2011) was not adjusted for the current patient population, 
as it can be argued that an average change in EEG magnitude of less than 8% might not be 
clinically relevant anymore.
In order for patients to be qualified as neurofeedback responders, both criteria had to be met. Next, 
percentage increase/decrease of median values for each TP relative to baseline was calculated, as 
well as average increase/decrease over all time periods. 
Statistical analysis
To test for changes between pre- and post-training, a Wilcoxon signed-ranks test was performed 
for behavioral measures DAQ-SF, BIS-11, and Cued Go/No-Go reaction time task. 
Multiple linear regression analyses were performed to investigate whether successful regulation 
of frequency bands could predict changes in the dependent variables BIS-11, DAQ-SF, and 
commission errors on the cued Go/No-Go reaction time task. For each behavioral measure, two 
regression models were computed. In the first model, the post-training score was predicted by 
the pretraining score to determine the percentage of variance of the post-training score that was 
already explained by the pretraining score. In the second model, the successful regulation of SMR 
and theta magnitude for 11 or more sessions, the average increase of SMR magnitude and the 
average decrease of theta magnitude were added subsequently and evaluated by a partial F-test 
to statistically decide whether this addition contributed significantly to the increase in explained 
variance. 
To test for changes in actual drug use, scoring of the item ‘substance abuse’ of the HKT-R was 
averaged for the weeks prior to training and the weeks after the training. A paired-sample t-test 
was performed to test for changes in drug use. 
Spearman’s rho correlations were performed to assess whether the number of times patients 
successfully achieved up- or down-regulation in the desired direction was correlated with the 
height of average increase or decrease in the frequency band. Spearman correlations were also 
calculated for outcomes on BIS-11, DAQ-SF, amount of commission errors on the Cued Go/No-
Go reaction time task and performance during neurofeedback. 




Results with regard to responding vs non-responding to neurofeedback training were analyzed in 
multiple ways. Results are given in Table 2. 
1. The first criterion for being a neurofeedback responder stated that the patient showed magnitude 
changes in the desired direction of frequency bands for at least 60% of the 19 sessions, resulting in 
magnitude changes during a minimum of 11 sessions. When inspecting sessions in which patients 
successfully decreased theta magnitude while also simultaneously increasing SMR magnitude, 
only 4 out of 19 patients (21%) were able to do so for 11 or more sessions. So, according to 
criterion one, only 4 out of 19 patients could be qualified as a neurofeedback responder. 
To test for differences between frequency bands, sessions in which only theta magnitude changed 
or only SMR magnitude changed, were also investigated. When inspecting mean decrease in 
theta magnitude, 7 out of 19 (37%) patients were able to decrease their theta magnitude during 
11 sessions or more. For increases in SMR magnitude, 12 out of 19 (63%) patients managed to 
consistently increase SMR magnitude in 11 or more sessions. 
2. The second criterion for establishing neurofeedback responding stated that, next to an magni-
tude change in the desired direction for 11 or more sessions, the average magnitude change had 
to exceed 8%. When inspecting magnitude change in the SMR frequency over all sessions, all 
4 responders showing magnitude changes in the desired direction achieved an average increase 
Table 2. Achieved treatment success in frequency bands and average increase/decrease in frequency bands 
over time periods per patient (N = 19).
 1 4 6 0 -4.8 1.5
 2 15  1 0 2.3 5.5
 3 0 0 0 -5.3 5.1
 4 5 3 0 -2.9 2.5
 5 6 0 0 -2.0 12.9
 6 0 16 0 -24.0 -12.1
 7 7 0 0 -1.8 10.3
 8 17 0 0 18.4 13.7
 9 3 5 0 -3.1 8.0
 10 17 6 5 13.5 4.1
 11 16 14 10 4.7 -11.9
 12 12 11 6 2.3 -1.3
 13 17 8 8 19.1 -.73
 14 17 6 5 15.4 1.8
 15* 17 16 16 12.2 -8.5
 16* 15 16 14 15.3 -11.4
 17* 17 15 15 9.5 -8.7
 18* 17 15 14 26.0 -6.7
 19 17 5 4 19.0 1.4

















in SMR magnitude of 8% or higher (range 10%-26%). For theta, 3 of 4 responders showed an 
average magnitude decrease of 8% or more (range 8%-11%). 
Average increase in SMR magnitude of 8% or higher (range 13%-19%) could also be observed 
for patients who did not manage to simultaneously decrease theta magnitude for 11 or more 
sessions, but who still managed to increase only SMR magnitude for 11 or more times (n=7), 
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Mean decrease theta in % for responders Mean decrease in % theta for non-responders
Figure 2. Percentage of theta amplitude change in % for TP 2 - TP 17 for responders versus non-responders. 
Figure 1 .Percentage of SMR amplitude change in % for TP 2 - TP 17 for responders versus non-responders. 
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except for two patients. For theta magnitude, this was the case for only two patients. 
Patients that could not be classified as a responder seemed unable to learn to regulate the targeted 
EEG-frequencies in the required direction. About a third of the patients (6 out of 19 patients (32 
%)) showed an increase in magnitude where a decrease was desired, and/or vice versa. 
Responders showed a steeper learning curve of SMR magnitude increase than non-responders. 
For theta magnitude, only responders showed a stepwise decrease in theta magnitude while theta 
magnitude of non-responders fluctuated but remained flat over all 17 TP’s. 
Figures 1 and 2 show the mean increase in SMR and theta magnitude for responders and non-
responders over all 17 TP’s. Responders showed a steeper learning curve of SMR magnitude 
increase than non-responders. For theta magnitude, only responders showed a stepwise decrease 
in theta magnitude while theta magnitude of non-responders fluctuated but remained flat over all 
17 TP’s.
Spearman’s rho correlations between number of times patients successfully achieved up- or 
downregulation in the desired direction and height of average increase or decrease in the 
frequency band was significant at the α<0.01 level in a single frequency (either theta or SMR) 
(theta: r=-.972, p<.01; SMR: r=.924, p<.01), as well as for the number of times SMR and theta 
were successfully regulated simultaneously (number of times SMR and theta were regulated 
simultaneously and average success SMR r=.619, p<.005, number of times SMR and theta were 
regulated simultaneously and average success theta r=-.697, p<.001) for the total patient group.
Behavioral measures 
A Wilcoxon Signed-ranks test indicated that results on the BIS-11 and DAQ-SF were significantly 
lower post-training (BIS-11: Z=-2.2, p<0.05, r=-.5; DAQ-SF: Z=1.982, p<0.05, r=.45) for the 
whole group of patients. Commission errors on the Cued Go/No-Go task did not show significant 
changes between pre and post-training (Z=-.6, p>0.05, r=-.14). 
A paired sample t-test showed that there was a significant difference (p<0.05) in degree of 
positive drug testing post-training (M=.29, SD=.43), indicating a decrease in positive drug testing 
post-training. 
Table 3. Multiple regression with results of DAQ-SF post-treatment as dependent variable in model 1, and the 
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18.27
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R2 Model 1 = .28 
R2 Model 2 = .46; Fpart = .04
Note: The t-test in model 2 is identical to the partial F-test, as there is only one variable added as compared 
to model 1.
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Table 3. Multiple regres ion with results of DAQ-SF post-treatment as dependent variable in model 1, and the 
average increase of SMR amplitude as predictor in model 2 (N=19).
Separate multiple linear regression analyses were performed to investigate results on DAQ-SF, 
BIS-11, and number of commission errors post-training based on various responding criteria. 
Only significant results are reported, see Table 3 for results. 
Discussion
To the best of our knowledge, this is the first study that employed an theta/SMR frequency 
neurofeedback protocol in forensic psychiatric patients with SUD and co-morbidities. It was 
investigated whether this complex group of patients is actually able to consistently regulate 
SMR and theta frequency band activity during a 20 session neurofeedback training and whether 
changes in these frequency bands were related to changes in level of impulsivity, craving, and 
actual drug use.
Patients were categorized as responders when they showed both a successful upregulation of 
SMR magnitude and a successful downregulation of theta magnitude during at least 11 out of 19 
sessions and showed an average increase/decrease in the desired direction of 8% or higher. Despite 
the fact that personality measures of impulsivity, level of craving for addictive substances, and 
degree of positive drug testing were significantly lower post-training than pre-training on a group 
level, only 4 out of 19 patients (21%) could be categorized as a responder to the neurofeedback 
training. The low number of patients who achieved a responder status was mainly due to the low 
number of patients who managed to consistently decrease theta, as the number of times patients 
successfully achieved up-training of SMR magnitude was much higher. Subsequent analysis 
showed that the ability to consistently train frequency bands in the desired direction was not 
related to scores on impulsivity measures post-training. Levels of craving post-training could 
partially be explained by whether patients could be categorized as responders, but were only 
related to the increase in SMR frequency and not to a decrease in theta frequency. 
Zuberer et al. (2015) differentiate between ‘EEG-learning’ (comparable to the trainability criterion 
by Zoefel et al., 2011) and ‘EEG-training response’. EEG-learning refers to the improvement in 
a targeted cortical training parameter in the desired direction, whereas ‘EEG-training response’ 
refers to any change in neurophysiological parameters due to neurofeedback training. The 
results of the current study showed that although all patients showed an EEG-training response, 
only a fifth of patients showed EEG-learning. This can be considered quite a low number. The 
difficulties patients seem to experience in downregulating theta as opposed to upregulating SMR 
activity have been observed in studies with other populations as well. Doppelmayr and Weber 
(2011) showed that non-clinical individuals were able to increase SMR frequency over the course 
of training, but failed to decrease the theta/beta ratio. Janssen et al. (2017) employed a theta/beta 
neurofeedback protocol in children with ADHD, and found theta to remain unchanged during 
the course of training when inspecting results on a group level, whereas a linear increase was 
observed for beta activity. However, when investigating individual learning curves in the study 
by Janssen et al. (2017), the number of participants that could be qualified as responders was 
much higher than that in the current study: 39% of participants could be qualified a responders 
with regard to theta, and 53% of participants could be qualified as responders with regard to 
beta. Research on which patients will be able to benefit from neurofeedback training in terms of 
EEG-training response is still in its infancy. Therefore, no adequate comparisons can be made 
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with regard to whether 21% of participants is a good representation of EEG-learning abilities in 
the current patient population. Janssen et al. (2017) also investigated individual learning curves 
of participants and found that 18% of participants displayed a change of theta in the opposite 
direction over the course of training whereas only 8% of patients showed a change of beta in 
the opposite direction. In the current study sample, the number of participants showing learning 
curves in the opposite of the intended direction was also much higher: 58% of patients actually 
increased their theta magnitude as opposed to decreasing it, whereas 36% patients decreased 
SMR as opposed to increasing it. With only one in five patients being able to achieve EEG-
learning, it is questionable whether this intervention will actually be able to lead to clinically 
significant improvements for a sufficient number of patients.
Several studies have suggested that training outcomes might depend on the number of frequency 
bands trained, with a negative correlation between the number of trained frequency bands and 
training success (Rogala et al., 2016). Especially when EEG-frequency bands are adjoining and 
effects in one frequency might be susceptible to training effects in another frequency band, this 
could pose a problem. However, SMR and theta frequency bands seem sufficiently far separated 
from one another to prevent that upregulation in one band is cancelled out by the down-regulation 
of the other. It might be possible, however, that for this specific patient population, the training 
of two frequency bands simultaneously is just too difficult. Future studies with this patient 
population might benefit from neurofeedback training that is focused solely on enhancing SMR 
frequency, since improvements on craving measures in this study were related to an increase in 
SMR magnitude specifically. 
Another possible explanation for the low number of responders might be the fact that patients 
were allowed to continue using prescription medication during the course of the study. It can be 
considered unethical to ask patients to stop taking medication for the sake of an intervention for 
which efficacy is not yet established. However, to date, the effects of medication on the trainability 
of EEG-frequency bands are unclear. It is possible that the effects of medication might ‘overrule’ 
training effects of neurofeedback. Previous research has shown that stimulant medication can 
produce a normalization of relative power in the theta band frequency in the resting-state EEG of 
patients with ADHD (Clarke et al., 2003). It is possible that patients with this type of medication 
might not be able to further normalize theta frequency through neurofeedback. Nonetheless, even 
if stimulant medication prevents patients from further decreasing their theta-frequency power, 
additional research is needed to investigate why more than half of the patients in the current study 
increased their theta frequency when the neurofeedback protocol was aimed at decreasing it.
Future studies need to assess the specific effects of neurofeedback training on the modulation of other 
EEG-frequency bands in forensic patients, as well as the necessary number of sessions to achieve 
optimal clinical results. It is possible that more patients would have been classified as responders if 
more than 20 training sessions had been applied. Strehl et al. (2006) argue that it is not a necessity 
for participants to show a positive learning curve over each individual session, as some participants 
might not find an optimal strategy until the end of the training. At the same time, it is of great 
importance to be able to predict as early as possible in the process which patients will be able to 
benefit from neurofeedback and which will not. Especially for vulnerable patient populations like 
forensic psychiatric patients, who are already difficult to engage in therapy as it is, it is important to be 
able to decide as quickly as possible whether they are likely to benefit from a neurofeedback training 
in order to not burden them with a therapy modality that they might not be able to benefit from. 
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Limitations
This study did not investigate within-session learning curves of patients. This makes it difficult 
to interpret results in terms of whether patients were actually able to regulate frequency bands 
within each session, and to draw conclusions on whether other mechanisms are involved that lead 
to the consolidation of cortical changes across sessions. Furthermore, it is important to note that, 
although 21% of patients did show neurofeedback training responses in the desired direction and, 
as a group, improved on self-report measures of impulsivity and levels of craving, the lack of a 
sham neurofeedback condition makes it difficult to rule out the possibility of a placebo effect. 
Furthermore, although participants were continuously encouraged to try their best and engage in 
neurofeedback training, it cannot be ruled out that some patients were not trying as hard as others. 
This is a general problem with neurofeedback training. There is no way to be absolutely certain 
that a patient really does focus on the training, or is just pretending to do so. In the current study, 
patients in the treatment facility did not receive more privileges due to participating in the study, 
and it can be argued that it is too hard and possibly too boring to just sit and stare at the monitor 
for twenty neurofeedback sessions. Seven patients dropped out during the course of the study, of 
which six patients dropped out due to lack of motivation. However, given that patients did receive 
a financial reward for participation, it is possible that some patients pretended to engage in the 
training in order to receive a financial compensation. This could be tackled by the use of a sham 
neurofeedback condition in future studies. 
Another limitation is the use of a modified version of the DAQ-SF. While the DAQ-SF itself has 
good reliability, the modification made to the questionnaire may have influenced the validity and 
reliability of the questionnaire to some extent. 
Another limitation concerns the way the HKT-item ‘substance abuse’ has been assessed. While 
the questionnaire differentiates between types of drugs (‘Soft drugs’, ‘Hard drugs’, ‘Alcohol’ and 
‘Other’), the scoring itself does not, as the scoring is based on the highest score given for any 
of the different types of drugs used. Therefore, the questionnaire is not able to detect changes in 
type of drug used. In SUD, substance abuse often times is not limited to one specific type of drug, 
but in many cases concerns polydrug abuse. It can be argued that a patient’s efforts to refrain 
from using hard drugs such as cocaine is a huge step in the recovery process, even though certain 
type(s) of soft drugs such as marijuana are still used. With the questionnaire employed in this 
study, this type of change could not be assessed. 
Conclusion
In conclusion, the trainability aspect of an theta/SMR neurofeedback training for forensic 
psychiatric offenders with SUD could partially be validated, as 21% of patients were able to 
regulate cortical activity in the desired direction. This study shows the importance of intervention 
sensitivity and assessment of responders and non-responders to the applied neurofeedback 
protocol. Additional research is needed to examine possible placebo effects of neurofeedback 
training and to establish criteria that can predict within a few neurofeedback sessions which 
patients will likely be able to benefit from neurofeedback and which patients will most likely not 
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Abstract
Forensic psychiatric patients are often diagnosed with psychiatric disorders characterized by high 
levels of impulsivity, as well as comorbid substance use disorders (SUD). The combination of 
psychiatric disorders and SUD increases the risk of future violence. Chronic substance abuse 
can lead to a structural state of disinhibition, resulting in more drug taking and eventually loss of 
control over drug intake. When treating SUD, it is crucial to address high levels of impulsivity 
and lack of inhibitory control. The current study set out to investigate the effects of a theta/
sensorimotor rhythm (SMR) neurofeedback training protocol on levels of impulsivity, levels of 
drug craving and actual drug intake in a population of forensic psychiatric patients with a diagnosis 
of SUD. 21 participants received 20 sessions of theta/SMR neurofeedback training in combination 
with treatment as usual (TAU). Results were compared to 21 participants who received TAU 
only. SMR magnitude showed a significant (p=.02) increase post-training for patients in the 
neurofeedback training group, whereas theta magnitude did not change (p>.05). Levels of drug 
craving, as well as scores on the ‘motor’ subscale of the BIS-11 decreased equally for patients 
in the neurofeedback training group and the TAU group. Other measures of impulsivity, as well 
as drug intake, did not change post-treatment (p>.05). Therefore, neurofeedback + TAU was not 
more effective than TAU only. The current study demonstrated evidence that forensic psychiatric 
patients are able to increase SMR magnitude over the course of neurofeedback training. However, 
at the group level, the increase in SMR activity was not related to any of the included impulsivity 
or drug craving measures. Further research should focus on which patients will be able to benefit 
from neurofeedback training at an early stage of the employed training sessions. 
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Introduction
Forensic psychiatric patients are often times diagnosed with disorders characterized by high 
levels of impulsivity. Schizophrenia, attention-deficit hyperactivity disorder (ADHD) and cluster 
B personality disorders are the most common disorder in forensic psychiatric patients (Schuringa, 
Heininga, Spreen, & Bogaerts, 2018; Simpson, Grimbos, Chan, & Penny, 2015). Substance use 
disorder (SUD) is a common comorbidity, occurring in a about 55-70% of all patients (Simpson 
et al., 205; Van Nieuwenhuizen, Bogaerts, Ruijter, Bonges, & Coppens, 2011).
Individuals abusing alcohol, stimulants and opioids tend to have higher levels of impulsivity as 
compared to non-abusing controls (Loree, Lundahl, & Ledgerwood, 2015). Furthermore, impul-
sivity is a risk factor for the development and maintenance of SUD (Hawinks, Catalano, & Miller, 
1992; Charney, Zikos, & Gill, 2010). Chronic substance abuse can cause a structural state of 
disinhibition over time, leading to permanent excessive abuse of substances (Jentsch & Taylor, 1999; 
Lyvers, 2000; Crews & Boettiger, 2009). This state is not limited to the acute stages of substance 
dependency, but is also present in patients after stopping regular drug intake (Roozen, van der Kroft, 
van Marle, & Franken, 2011). Elevated levels of impulsivity are also associated with more severe 
symptoms of SUD, that eventually lead to higher levels of drug craving (Bornovalova, Levy, Gratz, 
& Lejuez, 2010). Once patients receive substance-abuse treatment, high levels of impulsivity can 
increase chances of early relapse and premature termination of treatment (Charney et al., 2010; 
Roozen et al., 2011). For forensic psychiatric patients, substance use is highly associated with the 
use of violence, regardless of the type of drug used (e.g., (Boles & Miotto, 2003; Alniak, Erkiran, & 
Mutlu, 2016; Dugré, Dallazizzo, Giguère, Potvin, & Dumais, 2017). 
Important in the treatment of forensic patients with SUD is to determine levels of impulsivity and 
lack of inhibitory control. In accordance with this, common psychotherapeutic approaches for 
SUD involve the adaptation of strategies that promote conscious decision making, attention to 
action and control over behavior (Crews & Boettiger, 2009). Despite that, relapse rates following 
remission of treated SUD individuals are as high as 60% (Marissen, Franken, Blanken, van den 
Brink, & Hendriks, 2009), stressing the need for additional interventions. 
In the last two decades, electroencephalographic (EEG-)neurofeedback training has shown 
promising results in reducing high levels of impulsivity in patients suffering from ADHD (Zuberer, 
Brandeis, & Drechsler, 2015; Fuchs, Birbaumer, Lutzenberger, Gruzelier, & Kaiser, 2003; Arns, 
Drinkenburg, & Kenemans, 2012). Neurofeedback training uses real-time EEG measurements 
and displays this information back to the patient (Sokhadze, Stewart, Tasman, Daniels, & Trudeau, 
2011). EEG-neurofeedback training works by enhancing or inhibiting brain frequencies that have 
shown to underlie abnormal psychological states (Gunckelman, & Jonhstone, 2005). An often 
used neurofeedback protocol to train impulse control is the so-called theta (3.5 Hz- 7.5 Hz)/
sensorimotor rhythm (SMR, 12-15 Hz) protocol (e.g., Fuchs et al., Rossiter & LaVaque, 1995; 
Monastra, Lynn, Linden, Lubar, Gruzelier, & LaVaque, 2005). In this protocol, the magnitude of 
the SMR frequency is enhanced, while the magnitude of the theta frequency is inhibited. 
However, the effectiveness of a theta/SMR based neurofeedback protocol on levels of impulsivity 
and also on symptoms of SUD, such as levels of craving and actual drug use in forensic psychiatric 
patients is unclear. Only a few studies have investigated the effects of neurofeedback training in 
forensic psychiatric patients (e.g., Konicar et al., 2015; Martin & Johnson, 2005; Smith & Sams, 
2005; Quirk, 1995). Therefore, investigating effectiveness of neurofeedback training can add 
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value to treatment models that are currently used for this group, such as classical psychotherapy 
and pharmacological treatment. 
The primary objective of the current study was to examine to what extent a theta/SMR based 
neurofeedback training results in the reduction of impulsivity, drug craving and actual drug use 
in a population of forensic psychiatric patients with a diagnosis of SUD. Patients participated 
in 20 sessions of a theta/SMR neurofeedback training protocol in addition to treatment as usual 
(TAU). Levels of impulsivity, as measured with the Barratt impulsivity Scale-11 (BIS-11) (Lijffijt 
& Baratt, 2005) and a cued Go/No-Go reaction time task (Fillmore, 2003) were assessed. Levels 
of drug craving were measured with a modified version of the Desire for alcohol questionnaire 
(DAQ-SF) (Franken, Rosso, van Honk, 2003). Actual drug intake was assessed with urine or 
breathalyzer drug testing. Results on primary outcome measures were compared to patients from 
a control group who received TAU only. We hypothesized that patients receiving neurofeedback 
training + TAU would show reduced levels of impulsivity post-training, as well as a reduced 
levels of drug craving and drug use in comparison to patients receiving TAU only. 
Method
Study design and participants
This study reports the results from a randomized controlled trial (RCT) as described in (Fielenbach, 
Donkers, Spreen, & Bogaerts, 2017). The results of the n-of-1 clinical case series are reported in 
Fielenbach, Donkers, Spreen, Smit, & Bogaerts (under review). 
The study took place in a maximum security inpatient forensic psychiatric center (FPC) in 
Groningen, the Netherlands. All patients in this treatment facility are male criminal offenders, who 
were held only partially responsible for the crime they committed due to severe mental illness, 
according to Dutch jurisdiction (van Marle, 2002). Inclusion criteria were the presence of at 
least one DSM-IV-TR (American Psychiatric Association, 2000) diagnosis of SUD, positive drug 
testing in the past 24 months before inclusion, and sufficient knowledge of the Dutch language to 
understand training instructions. All patients had at least one comorbid axis I and/or II diagnosis. 
Exclusion criteria were a state of acute psychosis, in which patients experienced severe delusions 
and/or hallucinations and could possible become a threat to themselves or others (a diagnosis of 
schizophrenia, as well as disorders in the schizophrenia spectrum (e.g., schizoaffective disorder) 
were not considered exclusion criteria). A comorbid diagnosis of epilepsy; and visual and/or 
auditory impairments, which would hamper patients’ ability to follow instructions and adhere 
to the neurofeedback training were also exclusion criteria. Medication intake was not restricted. 
Patients were allowed to continue the use of medication over the course of the study. Treatment 
supervisors were informed that, during the course of the study, prescribed medication should 
preferably remain stable, and that a change in type as well as dosage of medication should not 
be made during the course of the study unless absolutely necessary. Treatment supervisors were 
asked to inform researchers in case a change in type or dosage of medication did occur. 
This study was conducted according to the principles of the Declaration of Helsinki (version 59, 
Seoul, October 2008) and in accordance with the Medical Research Involving Human Subjects 




In this study, a pre-post-test design was used. A power analysis calculation for the RCT, using 
G*Power 3 based on a 1-tailed alpha value of .05, a power value of 0.80, and an effect size (f) of 
0.80 yielded a recommended sample size of 21 participants each in the control and intervention 
conditions. 
Out of all participants that met the requirements, a random sample was drawn and randomly 
assigned to one of the two study conditions (neurofeedback training + TAU or TAU only). Patients 
were approached through treatment supervisors for participation and informed about the general 
outline of the study. If they expressed interest in participating in the study, they were approached 
by one of the researchers to explain the study design and randomization procedure. All patients 
signed the informed consent. Randomization was done by a random number generator. See 
Figure 1 for an overview of patient flow through the study. 
Participants in both conditions underwent pre-treatment measurements (T0), consisting of the 
measurements described below. Participants in the control group received TAU only. TAU 
was different for every patient, as treatment modalities are based on individual diagnosis and 
problematic behavior of the patient, as well as the cognitive ability to undergo different treatment 
modalities. Examples of treatment modalities were non-verbal therapy forms (e.g., psychomotor 
therapy, musical therapy) and cognitive-behavioral group therapy. After 10 weeks, participants 
in the control group underwent post-treatment measurements (T1), identical to pre-treatment 
measurements. 
Once pre-treatment measures were completed, participants in the intervention group started the 
neurofeedback training. They received 20 neurofeedback training sessions, scheduled two times 
a week for 10 weeks. Neurofeedback training was done by a certified neurofeedback therapist. 
The study was not blinded, as it was clear to patients as well as the neurofeedback therapist which 
patients received the neurofeedback training. 
Participants received a small financial compensation comparable to minimum wage in the 
treatment facility for participation. 
Neurofeedback training protocol
For neurofeedback training, electrode Cz was used as the feedback electrode recorded with Ag/
AgCl electrodes against a right ear mastoid reference and a FPz ground electrode. Neurofeedback 
was applied as implemented in the Brainmarker software engine (BrainMarker Device, 
Brainmarker BV Gulpen). A theta/SMR protocol was used, in which SMR (12-15 Hz) should 
be enhanced and theta (3.5-7.5 Hz) should be inhibited. If excess high beta (20-32 Hz) or delta 
(0.5-3.5 Hz) was detected, these frequency bands were inhibited as well, with a maximum of 
three frequency bands being trained in each session. Patients were shown simple video-games 
and instructed to find the most successful strategy to make the main character of the video game 
move. A movie-based neurofeedback paradigm was given as well, where patients had to stop 
black ‘curtains’ from appearing over the computer monitor. The software provided visual positive 
feedback for increasing SMR magnitude and decreasing theta magnitude. Each round (or trial) 
of video-games lasted 60 seconds, with short breaks in between rounds (trials). Movie-based 
feedback lasted 90 seconds at a time. The switch between video- and movie-based feedback was 
done in order to make neurofeedback more fun and less tiring, as choice of video games provided 
within the software was limited, as well as very simplistic. For each patient, about ten rounds 
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Figure 1. CONSORT flow diagram for individual randomized controlled trials of nonpharmacologic treatments.
*1 Patients who had hair that would was unsuitable for conducting EEG measurements or placement of 
 neurofeedback electrodes, such as dreadlocks.
*2 For analysis of drug testing, data from 19 patients was used. 
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122 patients eligible 
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• Lost interest in 
study (n=7) 
39 excluded 
• Pending leave of the 
treatment facility 
• within the foreseeable 
future (n=31)
• Not stable enough to 
participate (n=8) 
136 excluded 
• Lack of SUD (n=100)
• SUD, but no positive 
drug testing in past 24 
months (n=39)
• Not suitable for 
participation because 
• of language or hair*1
of video game-based feedback were employed. As for movie-based feedback, about 10 to 15 
rounds were employed. Neurofeedback training lasted for approximately 45 minutes, including 
preparation and clean-up.
Feedback thresholds were adjusted manually whenever participants were able to increase or 
decrease the desired frequency bands for 80% of the time. Participants were verbally encouraged 
to try to move the main character in the video game as much as possible, as well as to keep to 
monitor free from the curtains during video-based feedback and not just stare at the screen. See 
Figure 2 for an impression of one of the neurofeedback games. After all training sessions were 
completed, participants underwent post-treatment measurements (T1). 
Figure 2. Impression of one of the games used for neurofeedback training using one frequency band. Partici-
pants had to try to exceed the bar above the threshold, after which an encouraging smiley popped up on the 
screen, giving immediate positive reinforcement.
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Measures 
Electroencephalography. A 5 minute 21-channel EEG resting-state measurement with eyes 
closed was conducted with Nexus-32 hardware and Biotrace software (MindMedia BV). EEG 
measurements were collected from 19 standard 10/20 positions (Herbert & Jasper, 1958), and the 
right and left mastoid with a sampling rate of 512 samples per second. The left mastoid served 
as the online reference. Flat type electrodes were placed above and below the left eye and at the 
outer canthi of each eye to correct for vertical and horizontal eye movements. EEG magnitude 
across delta (0.5-3.5 Hz), theta (3.5-7.5 Hz), alpha (7.5-12 Hz), beta (12-20 Hz), SMR (12-15 Hz), 
high beta (20-32 Hz), and gamma (32-49 Hz) frequency bands was assessed. Magnitude changes 
in delta, theta SMR and high beta frequency were used for analysis. For analysis, custom-made 
Matlab scripts (version R2012b) were used. First, data from the resting-state measurements were 
imported into EEGLAB, bandpass filtered between 1-40 Hz, and inspected for gross movement 
artifacts which were then manually removed. Subsequently, epochs of 4 s length were created. 
Epochs containing amplitudes exceeding ±100 μV at any scalp electrode and/or epochs containing 
abnormally distributed data (i.e., joint probability or kurtosis >5 SD from expected mean values) 
were rejected. From the remaining epochs, the first 40 were transformed into FieldTrip format 
(version 20160620). Power values for electrode Cz were computed using a fast Fourier analysis 
with a Hanning taper as implemented in FieldTrip. Mean power values for delta, theta, SMR and 
high beta frequency bands were calculated and transferred to SPSS for statistical analysis.
Barratt Impulsivity Scale-11 (BIS-11). The Dutch version of the BIS-11 (Lijfijt & Barratt, 
2005) is a 30-item self-report questionnaire which assesses common impulsive behaviors 
and preferences across three second-order factors: motor, attentional and non-planning. An 
example of a BIS-11 item is ‘I do things without thinking’ and items are scored across a four-
point Likert scale ranging from ‘rarely/never’ to ‘almost always/ always’. The BIS-11 is an 
internally consistent measure of impulsivity among inmate populations (Cronbach’s α=. 80) 
(Patton, Stanford, & Barratt, 1995). 
Cued Go/No-go task. The cued Go/No-Go task is a continuous performance test designed to 
measure response inhibition (Fillmore, 2008). The task was programmed in E-Prime (version 
2.0.10.353). Participants are instructed to respond as quickly as possible to a green square 
appearing on a screen (‘Go target’), but to inhibit responses to a blue square (‘No-Go target’). 
The test consists of 250 targets with equal numbers of Go and No-Go targets. Each target is 
preceded by either a Go or a No-Go cue, indicating the likelihood of a Go or No-Go target to 
appear. The likelihood of a correct target after a cue is manipulated with a 80/20 ratio, with 
80% being a correct cue and 20% being an incorrect cue. Cues are presented with four fixed 
stimulus onset asynchronies (100, 200, 300, and 400 ms). The program displays feedback about 
the accuracy of the response back to the participant, as well as the time (in milliseconds) it took 
the patient to respond to the target. Outcome measure is the number of commission errors, 
reflecting the failure to inhibit a prepotent response to a no-go square. Number of commission 
errors in a cued Go/No-Go task is a valid measure of impulse control in a substance abusing 
population (Fillmore, 2003).
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Modified version of the Desire for Alcohol Questionnaire Short Form (DAQ-SF)
The short form of the DAQ-SF is a self-report questionnaire which measures levels of craving 
for alcohol among 14 items scored on a seven-point Likert scale (ranging from 1=strongly 
disagree to 7= strongly agree). The DAQ-SF has been shown to be a reliable measure to assess 
craving in a substance-dependent population (Cronbach’s α=.70) (Courtney et al., 2013). For the 
purpose of this study, items from the Dutch version of the questionnaire (Franken et al., 2003) 
were modified to measure desire for drugs in general, as opposed to being restricted to measure 
desire for alcohol only. An example of a modified item is ‘All my tension would completely 
disappear if I drank now’ into ‘All my tension would completely disappear if I used drugs now’. 
The modification was made due to the fact that alcohol use is very rare in an inpatient setting, 
whereas use of other drugs (e.g., cannabis or cocaine) is more common. 
Drug use. Scores on urine or breathalyzer drug testing were collected for each participant. Drug 
testing was performed regularly for each patient as part of treatment facility policy. Drug use was 
operationalized as any positive scoring for use of illegal substances. Illegal substances included 
all known drugs, as well as alcohol and non-prescribed medication used as recreational drug 
consumption (e.g., inhaled methylphenidate). According to treatment facility policy, refusal to 
undergo drug testing was scored as positive drug testing. To score substance abuse, the item 
‘substance abuse’ on the risk assessment scale ‘Historische, Klinische, Toekomst- Revised 
(HKT-R) (Historical, Clinical, Future - Revised) was used (Spreen, Brand, Ter Horst, Bogaerts, 
2014; Bogaerts, Spreen, Ter Horst, & Gerlsma, 2017). This item was scored on a five-point scale, 
indicating number of positive drug testing as well as willingness to undergo drug testing. Scores 
ranged from 0 - no drug use whatsoever, to 4 -the patient tested positive at least twice and also 
refused to undergo drug testing. 
Data and statistical analysis
All participants who completed pre- and post-treatment measures were included in the statistical 
analysis (N=42). For analysis of drug testing, weekly reports of two of the patients from the 
control group were not available, therefore the analysis of drug testing consists of data from 40 
patients. 
All data were analyzed with SPSS version 25 (IBM Corp).
Due to violations of statistical assumptions concerning normality and homoscedasticity of 
almost all dependent variables (BIS motor, BIS attentional, BIS, DAQ-SF, delta magnitude, 
theta magnitude, SMR magnitude and Cued Go/No-Go commission errors), non-parametric 
tests were employed. To test for differences between treatment conditions pre-treatment, 
Mann-Whitney U tests were performed for pre-treatment scores on BIS-11 total score, BIS-11 
subscales ‘motor’, ‘non-planning’, and ‘attentional’, as well as scores on DAQ-SF, number of 
commission errors, drug testing and mean theta and SMR magnitude. A Wilcoxon signed-ranks 
test was performed to assess changes within groups between pre- and post-treatment for all 
dependent variables. 
A repeated-measures ANOVA with Time as within-subject variable and Treatment condition as 
a between-subject variable was performed. To assess significance, a within-groups effect size 
was used (Eta squared ). Cut-off scores were used according to Cohens rules in order to assess 
whether effect size were small=0.02, medium=0.13 or large=0.26 (Cohen, 1988).
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Pearson’s correlations were performed to test for relations between changes in delta, SMR, high 
beta and theta frequency magnitude pre- versus post-treatment and all behavioral measures. Only 




Of those assessed (N=258), 47.3% of patients (n=136) were excluded due to not fitting the 
inclusion criteria. 52.7% (n=122) of patients were eligible for participation. Those eligible were 
randomly assigned to either the neurofeedback training + TAU group (N=42) or TAU only group 
(N=41). Figure 1 summarizes the flow of participants throughout the study. 
42 patients completed all post-treatment measurements, of which 21 patients participated in the 
TAU only group and 21 patients in the neurofeedback training + TAU group. None of the patients 
in the neurofeedback training + TAU group was able to complete training within the scheduled 
10 weeks. This was due to holidays and planning issues, but also because some patients were 
mentally unable to complete a training session, or caused aggressive incidents which resulted 
in temporary separation/placement on a specialized crisis unit. It sometimes also happened that 
patients were unmotivated to attend a training session. Participation in the study therefore lasted 
for an average of 14.1 (SD=5.32) weeks per patient. 
When pre-treatment measurements were assessed, mean number of months in treatment was 93.6 
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months (SD=67.18). The large standard deviation was caused by five patients who had already 
been hospitalized for more than 200 months in the treatment facility. Participants did not differ 
with regard to mean age between the neurofeedback training + TAU group (M=38.00, SD=9.18) 
and TAU only group (M=38.57, SD=8.41) (t(40)=-.22, p=.63), or mean number of Axis I and 
II DSM-IV-TR diagnoses (neurofeedback training group M=4.52, SD=1.47; TAU only group 
M=4.57, SD=1.63, t(40)=-.09, p=.38), or month in treatment prior to inclusion (neurofeedback 
training group M=91.90, SD=61.70; TAU only group M=95.30, SD=73.76, t(40)=-.16, p=.87). 
See Table 1, 2 and 3 for sample characteristics.
Baseline differences between groups
A Mann-Whitney U test indicated that scores on SMR magnitude on pre-treatment measurements 
were significantly higher for patients in the neurofeedback training group (Mdn=1.00) than for 
patients in the TAU group (Mdn=.58), U=131.00, p=.02, r=.35. 
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Table 3. Comorbid Axis I and II diagnosis and index offense for the neurofeedback training group and the 









































Disorders in the schizophrenia 
spectrum 
Mood and anxiety disorder
Pedophilia 
PTSD
Comorbid Axis II disorder  
Antisocial personality disorder
Borderline personality disorder










*1 Pervasive developmental disorder: Autism spectrum disorder, Asperger disorder, developmental disorder 
not otherwise specified
*2 ADHD: All types of attention-deficit disorder 
*3 Index offense: In case of more than one index offense, the most serious one is reported, based on the 
classification given in Nieuwenhuizen et al. (2011). 
=42)
Differences within groups
Only the neurofeedback training group showed significant effects between pre- and post-
treatment scores. Within-groups differences on the BIS-11 subscale ‘motor’ (pre-treatment: 
Mdn=23.00) showed a significant decrease post-treatment for patients in the neurofeedback 
training group (Mdn=21.00), Z=2.076, p=.04, r=.45, as well as a significant decrease in craving 
scores post-treatment (Mdn=34.00) as measured with the DAQ-SF, Z=2.091, p=.04, r=.46. SMR 
mean amplitude also significantly increased from pre-treatment (Mdn=1.00) to post-treatment 
(Mdn=1.22), Z=2.068, p=.04, r=.45. 
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Sample sizes were n=42, except for scores on drug use which was n=40.
Significant results are indicated in bold print.
Pearson’s correlations revealed no significant correlations (p>.05) between the difference in SMR or theta 
magnitude by the end of the training and behavioral outcome measures.  
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 Neurofeedback training TAU Post-/Premeasurement
T0 T1 T0 T1 Time Group Time x ES
       Group
M M M M F F F 
(SD) (SD) (SD) (SD) (P) (P) (P) 
67.05  63.10  63.33 62.62 3.02 .41 1.45 .03
(11.05) (10.88) (12.23) (11.5) (.09) (.52) (.24)  
24.10 21.67 21.81 20.95 5.61 1.27 1.28 .03
(6.24) (3.97) (4.49) (4.42) (.02) (.27) (.26) 
25.86 25.05 25.3 25.6 .14 .00 .6  .02
(4.21) (.5.82) (6.18) (6.03) (.71) (.99) (.44) 
17.10 16.38 16.19 16.05 .96 .36 .43 .01
(3.36) (3.2) (4.06) (3.79) (.33) (.55) (.52) 
44.19 36.38  42.72 39.24 6.23 .02 .92 .02
(17.77) (20.45) (17.48) (16.49) (.02) (.89) (.34) 
2.05  1.52 1.00 1.14  .3  1.59 .92 .02
(3.44) (1.91) (1.00) (1.42) (.59) (.21) (.34) 
.53 .38  .23 .22  1.67 2.91 1.27 .03
(.64) (.50) (.31) (.35) (.2) (.1) (.27) 
3.94 4.31 2.54 2.75  1.81 3.12 .14 .00
(3.67) (3.53) (1.64) (1.72) (.19) (.09) (.71) 
1.01 1.23 .65  .64  5.00 10.56 5.47 .12
(.52) (.66) (.39) (.35) (.03) (.00) (.02) 
η2
Outcome measures 
The main outcome measures are presented in Table 4. On the primary outcome measures, results 
on the ‘motor’ subscale of the BIS-11 showed a significant effect for Time (F(1, 40)=5.61, p=.02), 
but not for Time x Group (F(1, 40)=1.28, p=.28). For the drug craving measure DAQ-SF, there 
was a significant effect for Time (F(1, 40)=6.23, p=.02), but not for Time x Group (F (1, 40)=9.2, 
p=.34). There was a significant Time x Group effect for mean SMR magnitude (F (1, 40)=5.47, 
p=.02), indicating an increase for mean SMR magnitude in the neurofeedback training group 
post-treatment. Results for drug use, mean theta magnitude and number of commission errors 
post-treatment were not significant. 
Pearson’s correlations revealed no significant correlations (p>.05) between the difference in SMR 
or theta magnitude by the end of the training and behavioral outcome measures. 
Discussion
This RCT was conducted to investigate to what extent a theta/SMR neurofeedback training 
protocol in combination with TAU is able to reduce impulsivity and symptoms of SUD in a 
population of male forensic psychiatric patients residing in a FPC. The RCT compared a neuro-
feedback training group of 21 patients who received neurofeedback training in addition to TAU, 
to a control group of 21 patients receiving TAU only. Changes in targeted frequency bands and 
changes in levels of impulsivity, drug craving, and drug intake post-treatment were examined 
in the neurofeedback training group, and compared to patients in the TAU only group. Results 
indicate that SMR magnitude showed a significant increase post-treatment in the neurofeedback 
training group, whereas theta magnitude did not show any changes. Surprisingly, patients in 
the neurofeedback training group had significantly higher SMR magnitude pre-treatment than 
patients in the TAU only group. 
Levels of drug craving and motor impulsivity as assessed with the BIS-11 decreased equally for 
patients in the neurofeedback training group and the TAU only group. Therefore, the combination 
of TAU and neurofeedback training was not more effective than TAU only. Other measures of 
impulsivity and number of drug use did not change post-treatment. 
To the best of our knowledge, this is the first RCT study investigating the effects of neurofeedback 
training in a population of forensic psychiatric patients. Studies on investigating neurofeedback 
training have steadily increased in the past two decades, but neurofeedback training is rarely 
used as a treatment option for forensic psychiatric patients. This could partially be due to the 
fact that these patients usually present with a variety of disorders, and research on the effects 
of neurofeedback usually exclude patients with comorbid disorder (e.g., (Janssen et al., 2017; 
Kropotov, Grin-Yatsenko, Ponomarev, Chutko, Yakovenko, & Nikishena, 2005; Mayer, Wykoff, 
Schulz, & Strehl, 2012). Furthermore, practitioners might be hesitant to employ a treatment 
modality for which the efficacy in such a complex patient population has yet to be demonstrated. 
The fact that effects of neurofeedback training were not superior to TAU only has also been 
observed in other studies that applied neurofeedback in an attempt to reduce levels of impulsivity. 
Bink, van Nieuwenhuizen, Popma, Bongers, and van Boxtel (2015) employed a theta/SMR 
protocol in children with ADHD, but found the combination of TAU and neurofeedback 
as effective as TAU only. Schönenberg et al. (2017) also found no superiority of a theta/beta 
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neurofeedback training over a meta-cognitive therapy, or even a sham neurofeedback condition. 
Both Bink et al. (2015) and Schönenberg et al. (2017) applied the training in subjects with a 
single, well-defined disorder without any comorbidities. Hence it can be argued that for patients 
with multiple disorders and characterized by high levels of impulsivity, finding behavioral 
improvements due to neurofeedback training may be even more difficult. 
The results of the current study also raise the question as to how participants failure to decrease 
theta activity over the course of the training is associated with the lack of behavioral improvements 
post-treatment. To date, there are no clear guidelines how many neurofeedback training sessions 
are actually needed to achieve significant treatment effects, it is possible that improvements 
in the theta frequency band could have been achieved with more sessions. Bink et al. (2015) 
found that adolescents with ADHD were better able to suppress theta frequency by the end of 
the training sessions than at the beginning of neurofeedback training. In the study by Bink et al. 
(2015), 37 sessions were employed, but they still did not observe an effect of the neurofeedback 
training in the reduction of impulsivity. It may be the case that the 20 sessions of neurofeedback 
provided in the current study simply were not enough for this patient group to learn to regulate 
the theta frequency band. However, patients’ inability to adhere to the training schedule of 
two neurofeedback sessions a week might be indicative of the feasibility of a neurofeedback 
protocol that employs even more sessions. Throughout the current study, it was difficult to 
keep patients engaged in the study. While the specific patient population at hand is difficult to 
engage in treatment no matter which treatment is applied, the fact that none of the patients in the 
neurofeedback training group was able to attend two sessions a week is concerning. This was 
partially due the fact that neurofeedback software is still in its infancy and options concerning the 
employed training methods are limited. In most cases, the implemented video games are quite 
simplistic. A lot of patients reported that they found the intervention dull, which most likely was 
of negative influence on treatment motivation. An abbreviated protocol might be better suited for 
this patient population in terms of keeping patients engaged in the training. Also, as results of the 
current study showed no significant relation between patient’s reduction in theta magnitude and 
behavioral outcome measures, it remains unclear as to whether (more) improvements in theta 
activity regulation can lead to (better) clinical improvements at the behavioral level. However, 
patients did manage to increase SMR magnitude post-treatment. It is possible that the SMR 
frequency band is easier to regulate with neurofeedback training. In a recent study by Fielenbach, 
Donkers, Spreen & Bogaerts (2018a), that focused on whether forensic psychiatric patients are 
actually able to learn to regulate cortical activity through neurofeedback training, more patients 
were able to systematically increase SMR activity as opposed to reducing theta activity. In a 
study by Doppelmayr, and Weber (2011), healthy participants were better able to regulate SMR 
activity than to change the theta/beta ratio, and a recent study by Janssen et al. (2017) showed that 
adolescents were not able to inhibit their theta frequency, but did manage to increase beta activity. 
It is unclear why patients in the neurofeedback training group showed higher pre-treatment SMR 
magnitude than patients in the TAU only group, as patients distribution over groups was random. 
However, previous studies with healthy participants have suggested that pre-treatment SMR 
magnitude is a predictor of participants ability to increase of SMR magnitude over the course of 
neurofeedback training (Blankertz et al., 2010; Clarke, Barry, Bond, McCarthy, & Selikowitz, 
2002). Possibly, the high(er) pre-treatment levels of SMR magnitude contributed to the finding 
that patients did manage to increase SMR magnitude over the course of training. 
86
87
Recently, QEEG-guided neurofeedback protocols are increasingly implemented in clinical 
practice. With these protocols, pre-treatment EEG-deviations are first assessed and the applied 
neurofeedback protocol then focusses on treating these EEG-deviations, as opposed to applying a 
standard neurofeedback protocol to all participants. While there is also discussion in the literature 
about the use of QEEG approach of neurofeedback treatment (e.g., Johnson, & Bodenhamer-
Davis (2009), this approach fits with the rise of personalized medicine in the past decade, 
where a treatment approach tailored to the individual is applied rather than a one-size-fits all 
approach. Especially for forensic psychiatric patients, usually presenting with a wide range of 
comorbidities, manifesting through various deviations in EEG-frequencies, this might be a more 
suitable approach than applying standardized neurofeedback protocols. 
Limitations and recommendations for future studies
Patients taking prescription medication were allowed to keep taking these medications during the 
course of the study. Given the special setting where this study was conducted, limiting medication 
intake would have severely hampered patient recruitment. However, almost all types of medication 
commonly prescribed for forensic psychiatric patients tend to have effects on EEG-frequencies. 
Several studies have shown that stimulant medication such as methylphenidate normalizes EEG-
frequencies and may lead to a reduction of theta band magnitude and an increase in low beta 
bands magnitude (e.g., (Saletu, Anderer, & Saletu-Zyhlarz, 2006; Johnson & Bodenhamer-Davis, 
2009). Medication for disorders in the schizophrenia spectrum such as clozapine has been shown 
to increase theta activity (Hyun, Baik, & Kang, 2011). It is very well possibly that the results of 
this study were to some extent influenced by type and/or dosage of patient’s medication. A theta/
SMR neurofeedback protocol might not lead to significant changes in EEG-frequencies when 
these frequency bands are already normalized due to use of medication, although this remains 
speculative. In this study, changes in medication were insufficiently tracked during the course of 
the study. Future studies should investigate the effects of medication on the EEG spectrum more 
closely before applying neurofeedback, or should at least control for medication intake during 
the analysis to achieve more conclusive results. Another limitation concerning medication is the 
fact that some medication, such as aripiprazole is known to have positive effects on levels of 
craving (Beresford, Buchanan, Thumm, Emrick, Weitzenkamp, & Ronan, 2017), which could 
have influenced the results on the craving questionnaire DAQ-SF. 
Also, with the patient sample of this study, there was heterogeneity concerning substances used 
by study participants. This is quite common in patients with SUD, as many patients are polydrug 
abusers. This may have altered the results, and potentially influence the effects of neurofeedback 
in these patients. Also, we followed treatment facility policy, where a refusal to undergo drug 
testing is scored as having a positive drug testing. There is no way to be certain that patients who 
refused to undergo drug testing did, in fact, use illicit substances. However, given our clinical 
experience, patients refusal to undergo drug testing usually lies in the fact that they have relapsed 
in drug use, as patients have no reason to refuse to undergo drug testing other than fear of having 
drug use exposed. Refusal to undergo drug testing will result in loss of privileges, so that refusing 
to undergo drug testing comes at a reasonable cost to patients.
Also, the fact that none of the patients in the neurofeedback training group were able to complete 
the training in the scheduled amount of time could have influenced the results. Possibly, results 
achieved in terms of enhancing or inhibiting EEG frequencies were lost in between sessions 
because patients were not able to follow the scheduled training sessions. To date, there is no 
conclusive research indicating the ideal number of neurofeedback training sessions or the most 
beneficial interval time in between training sessions. For the current study, adhering to a very 
strict training schedule, where patients would have been excluded from further participation 
whenever they missed a session, would have resulted in a very high number of drop-out and 
consequently in lower power of the results found. Nonetheless, the failure of patients’ adherence 
to the schedule could have been of influence on the study results. 
Another limitation of the current study is that a sham-neurofeedback control group was not added 
to the study. While some authors challenge the use of a sham neurofeedback condition (e.g., 
Barth, Mayer, Strehl, Fallgatter, & Ehlis, 2017), as even a sham-based neurofeedback training can 
lead to treatment outcomes, it could have been useful to add a waiting list group as an untreated 
control condition. 
Future studies should also investigate whether results in terms of patients ability to increase or 
decrease their frequency magnitude vary when manually adjusted thresholds are applied versus 
when automatically adjusted thresholds are applied. Manually adjusted thresholds are subject to 
the expertise of the neurofeedback trainer, and therefore also subject to, for example, inattention 
of the trainer. Automatically adjusted thresholds provide a more objective way of adjusting 
thresholds, which might be better suitable for scientific purposes. 
Conclusion
The current study highlights that more research is needed to assess the efficacy of a theta/SMR 
neurofeedback protocol for the reduction of impulsivity, drug craving and drug intake in forensic 
psychiatric patients with substance abuse problems. Results showed that patients were unable to 
learn the whole neurofeedback protocol as they didn’t succeed in reducing theta activity. Future 
research should focus on assessing which patients will be able to benefit from neurofeedback 
training at an early stage of the employed training sessions. Given that neurofeedback training is 
often times applied in vulnerable patient populations such as children, adolescents and patients 
with severe mental illness or addiction, it can be considered unethical to enroll these patients in 
any treatment with the knowledge that it will most likely not lead to beneficial outcomes in terms 
of reduction of clinical symptoms. Weber, Köberl, Frank, and Doppelmayr (2011) have made an 
important start with their research on predicting successful learning of SMR neurofeedback in 
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Chapter 6
Theta/SMR neurofeedback training works well for some 
forensic psychiatric patients, but not for others: 
a sham-controlled clinical case series
          
Abstract
EEG-neurofeedback could be a promising treatment for forensic psychiatric patients. Increasing 
evidence shows some patients are unable to regulate cortical activity. Before neurofeedback 
can be applied successfully, research is needed to investigate the interpersonal mechanisms 
responsible for patients ability to respond to neurofeedback. A single-case experimental design 
allows for close monitoring of individual patients, providing valuable information about patients’ 
response to the intervention and the timeframe in which changes in clinical symptoms can be 
observed. Four patients with DSM-IV-TR substance use disorder and various comorbidities 
participated in a sham-controlled clinical-case study. Self-report level of impulsivity and craving 
were assessed. Results indicate that one patient benefitted significantly more from neurofeedback 
than the others. This patient reported less impulsivity and reduced levels of self-reported craving. 
The findings suggest that there may be great interindividual differences in patient’s ability to 
regulate cortical activity, as well as in the effectiveness in reducing clinical symptoms. 
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Introduction
Forensic patients are characterized by the presence of diverse and complex problems, such as 
persistent and co-morbid psychiatric disorders (Palijan, Radeljak, Kovac, & Kovacevic, 2010), 
serious criminal offenses and cognitive disorders. Their treatment motivation and readiness is 
often low, there is often times a lack of problem insight, and treatment compliance is problematic. 
A complicating factor for effective treatment and compliance is the presence of complex comorbid 
problems such as high levels of impulsivity and substance use disorder (SUD) (Schuringa, 
Heininga, Spreen, & Bogaerts, 2016). As a consequence, these individuals are more likely to 
reoffend (Palmer & Humphries, 2016). Following Gottfredson and Hirschi’s general theory of 
crime (1990), in which they state that low self-control and high impulsivity significantly predict 
recidivism, effective treatment of impulsivity is needed.
Studies have shown that changes in electroencephalographic (EEG-)frequencies after 
neurofeedback training can positively influence motor control and cortical inhibition function 
(Sokhadze, Stewart, Tasman, Daniels, & Trudeau, 2011). EEG-based neurofeedback training 
could therefore be a promising treatment method for forensic psychiatric patients. It is 
increasingly used in the treatment of various psychiatric disorders (for review see Fielenbach, 
Donkers, Spreen, Visser, & Bogaerts, 2018b). Training protocols where the sensorimotor rhythm 
(SMR, 12-15 Hz) frequency is enhanced, while inhibiting slower brain waves such as theta (3.5-
7.5 Hz) have shown promising results in the reduction of high levels of impulsivity commonly 
found in patients with ADHD (e.g., Fuchs, Birbaumer, Lutzenberger, Gruzelier, & Kaiser, 2003). 
Neurofeedback training uses real-time display of brain activity and aims at normalizing EEG-
frequencies that have shown to be deviant in various disorders and that are thought to underlie 
the manifestation of clinical symptoms by means of operant conditioning. 
The effectiveness of this type of training can be assessed in two complementary ways: 1. Through 
changes in cortical activity post-training, i.e., normalization of deviant brain wave patterns, or 
increase/decrease of EEG-activity in particular frequency bands, and 2. through improvements 
at the behavioral level underlying specific clinical symptoms (e.g., the ability to inhibit prepotent 
actions in favor of more suitable behavior) (Rogala, Jurewicz, Paluch, Kublik, Cetnarski, & 
Wrobel, 2016). 
There is increasing evidence that not all patients benefit from neurofeedback training, as they 
seem unable to learn to regulate cortical activity through neurofeedback within the number of 
sessions provided (e.g., Zuberer, Brandeis, & Drechsler, 2015). These patients do not show 
the assumed effects within the trained frequency bands, with as many as 25% of participants 
being categorized as so-called ‘non-responders’ (Enriquez-Geppert et al., 2013; Zoefel, Huster, 
& Herrman, 2011). Other studies show that patients do achieve regulation of deviant brain 
frequencies, but without showing improvements in clinical symptoms post-training (Fielenbach 
et al., 2018a). It can be argued that successful regulation of brain activity is a necessary condition 
for achieving behavioral symptom improvement. 
However, there are only a limited number of studies that report how many patients achieved 
successful regulation of cortical activity, and that also link successful regulation to behavioral 
outcomes. Also, most studies use randomized controlled trials (RCTs) designs, in which one 
group receiving the training is compared to another receiving treatment as usual (TAU), which 
does not reveal individual differences which might exist between patients (Alkoby, Abu-Rmileh, 
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Shriki, & Todder, 2017). Before neurofeedback can be applied successfully in populations with 
vulnerable patients, additional research is needed to investigate these interpersonal mechanisms 
between participants, which are (at least partially) responsible for a patients ability to respond to 
neurofeedback training. 
Clinical case studies involve an experimental design of a specific person, group or event. This 
designs offers the possibility to investigate the effect of a treatment over time. It allows for close 
monitoring of an individual patient, providing valuable information about a patients’ response 
to the intervention and the timeframe in which changes in clinical symptoms can be observed 
(Van Yperen, Veerman, & Bijl, 2017). It has also been shown that a series of well-conducted 
clinical case studies can provide the same level of experimental rigor and high level of internal 
validity as an RCT (Byiers, & Reichle, & Symons, 2012; Rizvi & Nock, 2008; Task Force 
APA; 1995). It will provide practitioners with detailed information about treatment effects in the 
current environmental setting, thereby reducing the gap between research and practice (Morgan 
& Morgan, 2001), providing valuable insights for further research. 
The current study will apply a restricted sham-controlled series of clinical-case studies in 
male forensic psychiatric patients. Two single-case experimental designs will employ a SMR 
neurofeedback protocol, where the SMR-frequency (12-15 Hz) is enhanced and the theta frequency 
(3.5-7.5 Hz) is inhibited, while two other clinical case studies will employ a sham neurofeedback 
protocol. In substance abuse, individuals present with elevated scores on impulsivity measures, 
independent of type of specific addiction (Nielsen et al., 2012; Fillmore & Rush, 2006). Drug 
intake can be seen as loss of control over a patients’ restriction from using. Especially for forensic 
psychiatric patients who present with SUD and various other comorbidities that are typically 
found in this patient population, it can be argued that impulsivity is especially pronounced. Higher 
levels of impulsivity have also shown to affect severity of symptoms of substance dependency, 
in that patients high in impulsivity report higher levels of drug craving (Tziortzis, Mahoney, 
Kalechstein, Newton, De la Garza, 2011; Bornovalova, Levy, Gratz, & Lejuez, 2010). Therefore, 
the current study will apply a SMR neurofeedback training protocol aimed at the reduction of 
self-reported levels of impulsivity. Between-session effects of mean SMR and theta magnitude 
will be monitored. Throughout the course of the study self-report measures of impulsivity (the 
Barratt Impulsivity Scale-11 (BIS-11) 11 (Patton, Stanford, & Barratt, 1995) and craving will 
be monitored frequently (a modified version of the Desire for Alcohol questionnaire DAQ-SF) 
(Franken, Rosso, & Honk, 2003).
Method 
Design
A single-subject ABA-design is employed (Rizvi & Nock, 2008). With this single-case experimental 
design, a no-training baseline phase (A1) is followed by a neurofeedback training phase (B), which 
is then followed again by a no-training follow-up phase (A2). In phase B, participants receive eight 
sessions of theta/SMR neurofeedback training during 10 weeks (Figure 1). Throughout the course 
of the study, self-report measures of impulsivity and levels of craving of the participating subjects 
are repeatedly measured two times a week. In the no-training phases A1 and A2, participants follow 
TAU only. TAU is different for every participant, as the different treatment modalities dependent 
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on the specific diagnosis and behavioral complaints of each patient. 
Participants are randomly assigned to either real or sham-neurofeedback training. The study 
is single-blind, with participants not knowing which type of feedback they are receiving. We 
hypothesized that after eight neurofeedback sessions, patients receiving real neurofeedback 
training should show: a) evidence of being able to regulate cortical activity by enhancing SMR-
frequency and reducing theta-frequency, and b) at least a trend towards behavioral improvement 
through reductions in BIS-11 and/or DAQ-SF scores. Figure 1 shows a graphic display of the 
study design. In this study, patients who receive the shame training will not benefit from the 
training. 
Participants
Participants in the current study were male forensic psychiatric patients residing in the Forensic 
Psychiatric Centre (FPC) Dr. S. van Mesdag, situated in the Netherlands. They all had at least 
one DSM-IV-TR diagnosis of SUD and a minimum of one comorbid axis I or II disorder, 
such as schizophrenia or personality disorder (American Psychiatric Association, 2000). 
They were receiving compulsory treatment by order of the state, after committing a violent 
crime with a minimum penalty of at least four years according to Dutch jurisdiction (called 
Terbeschikkingstelling, or TBS; Van Marle, 2002). Due to mental illness, these patients were 
held only partially responsible for the crime they committed. The patients participating in the 
current study were selected from the control group of an ongoing RCT, investigating the effects 
of neurofeedback on impulsivity, craving and substance use (Fielenbach, Donkers, Spreen, 
& Bogaerts, 2017). Participants in the control group of this RCT received TAU only, without 
previous neurofeedback training, but participated in assessing self-report scores of impulsivity 
(BIS-11) and craving (DAQ-SF). The patients for the current study were selected based on their 
high scores on the BIS-11 and the DAQ-SF. Patients received information about the study and 
gave informed consent. 
The study was conducted according to the principles of the Declaration of Helsinki (version 59, 
Seoul, October 2008), and in accordance with the Medical Research Involving Human Subjects 
Act. It has been approved by the Medical Ethical Council of Brabant, the Netherlands (study 
number NL46390.008.13).
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Barratt Impulsiveness Scale (BIS-11). The BIS-11 (Patton, Stanford, & Barratt, 1995) is a self-
report questionnaire measuring the behavioral and personality construct of impulsivity. It consists 
of 30 items scored on a four-point Likert scale ranging from 1 (rarely/never) to 4 (almost always/ 
always). The total score can be subdivided in three second-order factors: motor, attentional, and 
non-planning. The BIS-11 has been shown to be an internally consistent measure of impulsivity 
among inmate populations (Cronbach’s α=.80) (Patton, Stanford, & Barratt, 1995). The Dutch 
version of the BIS-11 was used (Lijffijt, & Barratt, 2005). 
Modified Desire for Alcohol Questionnaire - Short Form (DAQ-SF). The DAQ-SF is a self-
report questionnaire measuring desire for alcohol at the moment of assessment. It consists of 14 
items scored on a seven-point Likert scale, ranging from 1 (strongly disagree) to 7 (strongly agree). 
The DAQ-SF has shown to be a reliable measure to assess craving in a substance-dependent 
population (Cronbach’s α=.70) (Courtney et al., 2013). For the purpose of this study the word 
“alcohol” was replaced by the word “drugs” for all questions. Participants were instructed to 
assess the level of craving at the moment of measurement for drugs in general, with an extra 
instruction indicating that drugs can range from alcohol to soft- and hard drugs with examples 
provided. The Dutch version of the questionnaire was used (Franken, Rosso, & Honk, 2003). 
Intervention: Neurofeedback
Neurofeedback was applied as implemented in the BrainMarker software engine (BrainMarker 
Device, BrainMarker B.V. Gulpen). For both training protocols (sham or real), training was 
performed on the EEG signal recorded from electrode position Cz against a right ear mastoid 
reference. EEG magnitude was measured across delta (0.5-3.5 Hz), theta (3.5-7.5 Hz), alpha 
(7.5-12 Hz), beta (12-20 Hz), SMR (12-15 Hz), high beta (20-32 Hz), and gamma (32-49 Hz) 
frequency bands. For real-neurofeedback, a SMR-enhancement protocol was used, where SMR 
(12-15 Hz) was enhanced and theta (3.5-7.5 Hz) was inhibited. For sham-neurofeedback, higher 
beta bands were randomly selected for training (20-23 Hz, 23-26 Hz, 26-29 Hz, and 29-32 
Hz). No specific higher beta frequency band was trained systematically. During neurofeedback 
training sessions, participants learned to control simple video-games by systematically increasing 
or inhibiting the targeted EEG-frequencies in the desired direction. Patients received positive 
feedback once a frequency band was maintained above or below a set threshold for 80% of the 
time. Whenever a patient seemed to be able to successfully control EEG-activity, the feedback 
threshold was adjusted manually to a more difficult level. During training, participants were 
consistently encouraged to engage in the training and to not only stare at the screen. 
Statistical analysis
Non-overlap of all pairs. For single-case studies, non-overlap of all pairs-scores (NAP-scores) 
are proposed by some authors as a standard for evaluating single-subject progress (Horner, Carr, 
Halle, McGee, Odom, & Wolery, 2005). The NAP indicates data overlap between training and 
no-training phases in single-case studies, and is seen as one of the best indexes to provide insight 
into the effect of intervention (Parker & Vannest, 2009). NAP-scores are calculated through 
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pairing every data point between two predetermined phases (e.g., between data from a no-training 
phase A and data from a training phase B). The NAP-score is determined as the proportion of all 
pairs for which the baseline score is different from the intervention score in the hypothesized non-
overlapping direction (Van Yperen, Veerman, & Bijl, 2017). A NAP-score can range from 0 to 1, 
with .50 indicating chance level. Parker and Vannest (2009) propose calculating effect sizes for 
NAP-scores, with NAP-scores from 0.00-.65 indicating weak effects, .66-.92 indicating medium 
effects and .93-1.0 indicating large or strong effects. For a more detailed description regarding 
calculating NAP-scores see Parker and Vannest (2009). 
NAP scores were used to analyze changes in BIS-11, DAQ-SF, and mean magnitude of theta and 
SMR frequency bands. A McNemar change chi-square test was performed to assess significance 
of the NAP-scores. All data were analyzed with SPSS version 22 (IBM Corp). 
Simulation Modeling Analysis. A statistical approach that takes autocorrelation into account is 
Simulation Modeling Analysis (SMA) (Borckardt, Nash, Murphy, Moore, & O’Neil, 2008). SMA 
can test changes in level and slope factor of an outcome measure between two phases (Van Yperen, 
Veerman, & Bijl, 2017). The slope is correlated with five possible models of trend, indicating the 
goodness of fit of the different models. Model 1 indicates a decrease in outcome measure during 
phase one, which is then followed by an increase during phase two; model 2 indicates a stable 
phase one, with a decrease during the second phase; model 3 describes a decrease during phase 
one and subsequently a stable phase two; model 4 indicates a decrease during phase one, which 
continues during phase two; and model 5 describes a decrease during phase one, and a subsequent 
stable but then decreasing phase two. SMA-scores were analyzed with the software package 
‘SMA - Time series analysis program for short time series data streams’ (Borckardt, 2006). 
BIS-11 and DAQ-SF. To assess changes in scores on BIS-11 and DAQ-SF for each participant, 
data from the no-training phase was compared to data from the training phase. Specifically, to test 
for significant differences on outcome measures pre- versus post-training, data from the baseline 
phase A1 was paired with data from the follow-up phase A2.. It was expected that scores on self-
report questionnaires in follow-up phase A2 would be significantly lower than in baseline phase 
A1 for the two patients that received evidence-based neurofeedback training, but not for the two 
patients that received sham-neurofeedback. To test for changes between no-training and training, 
data from no-training phases A1 and A2 were compared to data from training phase B1. 
First, NAP-scores for all comparisons were calculated for each participant. Next, SMA-scores 
were analyzed. 
Change in frequency bands. Standardized values for each session of neurofeedback were 
calculated for theta and SMR magnitude. Training rounds in which the frequency magnitude 
differed more than two standard deviations from the mean were excluded, as these rounds were 
most likely influenced by artifacts (e.g., due to eye blinks and/or movement). Subsequently, 
NAP-scores were calculated, comparing the mean amplitude of theta and SMR frequency during 
the first four sessions of neurofeedback with the mean amplitude of theta and SMR frequency 
during the last four sessions of neurofeedback. 
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Results
Three out of four patients completed phase A1, B1 and A2. A fourth patient resigned from 
participation in the study during phase A1. Data from this patient was not included in the analysis. 
Patient characteristics can be found in Table 1. 
None of the patients was able to follow neurofeedback training as originally scheduled (two times 
a week). Due to scheduling issues, lack of motivation, and/or temporary declines in psychological 
well-being, phase B1 took slightly longer than the scheduled four weeks for all patients (mean 
duration 5.4 weeks). When patients didn’t attend neurofeedback training during this phase, the 
questionnaires were still administered. See Table 2 for study flow. 
Patient 1 (real neurofeedback training)
Patient 1 showed a significant decrease of BIS-11 scores over the course of the study. When 
comparing pre- and post-training phases (baseline phase A1 versus follow-up phase A2), he 
showed a significant decrease in BIS-11 total score, with NAP-scores showing a strong effect 
(NAP=1.00, p≤0.001). When correcting for autocorrelation of NAP-scores, SMA-analysis 
revealed a significant level change (r=-.85, p≤.05). The decrease in BIS-11 scores correlated 
significantly with model 4 of SMA (r=-.86, p≤.05), indicating a decrease in BIS-11 scores that 
was already present during baseline phase A1 and that continued during the intervention phase B 
and follow-up phase A2. Reduction in BIS-11 scores were not only observable in the total score 
of the BIS-11, but also in the subscales ‘motor’ and ‘non-planning’. When comparing baseline 
phase A1 with follow-up phase A2, the decrease fit best with model 3 of SMA (r=-.703, p≤.05), 
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Table 1. Patient characteristics. 
1Posttraumatic stress disorder
2 Personality disorder
Patient Age Axis I Axis II diagnoses  IQ (range) Type of  Type  
   diagnoses  substance use  of NFB
1 30 PTSD1 Borderline PD2
   Antisocial PD
   Histrionic PD
2 29 - Antisocial PD
3 43 Schizophrenia  Antisocial PD
  (paranoid
  subtype)
  Exhibitionism 
   
4 32 - Antisocial PD
   Narcissistic PD
   Mental  
   retardation
70-80 Cannabis  Real
 
74-83 Cannabis Real 
 Alcohol
   




 Alcohol  
 
Mental  Cannabis  Sham
retardation,  Amphetamines
(precise IQ-score  Alcohol
unknown) Cocaine 
indicating a decrease in outcome measure during baseline phase A1, followed by an increase 
during follow-up phase A2. Results regarding the DAQ-SF showed that patient 1 had a significant 
reduction in DAQ-SF scores when comparing baseline phase A1 with follow-up phase A2 
(NAP=1.00, p≤0.001). This effect was still highly significant when correcting for autocorrelation 
with SMA (level change r=-.96, p≤0.001). The decrease in DAQ-SF scores fitted best with model 
1 (r=-.91, p≤.05), indicating an increase during baseline phase A1 followed by a decrease in 
follow-up phase A2. See Tables 2, 3 and 4 for results and Figures 2 and 3 for a graphical display 
of BIS-11 and DAQ-SF scores. Patient 1 showed a significant increase in mean SMR magnitude 
when comparing the first four training sessions to the last four training sessions (NAP=.75; 
p≤.05), however, this effect did not remain significant when controlling for autocorrelation with 
SMA (r=.53, p=≥ .05). Changes correlated by trend with model 2 (p=.07), indicating a stable 
number of first sessions and an increase during the later sessions. Theta magnitude did not change 
significantly (NAP=.38, p≥.05) . See Table 2-5 for results. 
Patient 2 (real neurofeedback training)
Patient 2 showed a significant reduction in BIS-11 total score when comparing baseline phase 
A1 versus follow-up phase A2 (NAP=.82, p≤.001), however, this effect did not remain significant 
when controlling for autocorrelation with SMA (r=-.59, p=≥ .05). The decrease in BIS-11 scores 
did not significantly correlate with any of the SMA models. Reduction in BIS-11 scores were 
not only observable in the total score of the BIS-11, but also in all subscales when analyzed with 
NAP-scores, however these results didn’t remain significant when controlling for autocorrelation 
with SMA. Results regarding the DAQ-SF, showed that patient 2 had a significant slope change 
(r=-.67, p≤.05) that fitted best with SMA model 1, indicating an increase during baseline phase A1, 
followed by a decrease in follow-up phase A2. See Tables 2, 3 and 4 for results . SMR magnitude 
showed a decrease between the first four sessions and the last four sessions (NAP=.19, p≤0.01), 
but this effect did not remain significant when controlling for autocorrelation with SMA. Changes 
in theta magnitude were not significant (NAP=.50, p≥.05). See Table 2-5 for results. 
Patient 3 (sham neurofeedback training)
Patient 3 showed a significant increase in BIS-11 total score by the end of follow-up phase 
A2 (NAP=.22, p<.001), although this effect did not remain significant when controlling for 
autocorrelation with SMA. DAQ-SF scored remained unchanged (A1 versus A2: NAP=.50, p≥.05; 
A1 versus B: NAP=.64, p≥.05; B versus A2: NAP=.60, p≥.05). See Table2-5 for results. SMR 
magnitude showed a significant decrease by the end of follow-up phase A2 (NAP=.25, p<.05), 
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Table 2. Overview of study flow.
Patient 1 (real neurofeedback training)
Patient  Number of assessments A1 Number of assessments B1/  Number of assessments A2 
  Number of NFB sessions
1 6 11/8 6
2 6 10/8 6
3 6   9/8 6
4 6 - -
but this effect did not remain significant when controlling for autocorrelation with SMA. Theta 
magnitude increased significantly (NAP=.81, p<0.01). See Table 2-5 for results and Figures 2 and 
3 for a graphical display of BIS-11 and DAQ-SF scores. 
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Table 3. SMA-scores for comparison between baseline phase A1 and follow-up phase A2.
p ≤ 0.05 = *; p ≤ 0.01 = **; p ≤ 0.001 = ***
 Instrument NAP Level change Model 1 Model 2 Model 3 Model 4 Model 5
 BIS-11       
Patient 1   1.00*** -.85* -.14 -.74 -.86* -.86* -.24
Patient 2    .82*** -.59  .14 -.47 -.36 -.43  .17
Patient 3    .22***  .53 -.37  .73  .43  .64  .36
 DAQ-SF       
Patient 1  1.00*** -.96**  .16 -.91* -.78 -.91* -.15
Patient 2   .42 -.01 -.67*  .12 -.42 -.18 -.35
Patient 3   .50 -.28 -.2 -.09 -.25 -.17  .15
 SMA
≤0.05=*; p≤0.01=**;p≤0.001=***
Table 4. SMA-scores for comparison between baseline phase A1 and training phaseB.
p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***
 Instrument NAP Level change Model 1 Model 2 Model 3 Model 4 Model 5
 BIS-11       
Patient 1  .79*** -.44  .26 -.5 -.58* -.58* -.52
Patient 2  .58 -.04 -.21  .18  .03  .16  .31
Patient 3  .42***  .35  .13  .09  .29  .16 -.14
 DAQ-SF       
Patient 1  .47 -.17  .5 -.45 -.13 -.39 -.48
Patient 2  .79*** -.47 -.05 -.38 -.74* -.56* -.45
Patient 3  .64 -.22  .21 -.29 -.2 -.28 -.25
 SMA
<0.05=*; p<0.01=**; p<0.001=***
Table 5. NAP and SMA-scores for comparison between training phase B and follow-up phase A2.
p < 0.05 = *; p < 0.01 = **; p < 0.001 = ***
 Instrument NAP Level change Model 1 Model 2 Model 3 Model 4 Model 5
 BIS-11       
Patient 1  .95*** -.72* -.43 -.66* -.67* -.71*  .10
Patient 2  .79*** -.34  .16 -.29 -.04 -.12  .41
Patient 3  .49  .19 -.37  .41 -.02 .16 -.07
 DAQ-SF       
Patient 1  .98*** -.91*** -.44 -.88* -.79 -.88*  .15
Patient 2  .18***  .76*  .1  .84*  .55  .7 -.2





Figure 2: BIS-11 total scores for patient 1, 2 and 3 over all study phases.































Figure 3: DAQ-SF scores for patient 1, 2 and 3 over all study phases.



























Patient 2: DAQ-SF score




To the best of our knowledge, this is the first study to employ a sham-controlled clinical case 
experimental study among forensic psychiatric patients, investigating the efficacy of theta/
SMR neurofeedback training in reducing levels of impulsivity and craving. Four patients were 
randomly assigned to either eight sessions of theta/SMR or eight sessions of sham-neurofeedback 
training. During the course of the study, patients self-report level of impulsivity with the BIS-11 
and self-report levels of craving with a modified version of the DAQ-SF were assessed. 
One of the patients benefitted significantly more from neurofeedback training than the others. This 
patient reported significantly less impulsivity as measured with the BIS-11, as well as reduced 
levels of self-reported craving over time. The patient showed a decrease in impulsivity measures 
that was already observable during the baseline phase, and that was continued during and after 
the intervention. It is not clear what happened during the baseline phase that set reduction in 
levels of impulsivity in motion already at this phase. It is possible, though speculative, that since 
the patient was aware of the fact that his impulsivity measures would be monitored during the 
course of the study, he was more aware and reflective of his actions, which led to a decrease in 
impulsivity scores. However, this patient was also the patient with the most severe diagnoses 
concerning cluster B personality disorders, with a diagnosis of borderline, antisocial and 
histrionic personality disorder. This patient showed the highest impulsivity scores at the start of 
the study compared to the other two patients. Despite this, he was apparently better able to reduce 
impulsivity over the course of training. 
Only patient 1 was able to (at least partially) increase his SMR magnitude, although this was no 
longer significant when controlling for autocorrelation. He showed different patterns of change in 
EEG magnitude for SMR and theta frequency. For SMR, changes correlated by trend with model 
2, indicating a stable number of first sessions and an increase during the last four sessions. As this 
was only significant by trend, it is possible that more neurofeedback training sessions would have 
led to a stronger increase in SMR magnitude. 
Patient 2 did not seem to benefit much from the neurofeedback intervention, although he received 
real theta/SMR neurofeedback training as opposed to sham-training. It can only be speculated 
why this patient did not respond as well to the training as patient 1. As there are no clear guidelines 
about the necessary number of neurofeedback training sessions to achieve significant effects in 
terms of increase or decrease in magnitude of the targeted frequency bands, it is possible that the 
employed eight sessions of training were simply not enough to result in a significant decrease of 
mean SMR and/or theta amplitude. Common neurofeedback protocols range from 12-30 sessions 
(see for review Fielenbach et al., 2018b), hence a decrease in mean magnitude of the targeted 
frequency band might take more than 8 sessions to manifest. On the other hand, previous research 
has shown that performance in early neurofeedback training sessions predicts performance in 
later training sessions (Weber, Köberl, Frank, & Doppelmayr, 2011). More training sessions may 
not necessarily result in more clinically relevant results. 
Several possible psychological mechanisms that may influence neurofeedback performance have 
been suggested in the literature. Witte, Kober, Ninaus, Neuper, & Wood (2013) showed that 
subjects’ belief regarding their ability to gain control over technological devices predicted their 
performance in a SMR neurofeedback training protocol. Subjects’ level of locus of control over 
the neurofeedback device showed a negative correlation with the power of the SMR. Witte et 
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al. (2013) suggest that subjects who strongly believe in their ability to control a neurofeedback 
device consume additional cognitive resources. The higher effort may interfere with the state 
of relaxation necessary to achieve higher SMR power (i.e. SMR increases times of relaxation 
see Pfurtscheller, Brunner, Schlogl, Lopes da Silva, 2006; Pfurtscheller & Lopes da Silva, 
1999). Witte et al. (2013) showed that participants who reported that they did not apply any 
specific mental strategy to achieve SMR regulation showed better performance during training. 
It is also suggested that, with SMR neurofeedback training, participants’ motivation is related to 
successful learning response (Nijboer, et al., 2008; Nijboer, Birbaumer, & Kübler, 2010). In this 
study, motivation for treatment was not assessed, which is a limitation to this study. Motivational 
(self-report) questionnaires should be assessed in future studies to help gain insight into the role 
motivation of study participants plays with regard to neurofeedback performance. 
Some studies have suggested that a pattern of EEG-learning should be observable over every 
session of neurofeedback training (Weber et al., 2011). In our study, only patient 1 showed a 
significant change in EEG magnitude, but this change was not observable over every session, as 
the change in SMR magnitude correlated only by trend highest with SMA-model 2, indicating a 
stable number of first sessions and an increase later in the intervention. For theta, the change in 
mean magnitude indicated a decrease in mean magnitude at the beginning of training, followed 
by an increase in theta, which then again decreases later on in the intervention. It is possible that 
for patients with severe mental disorders, the patterns of EEG-learning are not congruent with 
patterns of learning in healthy subjects. 
Although offered, none of the patients were willing to undergo more than the eight training-
sessions provided during the first treatment phase. While it is possible that this reflects patients’ 
low motivation for treatment in general, it is also possible that patients experienced insufficient 
behavioral improvements to be willing to continue further neurofeedback training. Future 
research on neurofeedback should focus on investigating which patients will benefit from this 
type of intervention and which will not. Burdening patients with an intervention they are most 
likely not going to benefit from can be considered unethical. 
Limitations
It is possible that differences in the ability to learn successful regulation of cortical brain activity 
is at least partially influenced by interindividual differences in clinical diagnosis, IQ, type of 
substance use disorder or other (unknown) factors. In this study, one of the patients who received 
real neurofeedback training benefited more from the training than the patient who received 
sham neurofeedback, but this patient also had higher IQ-scores, and a less severe substance use 
diagnosis than the patient who received sham neurofeedback. Since the current study did not 
investigate the influence of other external factors on the effectiveness of neurofeedback training, 
more research is needed to be able to tell which type of patients will most likely benefit from 
neurofeedback treatment.
The current study did not investigate possible influences of medication use on the trainability 
of patients. It therefore remains unclear whether some patients showed better results than others 
due to differences in medication status. Forensic psychiatric patients tend to use various kinds of 
medication, it is possible that some patients perform better/worse than others in neurofeedback 
training due to medication that helps/hinders to regulate frequency bands in the desired direction. 
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Conclusion
The results of our clinical case studies suggest that at least for some forensic psychiatric patients, 
neurofeedback training may be a viable alternative form of treatment. Despite the fact that it is 
difficult to extrapolate the results of this study to the larger population, the findings suggest that 
there may be great interindividual differences in forensic psychiatrics patient’s ability to regulate 
cortical activity through neurofeedback, as well as in the effectiveness of the training in reducing 
clinical symptoms. 
Additional research is needed to identify the most efficient number of training sessions, to 
examine possible influences of medication on trainability of patients, and to investigate factors 
that maximize the possible beneficial effects of neurofeedback training for forensic psychiatric 
patients. As Alkoby et al. (2017) have stated: “Finding possible predictors that are linked to 
underlying mechanisms of cortical learning will help to identify important factors that should be 




The aim of this thesis was to investigate the efficacy of a theta/SMR neurofeedback intervention 
as an alternative for standard treatment of forensic psychiatric patients who suffer from disorders 
characterized by heightened levels of impulsivity, as well as comorbid substance use disorder 
(SUD). High levels of impulsivity as well as SUD can seriously hamper treatment compliance 
and progress of forensic psychiatric patients, and therefore can function as risk factors for future 
reoffending (Duke, Smith, Oberleitner, Westphal, & McKee, 2018; Van der Veeken, Lucier, & 
Bogaerts, 2016). Individuals with substance abuse problems suffer from a loop in which high 
levels of impulsivity are linked to the development and maintenance of abuse problems (Charney, 
Zikos, & Gill, 2010; Jentsch et al., 2014), whereas addictive substances themselves tend to increase 
impulsivity levels due to the detrimental chemical effects of addictive substances on the brain. 
This can lead to a structural state of disinhibition and loss of self-control over using (Perry & 
Carroll, 2008). To date, effective treatment of patients with SUD is still challenging, with relapse 
rates as high as 60% for opioid addicted patients (Gossop, Steward, Browne, & Marsden, 2002). 
Treatment forms such as cognitive behavioral therapy (CBT) tend to focus on verbal strategies 
to manifest change, such as promotion of strategies that promote conscious decision making 
and attention to action (Crews & Boettiger, 2009) making them less accessible to patients who 
have difficulties expressing thoughts and emotions. Also, effect sizes of CBT strategies tend to 
be small, and even diminish when investigated over the long term (Longabaugh & Morgenstern, 
1999; Magill & Ray, 2009). A lack of alternative therapies may result in insufficient opportunities 
to change impulsive and addictive behavior, which can significantly increase the chance of 
reoffending. Thus, there is a strong need to find suitable and efficient treatment methods for 
forensic psychiatric patients with SUD and high levels of impulsivity, which provide good results 
in a preferably short amount of time.
To that end, a randomized controlled trial (RCT), as well as four clinical case studies were 
conducted with the specific goal to investigate the effects of a theta/SMR neurofeedback training 
on reducing levels of impulsivity and symptoms of SUD. Successful learning of theta/SMR 
frequency regulation by neurofeedback training was investigated by determining to what extent 
performance during training sessions could distinguish responders from non-responders in the 
regulation of EEG rhythms. The thesis focused on two main components for the application of 
neurofeedback training in forensic psychiatric patients suffering from SUD: 1) Whether these 
patients were able to learn the regulation of the targeted EEG-activity through the training, and 
2) whether altered EEG-activity in the target frequency range lead to a decrease in levels of 
impulsivity and symptoms of drug addiction. 
Main findings
First of all, a systematic review was conducted of studies that applied neurofeedback training 
in adult patient populations presenting with disorders commonly found in forensic psychiatric 
patients. Only studies reporting changes in EEG-frequencies post-treatment (increase/decrease/
no change in EEG amplitude/power) were included in the review (chapter 2). Although the 
search was conducted for numerous disorders, as well as for behavior commonly associated 
with high levels of impulsivity, the search resulted in only 10 studies that fulfilled the inclusion 
criteria. The included studies were all related to neurofeedback training in patients with ADHD, 
schizophrenia, SUD and psychopathy. No studies could be identified that applied neurofeedback 
for cluster B personality disorders, or impulsive behavior often found in forensic psychiatric 
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patients, such as violence. 
For the studies included, EEG-training protocols as well as number of training sessions varied 
greatly. Number of applied training sessions ranged from 10 to 33 sessions. Also, results on 
patients’ ability for EEG-learning varied greatly between studies and patient populations. 
Changes in behavioral outcome measures post-training ranged from no improvements to 
significant symptom reduction. Uncontrolled studies (Arns, Drinkenburg, & Kenemans, 2012; 
Mayer, Wyckoff, Schulz, & Strehl, 2012) found improvements in impulsivity, but no superiority 
of neurofeedback training to TAU could be observed when a sham controlled, blinded approach 
was employed (Schönenberg et al., 2017). The included studies also investigated neurofeedback 
training applied in a single, well-defined disorder, with comorbidities usually being a reason 
to exclude patients from participation. Based on these findings, it can be concluded that more 
research is needed to be able to make inferences about which protocol or how many training 
sessions should result in the most beneficial effects for forensic psychiatric patients. 
In chapter 3, we presented the study protocol for the RCT, as well as for the n-of-1 clinical case 
series. The study took place in the FPC Dr. S. van Mesdag, a maximum security treatment facility 
in Groningen, The Netherlands. Patients in this treatment facility have committed a serious crime 
with a minimal sentence of four years according to Dutch Criminal Law. These patients could 
not be held fully responsible for the crimes they committed due to serious mental disorders. All 
patients in the current study had at least one diagnosis of SUD, as well as comorbid Axis I and/
or II disorders according to DSM-IV-TR (American Psychiatric Association, 2000). For both the 
RCT and the clinical case series, primary outcome variables were the degree of impulsivity, as 
well as levels of craving, and changes in resting-state EEG pattern. First, the RCT design was 
described, which sought to investigate the effects of 20 sessions of theta/SMR neurofeedback 
training and compare the results to a control group who received TAU. In this RCT, impulsivity 
was assessed through a cued Go/No-Go task. Furthermore, actual drug use throughout the study 
was investigated by collecting results on urine and/or breathalyzer analysis. A power analysis 
calculation based on a 1-tailed alpha value of .05, a power value of .80 and an effect size of 
.80 resulted in a recommended sample size of 21 participants in each group. Next, the design 
for a n-of-1 clinical case study was presented. In the clinical case series, four patients in the 
control group of the RCT were randomly assigned to either eight sessions of real theta/SMR 
neurofeedback training or sham neurofeedback training. Comparing the effects of real theta/SMR 
neurofeedback training to sham neurofeedback training allows for investigating possible placebo 
effects of this intervention. An ABA design was employed, where a no-training baseline phase 
(A1) was followed by a neurofeedback training phase (B), which was then followed again by a 
no-training follow-up phase (A2).
In chapter 4, learning success was investigated among a group of forensic psychiatric patients 
for EEG-learning by means of theta/SMR neurofeedback training. We examined whether these 
patients were able to respond to the applied neurofeedback training protocol by examining their 
success in regulation of EEG magnitude in the SMR and theta frequency bands, and to which 
extent these changes in frequency bands were related to improvements in measures of impulsivity, 
craving, and drug intake. Patients were categorized as a ‘neurofeedback-responder’ when they 
showed both a successful upregulation of SMR magnitude and a successful downregulation of 
theta magnitude during at least 11 out of 19 sessions, as well as an average magnitude increase/
decrease in the desired direction of 8% or higher by the end of the training. These criteria were 
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chosen based on the proposed protocol described in Weber, Köberl, Frank, and Doppelmayer 
(2011). Weber et al. (2011) proposed that EEG mean amplitude should change consistently across 
all sessions in the desired direction. As the study by Weber et al. (2011) was conducted with 
healthy participants, these criteria were adjusted to some extent to fit the population at hand. It 
was argued that a consistent change in mean EEG amplitude over all 19 sessions was probably too 
difficult to achieve for forensic psychiatric patients, but that a mean amplitude change over 60% 
of all sessions should be required in order to be qualified as a neurofeedback responder, resulting 
in 11 out of 19 sessions. The necessary average increase/decrease in the desired direction of 8% 
was not adjusted, as an average change in EEG magnitude of less than 8% might not be clinically 
relevant anymore. Results indicated that only four out of 19 patients (21%) were able to achieve 
successful regulation of both frequency bands by these criteria. Patients found it more difficult 
to regulate theta frequency than SMR frequency as evidence by the fact that 63% of patients 
managed to successfully increase the SMR magnitude, whereas only 37% of patients managed 
to decrease theta magnitude. As can be seen in chapter 4, Spearman’s rho correlations between 
number of times patients successfully achieved up- or downregulation in the desired direction 
and height of average increase or decrease in the frequency band was significant at the α<0.01 
level in a single frequency (either theta or SMR) (theta: r=-.972, p<.01; SMR: r=.924, p<.01), 
as well as for the number of times SMR and theta were successfully regulated simultaneously 
(number of times SMR and theta were regulated simultaneously and average success SMR r=.619, 
p<.005, number of times SMR and theta were regulated simultaneously and average success 
theta r=-.697, p<.001) for all patients. A Wilcoxon Signed-ranks test indicated that results on 
the Barratt Impulsivity Scale -11 (BIS-11) and the Desire for Alcohol Questionnaire-SF (DAQ-
SF) were significantly lower post-training (BIS-11: Z=-2.2, p<0.05, r=-.5; DAQ-SF: Z=1.982, 
p< 0.05, r=.45) for all patients, regardless of whether they had been qualified as neurofeedback 
responders or not. However, subsequent multiple linear regression analyses showed that the 
ability to consistently train frequency bands in the desired direction was not related to scores on 
impulsivity measures post-training. The variance in levels of craving post-training could partially 
be explained by whether patients could be categorized as responders, as this was related to the 
increase in SMR frequency but not to a decrease in theta frequency.
In chapter 5, the results of the RCT were presented. The RCT was conducted according to the 
design described in the study protocol in chapter 3. Patients eligible for participation according 
to the inclusion criteria were randomly assigned to either the neurofeedback training group or the 
treatment as usual (TAU) group. Forty-two patients completed all post-treatment measurements, 
of which 21 patients participated in the control group and 21 patients in the neurofeedback training 
group. Neurofeedback training lasted longer than the anticipated 10 weeks originally scheduled. 
This was due to holidays and planning issues, but also due to patients’ inability to commit to 
two training sessions a week. Patients did not feel well enough to attend training sessions, were 
not motivated to participate, or caused aggressive incidents resulting in temporary placement 
on a specialized crisis unit. Participation in the study therefore lasted for an average of 14.1 
(SD=5.32) weeks per patient. Randomization across treatment groups (neurofeedback training or 
TAU) was partially successful, as patients did not differ with regard to pre-treatment descriptive 
statistics, such as mean number of Axis I and II DSM-IV-TR diagnoses (neurofeedback training 
group M=4.52, SD=1.47; TAU group M=4.57, SD=1.63, t(40)=-.09, p=.38) or month in treatment 
prior to inclusion (neurofeedback training group M=91.90, SD=61.70; TAU group M=95.30, 
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SD=73.76, t(40)=-.16, p=.87). Surprisingly however, patients in the neurofeedback training 
group had significantly higher SMR magnitude pre-treatment (Mdn=1.00) than patients in the 
TAU only group (Mdn=.58), U=131.00, p=.02, r=.35). 
Results of the RCT showed that patients who received neurofeedback training managed to 
increase SMR activity over the course of training (Time x Group effect for mean SMR magnitude 
F(1, 40)=5.47, p=.02, medium effect=.12), but failed to decrease theta activity (F (1, 40)=.14, 
p=.71, small effect=.00). Levels of drug craving showed a significant effect for Time (F(1, 40)= 
6.23, p=.02, small effect=.02), but not for Time x Group (F (1, 40)=9.2, p=.34). The same was 
found for the ‘motor impulsivity’ subscale of the BIS-11, which showed a significant effect for 
Time (F(1, 40)=5.61, p=.02, medium effect=.03), but not for Time x Group (F(1, 40)=1.28, 
p=.28). Results for changes in drug use and number of commission errors post-treatment were not 
significant. Therefore, theta/SMR neurofeedback training was not superior to TAU with regards 
to behavioral improvements for the examined patient group. 
Next to the RCT, a small sham-controlled clinical case series was employed in chapter 6 to 
investigate interpersonal and individual differences between patients with regard to successful 
EEG-learning more deeply. As can be seen in the study protocol described in chapter 3, an ABA 
design was employed where a no-training baseline period (A1) was followed by eight sessions of 
neurofeedback training (B1), followed again by a no-training follow-up period (A2). Four patients 
were randomly assigned to a real theta/SMR neurofeedback intervention, as compared to sham 
neurofeedback, where no frequency band was trained systematically. One patient in the sham 
neurofeedback condition dropped out before the start of the neurofeedback training period (B1). 
Levels of impulsivity, drug craving, as well as drug intake were closely monitored over the course 
of this study. Results of this clinical case series were investigated by means of non-overlap of all 
pairs-scores (NAP-scores), which indicates data overlap between training and no-training phases 
in single-case studies and is seen as one of the best indexes to provide insight into the effect of 
intervention (Parker & Vannest, 2009). Also, simulation modeling analysis (SMA) was applied, 
testing change in level and slope of an outcome measure between two phases (Van Yperen, 
Veerman, & Bijl, 2017). Results of the clinical case study indicated that both patients in the real 
neurofeedback condition responded differently to the training in terms of change in outcome 
measures, with one of the patients receiving real theta/SMR neurofeedback benefitting more 
from the training than the other patient. This patient showed a significant decrease in impulsivity 
as measured with the BIS-11, with NAP-scores showing a strong effect (NAP=1.00, p≤0.001). 
When correcting for autocorrelation of NAP-scores, SMA-analysis revealed a significant level 
change (r=-.85, p≤.05). Reduction in BIS-11 scores were not only observable in the total score of 
the BIS-11, but also in the subscales ‘motor’ and ‘non-planning’. The subscale ‘motor’ showed 
a significant decrease over all phases (baseline phase A1 versus follow-up phase A2: NAP=1.00, 
p≤.001; baseline phase A1 versus training phase B: NAP=.95, p≤.001; training phase B versus 
follow-up phase A2: NAP=.92, p≤.001). Results regarding levels of craving as measured with 
the DAQ-SF showed that this patient also had a significant reduction in DAQ-SF scores when 
comparing baseline phase A1 with follow-up phase A2 (NAP=1.00, p≤0.001). This effect was 
still highly significant when correcting for autocorrelation with SMA (level change r=-.96, 
p≤0.001). He also showed partial signs of neurofeedback learning, as he was able to increase 
SMR frequency (NAP=.75; p≤.05) over the course of training, however, this effect did not remain 
significant when controlling for autocorrelation with SMA (r=.53, p=≥.05). Theta magnitude did 
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not change (NAP=.38, p≥.05). 
For the other patient who also received the real theta/SMR neurofeedback training, results 
indicated a significant reduction in BIS-11 total score when comparing baseline phase A1 versus 
follow-up phase A2 (NA =.82, p≤.001), however, this effect did not remain significant when 
controlling for autocorrelation with SMA (r=-.59, p=≥.05). Results regarding levels of craving 
showed that this patient had a significant slope change (r=-.67, p≤.05) that indicated an increase 
during baseline phase A1, followed by a decrease in follow-up phase A2. He showed no signs of 
EEG-learning, as SMR magnitude did not increase. 
The patient in the sham neurofeedback condition did not show significant results with regard to a 
decrease in impulsivity, but rather showed an increase in BIS-11 scores by the end of follow-up 
phase A2 (NAP=.22, p<.001), although this effect did not remain significant when controlling 
for autocorrelation with SMA levels of drug craving (A1 versus A2: NAP=.50, p≥.05; A1 versus 
B: NAP=.64, p≥.05; B versus A2: NAP=.60, p≥.05). While not training SMR magnitude during 
the intervention, mean SMR magnitude showed a significant decrease by the end of follow-
up phase A2 (NAP=.25, p<.05), but this effect did not remain significant when controlling for 
autocorrelation with SMA. Theta magnitude increased significantly (NAP=.81, p<0.01). In 
sum, although all patients in the real neurofeedback condition received the same theta/SMR 
neurofeedback training protocol, one of the patients benefitted significantly more than the other 
patient from the training in terms of clinical improvements. 
Reflection on findings - EEG-learning
In order to show the efficacy of neurofeedback training, it is a necessary first step to show that 
successful EEG-learning has occurred (Gruzelier, Egner, & Vernon, 2006; Zuberer, Brandeis, & 
Drechsler, 2015). The results of the current study show that the neurofeedback training protocol 
applied in this study did not result in the expected significant changes in EEG-frequency bands 
for 15 out of 19 patients who received theta/SMR neurofeedback in chapter 4, and for one of the 
two patients in the clinical case series. When comparing changes in frequency bands post-training 
to results from a control group, only the SMR magnitude showed a significant effect over time 
and group. 
In the study described in chapter 4, the criteria set by Weber et al. (2011) were slightly adjusted 
as these criteria were originally established in a group of healthy college students. Forensic 
psychiatric patients may have more difficulties in learning new behavior and hence the criteria 
for EEG-learning were less strict. However, even with the adjusted criteria, only four out of 
19 patients (21 %) managed to show evidence of EEG-learning. Also, not only did most of the 
patients not learn to increase or decrease their EEG magnitude in the desired direction, for six of 
the 19 patients investigated in chapter 4, a pattern of EEG magnitude change was observed that 
was opposite to the one the protocol was aiming for (decrease where an increase was the aim of 
the protocol and/or vice/versa). An important note to be made is that this study was the first in 
this target group, and that guidelines about which protocol best fits a group of forensic patients 
were not available.
In this study, conscious learning strategies applied by patients to regulate the video-games at 
hand with the neurofeedback intervention were not assessed. Therefore, the results with regard 
to EEG-learning found in this study must be interpreted with caution. Non-responder rates to 
neurofeedback training of about 15-20% are considered normal in research on so-called “brain-
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computer illiteracy” (Blankertz et al., 2010). However, the fact that almost 80% of the forensic 
psychiatry patients in this study were classified as non-responders suggests that the theta/SMR 
neurofeedback protocol might have been too difficult for this special patient population. Rogala 
et al. (2016) have investigated previous studies on neurofeedback training and EEG-learning, 
and suggested that performance in neurofeedback training is related to the number of training 
parameters, with less training parameters resulting in better outcome measures. Apparently, 
for healthy participants or patients with less severe disorders, two EEG-training parameters 
are manageable, but these EEG-learning patterns seem to be incongruent with EEG-learning 
observed in the current population. It is possible that for forensic psychiatric patients, the fact that 
two frequency bands had to be adjusted simultaneously provided too big a challenge. 
Another possible explanation is that for forensic psychiatric patients, EEG-learning might take 
different patterns to manifest than in other populations. EEG-learning might take more time to 
manifest, and may therefore require a higher number of sessions than the applied 20 sessions in 
the current RCT. However, performance in early sessions of neurofeedback training has been 
shown to predict performance in later sessions (e.g., Kübler, Neumann, Wilhelm, Hinterberger, 
& Birbaumer, 2004; Neumann & Bierbaumer, 2003; Weber et al., 2011). It therefore remains 
questionable whether more training sessions would have actually resulted in more EEG-learning 
in forensic psychiatric patients. Possibly, a more intense training protocol with sessions every 
day or every other day could perhaps have resulted in more training success. Rogala et al. (2016) 
found a tentative association between training success ratio and training intensity. It is debatable 
however, if a greater training intensity is actually possible in forensic patients because in general, 
forensic psychiatric patients tend to have low treatment motivation (e.g., Vandevelde, Broekaert, 
Schuyten, & van Hove, 2005), as well as lower capacity due to complex mental illness to comply 
with intense treatment schedules. In the RCT described in chapter 5, seven of the 29 patients 
dropped-out during the training due to lack of motivation to follow the planned 20 sessions. It 
is likely that even more patients would have dropped out if more sessions and/or a more intense 
training schedule had been required. Also, none of the patients was able to follow the training as 
originally scheduled, as training sessions twice a week were apparently too intensive for some 
patients. It remains uncertain why so few patients managed to successfully regulate the targeted 
EEG-frequencies. Psychological factors such as level of education, personality, personality 
disorders, psychopathology in general, mood, and age have also been proposed to influence the 
success of EEG-learning. Results of previous studies are, however, inconclusive. Some studies 
showed no association between the factors listed above (Hammer et al., 2012; Reichert, Kober, 
Neuper, & Wood, 2015), whereas other studies have demonstrated positive effects of motivational 
factors on learning performance (e.g., challenge and mastery confidence: Nijboer, Birbaumer, & 
Kübler, 2010). For all possible mechanisms assessed in previous studies, results must be examined 
with caution, especially because mechanisms that apply to a healthy population (or even a patient 
population with less sever psychopathology) cannot simply be applied to a forensic population. 
As can be seen from the systematic review of the literature in chapter 2, there are hardly any 
previous studies using neurofeedback training in populations comparable to the population at 
hand. Although the influence of psychopathology on patients ability to regulate EEG-frequencies 
has been investigated in some patient populations (e.g., in schizophrenia patients in the study 
by Schneider et al., 1992; or in psychopathic patients in the study by Konicar et al., 2015), it 
is unclear how this manifests in such a heterogeneous sample as the one in this study, where 
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patients suffered from multiple disorders and comorbid problems. Replication studies are needed, 
as well as studies on new EEG protocols for patients with severe mental illness to be able to make 
inferences about the precise nature of this association. 
With regard to the current study, and patients’ ability to regulate EEG-frequencies, we observed a 
difference between patients’ ability to increase SMR magnitude and to decrease theta magnitude. 
For the patients in our study, it seemed easier to increase the SMR frequency than to decrease 
the theta frequency. The results reported in chapter 4 show that more patients could have been 
qualified as responders if only SMR activity had been considered, and the results of the RCT 
described in chapter 5 show a significant effect for SMR magnitude post-training, but not for 
theta magnitude. Of the three forensic psychiatric patients included in the clinical case-series 
described in chapter 6, one patient showed a trend towards successful SMR regulation, while 
none of the patients showed effects with regard to theta activity. 
A few studies have identified predictors for successful SMR regulation. In studies by Reichert et 
al. (2015), and Blankertz et al. (2010), healthy participants’ ability to enhance SMR power was 
related to their resting-state SMR power pre-training, and this SMR resting-state power was a 
predictor of learning performance of SMR. This phenomenon has been explained by very low 
levels of SMR found in some individuals, which make it difficult to record SMR activity on 
the scalp (Reichert et al., 2015), resulting in inadequate feedback during neurofeedback training 
trials. Surprisingly, patients in the intervention group of the RCT described in chapter 5 had 
higher levels of SMR magnitude at baseline. We cannot explain why this baseline difference 
was observed, as participants were randomly assigned to either one of the two conditions, and 
did not differ with regard to any other baseline characteristic. However, this baseline difference 
could possibly be of influence in patients’ ability to increase SMR activity. Possibly, the higher 
resting-state SMR power helped patients to be better able to further increase SMR over the course 
of training. However, resting-state SMR power was not used to investigate learning performance, 
so conclusions remain tentative. 
When looking at an individual patient level by investigating the personality characteristics of 
single patients in the clinical case series reported in chapter 6, we could conclude that the patient 
who managed to increase SMR activity and benefitted most from neurofeedback training, was 
the same patient with the most severe cluster B personality disorders, presenting with a diagnosis 
of borderline, antisocial and histrionic personality disorder. This patient showed the highest score 
on impulsivity at the start of the training compared to the other two patients, but was apparently 
more able to reduce impulsivity over the course of training. He also had the least amount of SUD 
diagnoses and showed the lowest magnitude of SMR in the first two sessions as compared to the 
other patients.
It has been suggested that the feedback-learning of EEG parameters is comparable to common 
motor learning (Hammer et al., 2012; Lang & Twentyman, 1976), and that participants with 
better visual-motor coordination abilities seem to learn better SMR regulation (Hammer et al., 
2012). Participants’ ability to focus and concentrate at the task at hand has also been shown to be 
of influence for SMR training performance (Hammer et al., 2012). This point might underline the 
difficulties that treatment supervisors face when it comes to applying neurofeedback training in 
forensic treatment settings, as highly impulsive patients have more trouble to sit still, and to focus 
and concentrate on the task at hand due to the disorders they seek treatment for. 
It seems unlikely that the differences between SMR and theta band regulation were due to the fact 
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that participants found it easier to up-train a brain frequency rather than to down-train a frequency 
band. In a study by Blankertz et al. (2010), SMR frequency was trained, but unlike the approach 
of the current study, participants were instructed to systematically reduce SMR power over the 
course of training. Still, about 23.5% of participants were qualified as non-responders. It appears 
that either the theta frequency possesses special challenges for regulation with neurofeedback 
training, or regulating more than one parameter is already too difficult. 
In sum, the applied theta/SMR neurofeedback protocol only resulted in partial effects on EEG-
frequencies, as only significant changes in the SMR frequency could be found post-training. It 
remains speculative as to which factors led to the results found in this study and this should be 
further investigated in future studies. 
Reflections on findings – behavioral effects of neurofeedback training
Results of neurofeedback training should also adhere to the condition of interpretability (Zoefel, 
Huster, & Herrmann, 2010). That is, before applying neurofeedback, the targeted EEG-frequency 
bands should be associated with certain cognitive functions in order to increase the probability 
of reliable behavioral effects post-training. A central hypothesis in neurofeedback research is that 
the normalization of deviant EEG-frequencies leads to improvements in behavior. In the current 
thesis, results on behavioral measures were mixed. In the study described in chapter 4, patients 
showed a decrease in impulsivity as assessed with the BIS-11, as well as in drug craving and 
number of positive drug testing. However, when these patients were compared to patients in the 
TAU-only group in chapter 5, none of the measurements showed a significant decrease post-
training for the neurofeedback training group that was superior to patients in the TAU-only group. 
When linking results on EEG-regulation to effects on a behavioral level, it seemed that only 
changes in SMR-activity were related to changes in behavioral outcome measures.
In chapter 4, only a decrease in levels of craving post-training was associated with the average 
increase in SMR-activity. In the clinical case series presented in chapter 6, self-report scores of 
impulsivity did decrease for one of the patients who also showed a significant increase in mean 
SMR magnitude. However, the association between these two measures was not assessed, so 
no conclusions can be drawn about the association between SMR increase and decrease in self-
reported impulsivity for this patient. 
Paradoxically, there are many studies that report improvements in clinical symptoms while 
no changes on a cortical level could be found. Gevensleben et al. (2014) for example used a 
slow cortical potential neurofeedback training in children with high levels of impulsivity 
due to ADHD, and they report a reduction in impulsivity symptoms of 20% post-training, 
while participants were only able to partially learn the neurofeedback paradigm. Liechti et al. 
(2012) found no changes in theta and/or beta frequency bands, but observed improvements in 
impulsivity post-training. The study by Arani, Rostami, and Nostratabadi (2010) found only a 
partial change in frequency bands in the desired direction, but did find significant improvements 
in symptoms of SUD, such as desire to use and relief from withdrawal. Behavioral effects have 
even been found when participants regulated their cortical activity in the opposite direction as 
intended, as Arns et al. (2012) found improvements in levels of impulsivity, even though SMR 
magnitude decreased instead of increased. These findings raise the question whether unspecific 
effects of neurofeedback training possibly play a role in explaining effects of the intervention. It 
has frequently been suggested that much of the behavioral effects observed for neurofeedback 
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training result from patient-therapist interaction, learning to sit still and positive expectations of 
outcomes (Barth, Mayer, Strehl, Fallgatter, & Ehlis, 2017). 
Other studies report outcomes on behavioral measures that are comparable to the outcomes 
reported in the current study. In Schönenberg et al. (2017), impulsivity levels decreased equally 
for participants in a neurofeedback training group as for participants in the sham or meta-
cognitive therapy group. In a study by Bink, Nieuwenhuizen, Popma, Bongers and van Boxtel 
(2015), hyperactivity/impulsivity levels in ADHD participants decreased equally for participants 
in the control group and the intervention group. Most importantly, the studies by Schönenberg et 
al. (2017) and Bink et al. (2015) also found no changes in EEG-frequencies due to neurofeedback 
training. No changes could be observed in participants’ theta/beta ratio by the end of the training 
in Schönenberg et al. (2017), and in Bink et al. (2015), none of the frequency bands showed 
an effect over time. In a sample of alcohol dependent patients, Lackner et al. (2016) found no 
significant improvements on craving levels, as well as non-specific symptoms such as depressive 
and psychiatric symptoms. Changes in alpha and theta frequency were only significant by trend. 
In conclusion, the current study did not find results on a behavioral level that can be linked 
to the employed theta/SMR neurofeedback training protocol. As mentioned above, only partial 
changes in EEG-frequencies in this study could be observed. Changes in theta frequency post-
training were not found to be related to changes on behavioral outcome measures, so it seems 
unlikely that more improvements in the intended EEG-frequency bands would have resulted in 
more improvements on a behavioral level. 
Limitations of the current study
As with every research, there are some limitations of the current study. First of all, we did not 
apply a pilot study to test for possible omissions with the applied neurofeedback training protocol. 
A pilot study might have helped to assess the apparent difficulties patients had in learning the 
theta/SMR neurofeedback training protocol used in this study early on. The main reason not to 
employ a pilot study was the difficulties we expected concerning patient recruitment. Forensic 
psychiatric patients are a difficult patient group when it comes to conducting large randomized 
trials, partly because of a lack of motivation and heightened levels of suspiciousness about 
possible negative influences of outcome measures in legal documents. We did our best to inform 
patients about their right to resign from the study at any point during participation without any 
negative consequences, and yet found it difficult to include more than the necessary 42 patients 
to reach the necessary power. 
Next, except for the clinical case series in chapter 6, the studies described in this thesis were 
not sham controlled. While sham controlled studies are considered the highest possible standard 
for assessing the efficacy of an intervention, it is questionable whether this approach is the most 
suitable for assessing the efficacy for neurofeedback in such a vulnerable patient population. 
First, some learning of EEG-regulation cannot be ruled out when using a sham condition where 
assumingly irrelevant frequency bands are trained. Second, a placebo condition does not allow 
for the assessment of the indirect non-specific effects mentioned above. Most importantly, the 
use of a placebo or sham condition raises ethical questions when it comes to applying these 
conditions to forensic psychiatric patients. Given that these patients lack motivation to participate 
in treatment as it is, but are also often times not able to undergo long treatment sessions due to 
their clinical symptoms, forcing a large number of mock training sessions on these patients might 
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further diminish their motivation to participate in treatment. 
Another limitation of the current study is the fact that effects were not controlled for possible 
medication intake of patients. Stimulant medications such as methylamphetamine and/or 
dexamphetamine have shown to normalize certain EEG-frequencies, and lead to a reduction of 
theta activity and an increase in low beta band activity (e.g., Clarke, Barry, McCarthy, Selikowitz, 
Brown, & Croft, 2003; Saletu, Anderer, & Saletu-Zyhlarz, 2006). Other studies reported no 
differences with regard to effects of neurofeedback training on the core symptoms of ADHD 
(inattention, hyperactivity and impulsivity) between participants medicated with methylphenidate 
and participants without medication (Arns, de Ridder, Strehl, Breteler, & Coenen, 2009). Although 
type of medication and dosage were assumed to be stable over the course of the current study, 
and generally, patients had been on their particular medication for quite a while, it is possible that 
different types of medication will influence baseline EEG-activity and therefore also patients’ 
ability to regulate their own EEG-activity. Patients might not be able to regulate their EEG-
activity beyond what is already established by medication use. Additional research is needed 
to investigate effects of different types of medication and medication dosage on EEG-learning. 
However, with regard to medication intake, an important note must be made: It can be considered 
unethical to ask patients to stop medication intake for the sake of an intervention of which the 
clinical benefits are still uncertain. Given the special setting of the current research, terminating 
medication intake could also be considered irresponsible, as this might have increased chances 
for patients to experience more symptoms that could have increased risks for aggressive and 
violent behavior. 
It is possible that medication intake of some patients also affected behavioral outcome measures. 
Some common antipsychotic medications like risperidone, olanzapine or clozapine are 
hypothesized to affect levels of craving (Machielsen et al., 2012). Machielsen et al. (2012) for 
example found diminished levels of craving for cannabis dependent schizophrenic patients using 
risperidone, as well as van Nimwegen et al. (2008) who found a decrease in craving levels for 
risperidone and olanzapine. More than 50% of patients in the RCT described in chapter 5, and in 
the study in chapter 4 were diagnosed with schizophrenia or related disorders. While the use of 
medication was not assessed, it is very likely that these patients received one of the antipsychotic 
medications described above, and that these patients report less craving due to their medication. 
Clinical implications and directions for future studies
Based on the results of the studies in this thesis, it can be concluded that the applied theta/SMR 
neurofeedback protocol in the current form is only suitable for a small group of forensic psychiatric 
patients. The results of this study suggest that forensic psychiatric patients with SUD and comorbid 
disorders are not able to simultaneously regulate their theta as well as SMR magnitude. Future 
research should focus on identifying interpersonal mechanisms that predict successful learning of 
EEG-activity in general, as this can be seen as a necessary condition that must be met in order to 
establish improvements on clinical outcome measures. More specifically, future research should 
focus on a) whether forensic psychiatric patients are able to train more than one EEG-frequency 
at a time and b) whether differences in EEG-learning abilities can be traced back to specific 
EEG-frequency bands. This study only made use of one specific neurofeedback training protocol, 
while many other protocols can be considered. Possibly, a SMR-only neurofeedback training 
protocol is better suited for forensic psychiatric patients instead of a protocol that trains two 
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parameters at once. There are also more types of neurofeedback training protocols to consider, 
which might be able to achieve better effects for this patient population. However, specifically for 
highly impulsive patients, the meta-analysis by Arns et al. (2009) found no differential effects for 
different neurofeedback training protocols such as theta/beta training, theta/SMR or training of 
the slow cortical potential on impulsivity, but the study did not investigate differential effects of 
the different protocols on EEG-frequency bands. Possibly, other training protocols will achieve 
more EEG-learning in forensic psychiatric patients. Future studies should then also investigate 
whether specific patient populations are better able to regulate specific brain frequencies, and to 
what extent this affects clinical outcome measures. Patients who are not able to regulate brain 
frequencies then need to be offered different forms of treatment that are better suited. 
As mentioned above, some studies have suggested ways to predict patients’ EEG-performance 
from baseline characteristics or performance during early sessions, but these lines of research 
need to be investigated further to establish clear performance indicators. Especially for the 
patients studied in this thesis, it is crucial to not force a large number of training sessions upon 
them, which will most likely not help them, and therefore diminish their motivation for treatment 
even further. “Finding possible predictors that are linked to underlying mechanisms of cortical 
learning will help to identify important factors that should be taken into account to promote 
neurofeedback efficacy” (Alkoby, Abu-Rmileh, Shriki, & Todder, 2017, p.4).
Halligan and David (2001) have termed the phrase ‘cognitive neuropsychiatry’, which attempts 
to establish the functional organization of psychiatric disorders within a framework of cognitive 
neuropsychiatry and psychopathology, and linking this framework to relevant brain structures 
and their pathology in order to better understand psychiatric conditions. Within this framework, 
they emphasize the importance of clinical case studies. They argue that, averaging symptoms 
over a whole patient group might neglect important individual differences, as psychopathology 
or brain damage might manifest differently between individuals. Concerning our current study, 
applying a one-size-fits-all neurofeedback training protocol in order to be able to compare effects 
of a treatment for a whole group of patients might not have been the most suitable approach, 
given that in this specific patient population, clinical symptoms and disorders manifest in a highly 
variable way. The different comorbidities and SUD, as well as varying forms of medication, might 
lead to different manifestations in brain and behavior as compared to patient populations where 
medication intake is restricted, and patients with comorbidities are excluded from participation. 
For this thesis, the decision to not restrict inclusion criteria any further had been well thought 
through. First, restricting participation for the study to patients without an axis I disorders for 
example, would have seriously diminished our sample size, which wasn’t an option since the 
research group was already small. Although our response rate was quite large with 63%, and the 
drop-out rate for the neurofeedback training group was rather low (27.5%), we still encountered 
difficulties when recruiting patients for participation. Of all patients residing in the treatment 
facility who were diagnosed with a SUD, more than 30% were not eligible for participation 
because of pending release or transfer from the treatment facility, or clinical symptoms too severe 
to be able to participate (such as psychotic symptoms). Also, many patients were hesitant to 
undergo 20 sessions of an intervention of which the efficacy has yet to be proven. Especially for 
patients with schizophrenia, the thought of participating in an intervention where electrodes are 
placed on the scalp in order to record brain activity was often times a scary thought that prevented 
them from signing up for participation. Notwithstanding the power requirement was met, the 
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sample size in the RCT was quite small, yet, it was comparable to most of the studies assessed 
in chapter 2 (with the exception of the study by Konicar et al., 2017). Second, heightened levels 
of impulsivity can be found in almost all forensic psychiatric patients, regardless of diagnosis. 
The aim of this thesis therefore was to assess the applicability and efficacy of neurofeedback for 
forensic psychiatric patients with SUD, not only for a specific subset of forensic patients. 
In recent years, the approach of personalized medicine has received increasing attention in 
psychiatric treatment and research. In line with that, studies have emphasized the benefits of 
QEEG-guided neurofeedback protocols, in which baseline EEG-deviations are assessed, and 
neurofeedback training protocols are then tailored to the specific deviations found on pre-
training assessment, as well as to the specific clinical complaints of the patient. This approach 
might also treat more than one specific clinical complaint and improve well-being in general, 
as EEG-deviations can result in a number of subjective complaints. Investigating the effects of 
neurofeedback training with a clinical case study could then provide practitioners with valuable 
information about interpersonal differences that they can apply in subsequent cases.
The success of neurofeedback training for forensic patients might also lie more in secondary 
factors such as dealing with stress and/or anxiety, which are especially pronounced during the 
first phases of recovery (Scott, Kaiser, Othmer, & Sideroff, 2005), rather than normalizing (all) 
EEG-deviations. Previous studies have shown that patients who underwent neurofeedback 
training stayed in treatment significantly longer than patients who did not (e.g., Scott et al., 2005). 
For forensic psychiatric patients, treatment progress will almost certainly benefit from treating 
attention deficit and/ or impulsivity (Keith, Rapgay, Theordore, Schwartz, & Ross, 2015).
Concluding remarks
Suffering from addiction is a life changing clinical disease, affecting every part of an individual’s 
life and his environment. Decades of studies with individuals suffering from substance use 
disorder have shown that addiction recovery is not sobriety alone. High rates of comorbid 
disorders, PTSS, childhood (sexual) abuse and trauma seem to play an important part in present 
attempts to recovery (Vigilant, 2008), and these factors are also present in many forensic patients. 
The phrase ‘multiple recoveries’ has been termed to describe the many stages of reparations 
involved (Giddens, 1991) in order for individuals to recover from the psychological, physical 
and emotional strains of addiction (Vigilant, 2008). For forensic psychiatric patients, the road 
to recovery may provide even more challenges, and gaining control over addiction is a crucial 
step towards starting a new life after inpatient treatment. Substance abuse treatment, where the 
treatment matches a patient’s etiology and maintaining factors should be more effective than a 
generalized substance abuse treatment aimed to fit a wide variety of patients (Tomko, Bountress, 
& Gray, 2016). Neurofeedback training may just be one of the interventions employed in order 
to achieve recovery, but it can never stand alone. Future studies will hopefully help to shed light 
on which patients will be able to benefit most from the training, but even so, integrating this 
treatment into a wider treatment approach, where impulsive behavior is understood as affecting 
not only addictive behavior, but also chances for violence, aggression and self-harming behavior, 
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This study is set in the FPC Dr. S. van Mesdag, a forensic psychiatric center (FPC) in Groningen, 
The Netherlands. Patients in this maximum security treatment facility are male forensic 
psychiatric patients with at least one mental disorder according to DMS-IV-TR (APA, 2000). 
Next to other mental disorders, about 70% of patients are diagnosed with substance abuse 
problems. Patients are receiving compulsory treatment by order of the state after committing 
a violent crime with a minimum penalty of at least four years according to Dutch jurisdiction 
(called Terbeschikkingstelling, or TBS; Van Marle, 2002). Due to mental illness, these patients 
were held only partially responsible for the crime they committed. The aim of the treatment is to 
reduce clinical symptoms that are considered high-risk for reoffending, and to integrate patients 
back into society by the means of stepwise furlough and expansion of liberties. 
Background
Individuals with mental illness tend to exhibit inadequate coping mechanisms in response to 
stressful situations. Their behavior is often times rash and impulsive and can, in some cases, lead 
to acting-out behavior with significant negative consequences in the long term, such as the use of 
violence and committing criminal acts (Samuels, 2011; Pompili, Carlone, Silvestrini, & Nicole, 
2017). Patients within a forensic psychiatric treatment facility usually present with an average of 
3.5 diagnoses per patient (Van Nieuwenhuizen et al., 2011). Most common disorders are SUD, 
schizophrenia, attention-deficit/hyperactivity disorder (ADHD), impulse control disorders, and 
cluster B personality disorders, such as antisocial, borderline or narcissistic personality disorder 
(Schuringa, Heininga, Spreen, & Bogaerts, 2018; Simpson, Grimbos, Chan, & Penny, 2015). 
In order to treat these disorders, a broad range of treatment forms is applied, such as cognitive 
behavioral therapy, schema-focussed therapy and/ or non-verbal therapy. A complicating factor 
for effective treatment and compliance is the presence of complex comorbid problems such as 
high levels of impulsivity and substance use disorder (SUD). Impulsivity can be defined as a 
dysfunctional personality trait, resulting in a tendency for an individual to display behavior that 
is performed with little or inadequate forethought and little consideration for consequences of 
the own behavior (Evenden, 1999; Verdejo-Garcia, Lawrence, & Clark, 2008). For disorders 
high in impulsivity, increased prevalence of SUD is rather common (e.g. Loree et al., 2015). 
High levels of impulsivity are strongly associated with the development, maintenance and relapse 
in substance abuse and addiction (Hawinks, Catalano, & Miller, 1992; Charney, Zikos, & Gill, 
2010)  When moving from recreational to compulsive drug use, the use of an addictive substance 
is continued despite the negative consequences of prolonged drug abuse. Poor response control 
is associated with rapidly escalating drug use, where control over drug intake is lost and drug 
use starts to become compulsive (Perry & Carroll, 2008). Highly impulsive patients also tend to 
experience symptoms of withdrawal more seriously than less impulsive patients, as they report 
higher scores of craving for substances than patients with lower impulsivity scores (Joos et 
al., 2013), making them even more prone for relapse. Addictive substances may also increase 
impulsivity levels, as a structural state of reduced inhibitory control due to substance abuse leads 
to long-lasting neurocognitive and neurophysiological changes (Perry & Carroll, 2008). Once 
individuals seek treatment for substance abuse problems, treatment success is seriously hampered 
by high level of impulsivity (e.g., Charney, Zikos, & Gill, 2010; Van der Veeken, Lucieer, & 
Bogaerts, 2016). For forensic psychiatric patients especially, the maintenance of substance 
abuse poses risk for treatment failure. Drug abuse is a strong predictor of violent behavior, and 
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subsequent violent criminal recidivism (Duke, Smith, Oberleitner, Westphal, & McKee, 2018; 
MacDonald, Erickson, Wells, Hathaway, & Pakula, 2008). 
Neurofeedback is an intervention that uses real-time EEG measurements and displays 
information about these EEG measurements back to the participant, allowing them to not only 
see but also change their brain electrical activity over time (Sokhadze, Stewart, Tasman, Daniels, 
& Trudeau, 2011). By principles of operant conditioning, participants learn to reinforce or inhibit 
specific frequencies of the EEG-activity (Scott, Kaiser, Othmer, & Sideroff, 2005) and thereby 
normalize abnormal EEG states, which in turn aims at changing abnormal psychological states 
(Gunckelman & Johnstone, 2005). Sensors are placed on the scalp and moment-to-moment 
information about brain activity is fed back to the participant (Hammond et al., 2011). Several 
studies have shown neurofeedback to be a promising intervention for various disorders, ranging 
from SUD to attention deficit hyperactivity disorder (ADHD) (Sokhadze et al., 2011). For the 
reduction of high levels of impulsivity, neurofeedback protocols typically focus on the reduction 
of slow wave activity such as theta, and enhancement of faster activity such as beta or SMR. 
Elevated theta activity has been consistently linked with higher levels of impulsivity across 
various subject populations (e.g., Bresnahan & Barry, 2002; Hermens, Kohn, Clarke, Gordon, 
& Williams, 2005; Stenberg, 1992). Increased SMR activity is seen when humans try to inhibit 
a motor response, and neurofeedback training where the SMR activity has been up-trained has 
been found to facilitate thalamic inhibitory mechanisms. 
Neurofeedback is in its basics non-verbal and relies on the principles of operant condition, 
making it a suitable treatment intervention for a wide range of patient populations. Still, to date 
neurofeedback is hardly used in the forensic psychiatric domain. A possible reason for this could 
be the lack of guidelines that indicate how many sessions are needed to reach desired effects, 
or which patients are most likely to benefit from the training in terms of reduction of clinical 
symptoms. 
This dissertation set out to investigate the efficacy of a theta/SMR neurofeedback intervention as 
an alternative for standard treatment of forensic psychiatric patients who suffer from disorders 
characterized by heightened levels of impulsivity, as well as comorbid substance use disorder. 
Systematic review of the literature
In order to investigate to what extent neurofeedback training has been applied in disorders most 
commonly found in forensic psychiatric patients, chapter 2 presents a systematic review of 
previous studies on neurofeedback training for mental disorders commonly found in forensic 
psychiatric patients. The article discusses the implications of these studies for the applicability 
of neurofeedback training in forensic psychiatric patient populations. Although the search was 
conducted for numerous disorders, as well as for behavior commonly associated with high levels 
of impulsivity, the search resulted in only 10 studies that fulfilled the inclusion criteria. The 
included studies were all related to neurofeedback training in patients with ADHD, schizophrenia, 
SUD and psychopathy. No studies could be identified that applied neurofeedback for cluster B 
personality disorders, or impulsive behavior often found in forensic psychiatric patients, such as 
violence. 
For the studies included, EEG-training protocols as well as number of training sessions varied 
greatly. Number of applied training sessions ranged from 10 to 33 sessions. Also, results on 
patients’ ability for EEG-learning varied greatly between studies and patient populations. 
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Changes in behavioral outcome measures post-training ranged from no improvements to 
significant symptom reduction. Uncontrolled studies (Arns, Drinkenburg, & Kenemans, 2012; 
Mayer, Wyckoff, Schulz, & Strehl, 2012) found improvements in impulsivity, but no superiority 
of neurofeedback training to TAU could be observed when a sham controlled, blinded approach 
was employed (Schönenberg et al., 2017). Based on these findings, it can be concluded that more 
research is needed to be able to make inferences about which protocol or how many training 
sessions should result in the most beneficial effects for forensic psychiatric patients. 
Study Protocol
In order to investigate the effects of neurofeedback training on forensic psychiatric patient, several 
studies were performed. Chapter 3 describes the study protocol for a randomized controlled trial 
(RCT) design with a n-of-1 clinical series. All patients in this study had at least one diagnosis 
of SUD, as well as comorbid Axis I and/or II disorders according to DSM-IV-TR (American 
Psychiatric Association, 2000). For both the RCT and the clinical case series, primary outcome 
variables were the degree of impulsivity, as well as levels of craving, and changes in resting-
state EEG pattern. The RCT compared the effects of 20 sessions of theta/SMR neurofeedback 
training to a control group who received TAU only. In this RCT, impulsivity was assessed with 
the Barratt Impulsivity Scale (BIS-11) and a cued Go/No-Go task. Furthermore, levels of craving 
were assessed with a modified form of the Desire for Alcohol Questionnaire, as well as actual 
drug use by collecting results on urine and/or breathalyzer analysis. 
To investigate interpersonal and individual differences between patients with regard to successful 
EEG-learning more deeply, a N-of-1 clinical case series was also employed. In the clinical case 
series, four patients in the control group of the RCT were randomly assigned to either eight 
sessions of real theta/SMR neurofeedback training or sham neurofeedback training. Comparing 
the effects of real theta/SMR neurofeedback training to sham neurofeedback training allows for 
investigating possible placebo effects of this intervention. An ABA design was employed, where 
a no-training baseline phase (A1) was followed by a neurofeedback training phase (B), which was 
then followed again by a no-training follow-up phase (A2). During the course of the study, the 
same questionnaires that were assessed during the RCT were also assessed. 
Neurofeedback learning
Chapter 4 reports the results for a subset of the patients who participated in neurofeedback 
training. It was investigated whether forensic psychiatric patients diagnosed with SUD were 
able to learn to regulate neurophysiological activity through a theta/SMR neurofeedback and 
to what extent magnitude changes in these frequency bands were related to changes in levels 
of impulsivity. Criteria for qualifying patients as responders were established and scores on 
impulsivity measures and changes in level of craving over time were assessed. Patients were 
categorized as a ‘neurofeedback-responder’ when they showed both a successful upregulation 
of SMR magnitude and a successful downregulation of theta magnitude during at least 11 out 
of 19 sessions, as well as an average magnitude increase/decrease in the desired direction of 8% 
or higher by the end of the training. These criteria were chosen based on the proposed protocol 
described in Weber, Köberl, Frank, and Doppelmayer (2011). Results indicated that only four 
out of 19 patients (21%) were able to achieve successful regulation of both frequency bands by 
these criteria. Patients found it more difficult to regulate theta frequency than SMR frequency as 
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evidence by the fact that 63% of patients managed to successfully increase the SMR magnitude, 
whereas only 37% of patients managed to decrease theta magnitude. As can be seen in chapter 
4, Spearman’s rho correlations between number of times patients successfully achieved up- 
or downregulation in the desired direction and height of average increase or decrease in the 
frequency band was significant at the α < 0.01 level in a single frequency (either theta or SMR), 
as well as for the number of times SMR and theta were successfully regulated simultaneously. 
Results also indicated that impulsivity levels, as well as levels of craving were significantly lower 
post-training for all patients, regardless of whether they had been qualified as neurofeedback 
responders or not. However, subsequent analyses showed that the ability to consistently train 
frequency bands in the desired direction was not related to scores on impulsivity measures post-
training. The variance in levels of craving post-training could partially be explained by whether 
patients could be categorized as responders, as this was related to the increase in SMR frequency 
but not to a decrease in theta frequency.
Effects of neurofeedback training
In chapter 5, the results of the RCT were presented. The RCT was conducted according to the 
design described in the study protocol in chapter 3. Patients eligible for participation according 
to the inclusion criteria were randomly assigned to either the neurofeedback training group or 
the treatment as usual (TAU) group. 42 patients completed all post-treatment measurements, of 
which 21 patients participated in the control group and 21 patients in the neurofeedback training 
group. Results of the RCT showed that patients who received neurofeedback training managed to 
increase SMR activity over the course of training, but failed to decrease theta activity. Levels of 
drug craving showed a significant effect for Time, but not for Time x Group. Results for changes in 
drug use and number of commission errors post-treatment were not significant. Therefore, theta/
SMR neurofeedback training was not superior to TAU with regards to behavioral improvements 
for the examined patient group. 
Chapter 6 describes the results of a sham-controlled series of clinical case studies, where two 
cases employed a SMR neurofeedback protocol and two cases employed sham neurofeedback. 
Self-report level of impulsivity and craving were assessed.
Results of this clinical case series indicated that both patients in the real neurofeedback condition 
responded differently to the training in terms of change in outcome measures, with one of the 
patients receiving real theta/SMR neurofeedback benefitting more from the training than the other 
patient. This patient showed a significant decrease in impulsivity as measured with the BIS-11. 
Results regarding levels of craving as measured with the DAQ-SF showed that this patient also 
had a significant reduction in DAQ-SF scores when comparing baseline phase A1 with follow-
up phase A2. He also showed partial signs of neurofeedback learning, as he was able to increase 
SMR frequency over the course of training, however, this effect did not remain significant when 
controlling for autocorrelation. Theta magnitude did not change.
Neurofeedback as a suitable treatment for forensic psychiatric patients? 
The results of this dissertation show that for forensic psychiatric patients with SUD, it is 
difficult to learn the principles of neurofeedback training. In studies with healthy participants 
or patients with less severe disorders, training two EEG-training parameters at the same time 
seems manageable, but these EEG-learning patterns seem to be incongruent with EEG-learning 
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observed in the population that was investigated in the studies of this dissertation. It is possible 
that for patients with severe mental disorders, the patterns of EEG-learning are not congruent 
with patterns of learning in healthy subjects. It remains unclear why patients were more able 
to train their SMR magnitude than their theta magnitude. Possibly, EEG-learning might take 
different patterns to manifest than in other populations. EEG-learning might take more time to 
manifest, and may therefore require a higher number of sessions than the applied 20 sessions in 
the current RCT. However, performance in early sessions of neurofeedback training has been 
shown to predict performance in later sessions (e.g., Kübler, Neumann, Wilhelm, Hinterberger, 
& Birbaumer, 2004; Neumann & Bierbaumer, 2003; Weber et al., 2011). It therefore remains 
questionable whether more training sessions would have actually resulted in more EEG-learning 
in forensic psychiatric patients. Also, none of the patients was able to follow the training as 
originally scheduled, as training sessions twice a week were apparently too intensive for some 
patients. It is likely that more patients would have dropped out if more sessions and/or a more 
intense training schedule had been required. With regard to improvements on behavioral 
measures, the RCT showed that neurofeedback training was not more effective than TAU only. 
This may not be entirely unexpected as only a small proportion of patients were able to actually 
change their brain frequencies through the training. Since neurofeedback training is based on the 
hypothesis that changes at behavioral level are brought about by changes in EEG-frequencies, it 
seems obvious that no changes at behavioral level have been found.
Directions for future studies
This is one of the first studies to apply a neurofeedback intervention in a forensic psychiatric 
population with various disorders and comorbid SUD. This dissertation gives a first start for the 
application of the training in this population, and we hope that future research can build on the 
results described in this dissertation. 
A necessary condition for the broad application of neurofeedback training is to investigate which 
patients are capable of actually learning the principles of the training. Future research should 
therefore focus on developing a method that can determine early on in the training whether 
a patient will be able to regulate his EEG-frequencies, and which patient will most likely not 
achieve successful regulation, even with more sessions. Given that forensic psychiatric patients 
are a very vulnerable patient population that is difficult to motivate for treatment as it is, it is of 
great importance to offer these patients treatment modalities that offer them the greatest chance of 
reduction of symptoms. Identifying interpersonal mechanisms, which determine which patients 
benefit most from this intervention, should therefore be a high priority.    
In addition, it is necessary to further investigate whether successful regulation of brain frequencies 
will actually lead to changes at behavioral level. Possibly, the protocol used in this thesis is not 
effective for this patient population, but other protocols can bring about changes at behavior level. 
In doing so, it also needs to be examined how many sessions are needed to find effects, as well as 
how many and which frequencies generate the most improvements. 
The recent revival of personalized medicine, in which the specific characteristics of individual 
patients are more closely considered in the treatments to be used, also gives hope for the further 
application of neurofeedback training, where individual differences determine which training 





Die Studien in dieser Dissertation sind im Forensisch Psychiatrischen Centrum Dr. S. van Mesdag 
in Groningen durchgeführt. In dieser Klinik befinden sich ungefähr 250 männliche Patienten mit 
einem Maßregelvollzug. Diese Personen haben alle eine Straftat begangen, wofür sie allerdings 
aufgrund einer psychischen Störung oder mangelnden Entwicklung der geistigen Fähigkeiten nur 
begrenzt schuldfähig befunden wurden. In diesen Fällen kann dem Straftäter ein Maßregelvollzug 
aufgelegt werden, bei dem er in einer entsprechenden Maßregelvollzugsklinik therapiert wird. 
„Ohne Schuld handelt, wer bei Begehung der Tat wegen einer krankhaften seelischen Störung, 
wegen einer tiefgreifenden Bewusstseinsstörung oder wegen Schwachsinns oder einer schweren 
anderen seelischen Abartigkeit unfähig ist, das Unrecht der Tat einzusehen oder nach dieser 
Einsicht zu handeln”(§20 StGB). Das Ziel eines Maßregelvollzugs besteht darin, Patienten auf 
ein Leben in Freiheit so vorzubereiten, dass sie keine weitere Straftaten begehen. 
Diese Dissertation studiert die Auswirkungen eines Neurofeedback Trainings auf die Impulsivität 
und die Symptome von Suchterkrankung von diesen Patienten. Die Dissertation besteht aus 
mehreren Teilen, die in den folgenden Abschnitten näher erläutert werden.
Hintergrund 
Menschen mit einer psychischen Störung haben oft unzureichende Bewältigungsmechanismen, 
mit denen sie auf stressige Situationen oder Ereignisse angemessen reagieren können. Ihr 
Verhalten ist oft spontan und unüberlegt und bezieht mögliche (negative) Konsequenzen nicht 
mit ein. Dies kann soweit führen, dass sie ein Verbrechen begehen.
Patienten, die mit einem Maßregelvollzug in einer Maßregelvollzugsklinik verbleiben, leiden 
häufig an einer Kombination mehrerer psychischen Störungen. Die häufigsten Störungen sind 
Persönlichkeitsstörungen, Störungen im Schizophrenie-Spektrum oder Suchterkrankungen. 
Um diese Störungen zu behandeln, gibt es verschiedene Therapiemethoden, die eingesetzt 
werden können, wie z. B. kognitive Verhaltenstherapie, medikamentöse Behandlungen und/oder 
Therapiemethoden wie zum Beispiel Ergotherapie. Die Behandlung von diesen Patienten erweist 
sich jedoch oft als langwieriger und mühsamer Prozess. Da die Behandlung in einem gesetzlich 
vorgeschriebenen Rahmen erfolgt, ist die Therapiemotivation dieser Patienten oft gering und 
es besteht die Möglichkeit, dass es innerhalb des Maßregelvollzugs zu aggressiven Vorfällen 
kommt.
Ein hoher Grad an Impulsivität ist ein häufiges Merkmal psychiatrischer Störungen. Impulsivität 
ist ein dysfunktionales Persönlichkeitsmerkmal, bei dem eine Person nicht länger in der Lage 
ist, die positiven, kurzfristigen Konsequenzen gegen die möglichen negativen längerfristigen 
Konsequenzen abzuwägen.
Impulsivität spielt auch eine wichtige Rolle bei der Entwicklung und Aufrechterhaltung von 
Suchtverhalten. Sehr impulsive Menschen haben ein größeres Risiko, eine Suchterkrankung zu 
entwickeln, die oft schon in der Pubertät angelegt wird. Hier kann ein Mangel an Impulskontrolle 
dazu führen, dass sie schneller die Kontrolle über den Gebrauch von Suchtmitteln verlieren und 
der Gebrauch hiervon auf lange Sicht zwanghaft wird. Es besteht hierbei oft eine Wechselwirkung 
zwischen einem bereits vorhandenen, erhöhten Grad an Impulsivität und der weiteren 
enthemmenden Wirkung von Suchtmitteln. Drogen und Suchtstoffe können zu strukturellen 
neurophysiologischen und neurokognitiven Veränderungen führen, die die Impulskontrolle noch 
weiter negativ beeinflussen.
Patienten haben durch ein hohes Maß an Impulsivität ein erhöhtes Risiko, die Therapie ihrer 
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Suchterkrankung vorzeitig zu beenden. Da eine unbehandelte Suchterkrankung das Risiko auf 
einen Rückfall in ein Strafverhalten erhöht, ist das Scheitern einer Suchtbehandlung für Patienten 
in einem Maßregelvollzug besonders riskant. Daher sind Therapiemethoden, die die Chance 
einer erfolgreichen Reduktion von Impulsivität und Drogenabhängigkeit erhöhen, von großer 
Bedeutung.
Was ist Neurofeedback Training?
Neurofeedback Training ist eine relativ neue Therapiemethode, die heutzutage häufig zur 
Behandlung von ADHS eingesetzt wird. Neurofeedback Training richtet sich auf das korrigieren 
von abnormale Gehirnfrequenzen. Diese abnormalen Gehirnfrequenzen unterliegen den 
Symptomen psychischer Störungen. Das Erhöhen oder Verringern bestimmter Gehirnfrequenzen 
kann die Symptome von psychischen Störungen reduzieren. Patienten lernen hierbei, ihre 
abnormalen Gehirnfrequenzen zu normalisieren, indem sie Computerspiele ansteuern, die ihre 
Gehirnaktivität widergeben. 
Eine erhöhte Theta-Frequenz wird oft bei sehr impulsiven Menschen beobachtet. Darüber 
hinaus scheint eine Erhöhung der sensorimotor rhythm frequenz mit einer Verringerung der 
Motorimpulsivität verbunden zu sein. Um die Impulsivität zu reduzieren, werden darum häufig 
Neurofeedback Protokolle verwendet, die sich auf die Senkung der Thetafrequenz (3,5-7,5 Hz) 
und die Erhöhung der SMR frequenz (12-15 Hz) konzentrieren. Neurofeedback könnte eine 
geeignete Therapiemethode darstellen, um einen hohen Grad an Impulsivität bei forensisch 
psychiatrischen Patienten zu reduzieren und hierdurch möglicherweise auch suchtbezogenes 
Verhalten, wie etwa das Verlangen nach Drogen und die Einnahme von Drogen, zu reduzieren. 
Neurofeedback wird jedoch heutzutage zur Therapierung von forensisch psychiatrischen 
Patienten sowohl in den Niederlanden als auch international noch nicht häufig eingesetzt. Der 
Grund dafür könnte darin liegen, dass es bisher keine klaren Richtlinien darüber gibt, wie viele 
Therapiesitzungen des Trainings benötigt werden, um die bestmögliche Wirkung des Trainings 
zu erzielen. Es ist außerdem unklar, welche Patienten am meisten von diesem Training profitieren 
können. 
Systematische Aufarbeitung des Forschungsstands
Um zu untersuchen, inwieweit diese Therapiemethode bei den am häufigsten vorkommenden 
psychischen Störungen eingesetzt wird und welche Auswirkungen dies hatte auf Symptome 
der psychischen Erkrankungen, wurde in Kapitel 2 eine systematische Aufarbeitung des 
Forschungsstands durchgeführt. Dies ergab, dass in forensischen Patientenzielgruppen kaum 
Effektstudien zu Neurofeedback Training durchgeführt wurden, die die möglichen Auswirkungen 
dieses Trainings auf psychische Störungen und damit verbundenes Problemverhalten, wie Aggression 
und/oder impulsives Verhalten, untersuchen. Es konnten nur Studien identifiziert werden, die die 
Auswirkungen des Trainings auf ungefähr vergleichbare Patientenzielgruppen untersucht haben. 
Die Literaturstudie ergab auch, dass die Anzahl der verwendeten Therapiesitzungen stark variiert 
zwischen den untersuchten Studien, sowie den gefundenen Effekten des Trainings. Einige der 
Studien zeigten eine Verbesserung der Symptome auf Verhaltensebene, andere Studien hingegen 
konnten keine eindeutige Wirkung des Trainings finden. In einem Teil der Studien wurde zudem 
untersucht, inwieweit Patienten die Prinzipien des Neurofeedback Trainings erlernen konnten. 
Hierzu wurde analysiert, ob und in welchem  Ausmaß sich die Gehirnfrequenzen der Patienten nach 
145
dem Training tatsächlich normalisierten. Auch hierzu waren die Ergebnisse zu divers um eindeutige 
Schlussfolgerungen zu ziehen, die für den Einsatz von Neurofeedback Training in einer forensisch 
psychiatrischen Zielgruppe genutzt werden könnten. Es ist daher notwendig, die Auswirkungen 
des Neurofeedback Trainings auf den Grad der Impulsivität und Drogenabhängigkeit in einer 
forensischen Patientenzielgruppe genauer zu untersuchen. 
Study Protocol 
Um die Auswirkungen des Neurofeedback Trainings in einer forensisch psychiatrischen 
Patientenzielgruppe zu untersuchen, wurden eine Reihe von Studien durchgeführt. Kapitel 
3 beschreibt den Aufbau eines randomized controlled trial (RCT) sowie den Aufbau von vier 
N = 1 Fallstudien. Für den RCT untersuchten wir die Effekte von 20 Sitzungen einer Theta/
SMR Neurofeedback Therapie auf 21 männlichen Patienten mit verschiedenen Störungen und 
komorbider Suchterkrankung. Die Patienten in diesem RCT hatten alle in den letzten 24 Monaten 
einen Rückfall in Drogenkonsum. Ziel dieses RCT war es, den Grad der Impulsivität, sowie die 
Sucht nach Drogen und den tatsächlichen Konsum hiervon zu verringern. 
Bei dem eingesetzten Neurofeedback Protokoll wurde die Thetafrequenz reduziert und die SMR-
Frequenz erhöht. Um die Auswirkungen des Trainings zu erfassen, wurden diese Patienten mit 
21 Patienten verglichen, die zur gleichen Zeit das reguläre Therapieprogramm absolvierten, aber 
kein Neurofeedback Training erhielten (treatment as usual, TAU). 
Um zwischenmenschliche Unterschiede hinsichtlich des Neurofeedback Lernverhaltens genauer 
untersuchen zu können, wurden anschließend vier Fallstudien durchgeführt. In diesen Fallstudien 
wurden die Effekte eines Neurofeedback Trainings von 8 Sitzungen mit den Effekten eines Sham-
Neurofeedback Trainings verglichen, in dem keine einzige Gehirnfrequenz strukturell trainiert 
wurde. Die teilnehmenden Patienten wussten nicht, in welche Trainingsgruppe sie eingeteilt 
wurden. In dieser Studie wurde ein ABA-Design eingesetzt, bei dem der Trainingsverlauf von 
Patienten in mehrere Phasen unterteilt wurde. In der ersten Phase (A) füllten Patienten lediglich 
Fragebögen zum Grad der Impulsivität und des Suchtverhaltens aus, wohingegen sie in der 
zweiten Phase (B) zusätzlich 8 Therapiesitzungen des Neurofeedback Trainings erhielten. Nach 
dieser Phase wurde Phase A wiederholt. 
Sind forensich psychiatrische Patienten in der Lage, das Training zu erlernen? 
Bevor die Auswirkungen des Neurofeedback Trainings untersucht werden konnten, war es uns 
allerdings wichtig zu erfahren, inwieweit Patienten aus der Neurofeedback Trainingsgruppe die 
Prinzipien des Trainings erlernen konnten. In Kapitel 4 wird analysiert, inwiefern Patienten in 
der Lage waren, ihre Gehirnfrequenzen gezielt durch das Training zu regulieren. Hierzu wurde 
ein Teil der Zielgruppe von 19 Patienten untersucht. Um das Training als erfolgreich betrachten 
zu können, musste ein Patient zeigen, dass er sowohl seine Theta- als auch SMR-Frequenz in 11 
von den 19 untersuchten Therapiesitzungen regulieren konnte. Darüber hinaus musste der Patient 
am Ende des Trainings eine Verbesserung der relevanten Frequenzen um 8% nachweisen. 
Die Ergebnisse dieser Studie zeigen, dass das verwendete Neurofeedback Trainingsprotokoll bei 
15 von 19 Patienten nicht zu den erwarteten Veränderungen der Gehirnfrequenzen geführt hat. 
Nur 21% der Patienten konnten alle Kriterien für eine erfolgreiche Therapie erfüllen. Weitere 
Analysen zeigten, dass es für Patienten leichter war, die SMR-Frequenz erfolgreich zu regulieren 
als die Thetafrequenz. 
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Darüber hinaus wurde untersucht, inwieweit die erfolgreiche Regulation der Frequenzbänder 
mit Verbesserungen der Symptome auf Verhaltensebene zusammenhängt. Dies zeigte, dass eine 
erfolgreiche Regulation von Frequenzbändern nicht mit Veränderungen des Grads der Impulsivität 
zusammenhängt. Eine Reduktion der Sucht nach Drogen hing nur mit der erfolgreichen 
Regulierung der SMR-Frequenz zusammen, jedoch nicht mit der Thetafrequenz.
Auswirkungen des Neurofeedback Trainings 
Anschließend untersuchten wir in Kapitel 5 die Auswirkungen des Neurofeedback Trainings 
für die gesamte Patientengruppe und verglichen diese mit den Patienten, die das Training nicht 
erhalten hatten. Es stellte sich heraus, dass Patienten aus der Neurofeedback Trainingsgruppe 
in der Lage waren, ihr SMR-Frequenzband durch das Training zu erhöhen, aber dass keine 
Veränderungen beobachtet werden konnten für die Theta-Frequenz. 
Die Sucht nach Drogen nahm für alle Patienten ab, unabhängig davon, ob sie in die Trainingsgruppe 
eingeteilt wurden oder nicht. Es gab keine Veränderung, was den Grad der Impulsivität betraf. Das 
verwendete Neurofeedback Training war daher nicht effektiver als reguläre Therapiemethoden. 
Fallstudien
Kapitel 6 beschreibt die Ergebnisse der Fallstudien. Diese Fallstudien zeigen, dass die Patienten, 
die das Theta/SMR Neurofeedback Training absolvierten, unterschiedlich auf das Training 
reagierten. Von den zwei teilnehmenden Patienten zeigte nur der erste Patient Verbesserungen 
im Hinblick auf den Grad der Impulsivität sowie auf das Suchtverhalten. Er konnte seine SMR-
Frequenz während des Trainings erhöhen, allerdings nicht seine Thetafrequenz reduzieren. Der 
zweite teilnehmende Patient zeigte weder eine signifikanten Veränderung in der SMR- noch in 
der Thetafrequenzen nach dem Training. Darüber hinaus konnten keine signifikanten Effekte 
für Veränderungen des Impulsivitätsgrads und der Sucht nach Drogen gefunden werden. Für 
den Patienten, der das Sham Neurofeedback Training absolvierte, wurden keine Verbesserungen 
gefunden.
Neurofeedback als geeignete Therapiemethode für forensisch psychiatrische Patienten mit 
Substanzabhängigkeit?
Die Ergebnisse der verschiedenen Studien in dieser Dissertation zeigen, dass es für forensisch 
psychiatrische Patienten mit komorbider Suchterkrankung schwierig ist, Gehirnfrequenzen 
mittels Neurofeedback Training zu regulieren. In Studien mit gesunden Probanden scheint 
ein Neurofeedback Trainingsprotokoll, bei dem zwei Gehirnfrequenzen gleichzeitig trainiert 
werden, gut geeignet zu sein. Dies gilt auch für Studien, in denen Patienten an einer einzigen 
psychischen Störung leiden, statt wie in unserer Zielgruppe an verschiedenen Störungen. Das 
Lernverhalten scheint sich jedoch anders zu manifestieren in forensischen Zielgruppen mit 
mehreren psychischen Störungen. Möglicherweise ist es für forensisch psychiatrische Patienten 
zu schwierig, zwei Gehirnfrequenzen gleichzeitig zu trainieren. Es ist unklar, warum Patienten 
weniger Schwierigkeiten hatten, ihre SMR-Frequenz zu regulieren, als ihre Thetafrequenz. 
Eine mögliche Erklärung ist, dass Patienten mit 20 Therapiesitzungen nicht genug Zeit 
hatten zu lernen, ihre Gehirnfrequenzen und insbesondere ihre Thetafrequenz zu regulieren. 
Möglicherweise würde diese doch sehr spezielle Patientenzielgruppe von einer höheren Anzahl 
Therapiesitzungen profitieren. Jedoch haben Studien auch gezeigt, dass die Leistung der 
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Patienten zu Beginn des Trainings ein Prädiktor für die Leistung in späteren Sitzungen ist. Dies 
würde bedeuten, dass Patienten, denen es nicht gelungen ist, ihre Frequenzbänder innerhalb von 
20 Sitzungen zu regulieren, dies wahrscheinlich auch in späteren Sitzungen nicht mehr gelernt 
hätten. Es ist allerdings fragwürdig, ob eine höhere Anzahl von Therapiesitzungen tatsächlich zu 
besseren Ergebnissen geführt hätte. Weitere Studien sind nötig, um eindeutigere Schlüsse ziehen 
zu können. Darüber hinaus war es für Patienten, die an dieser Studie teilnahmen, sehr schwierig, 
sich auf den vorgegebenen Trainingsplan von zwei Therapiesitzungen pro Woche festzulegen. 
Eine höhere Anzahl an Sitzungen hätte höchstwahrscheinlich zu einer höheren vorzeitigen 
Abbruchrate der Therapie geführt. 
Empfehlungen für zukünftige Studien
Dies ist eine der ersten Studien, die Neurofeedback Training in einer forensisch psychiatrischen 
Zielgruppe mit verschiedenen, psychischen Erkrankungen und komorbider Suchterkrankung, 
untersucht. Diese Dissertation gibt einen ersten Anstoß für die Anwendung dieser Therapieform 
in dieser Patientengruppe und wir hoffen, dass zukünftige Studien auf den Ergebnissen dieser 
Arbeit aufbauen können.
Eine notwendige Voraussetzung für die breite Anwendung von Neurofeedback Training ist die 
Identifikation von den Patienten, die in der Lage sind, die Prinzipien des Trainings tatsächlich 
zu erlernen. Zukünftige Studien sollten sich daher darauf konzentrieren, eine Methode zu 
entwickeln, die schon in einem frühen Stadium der Therapiesitzungen feststellen kann, ob ein 
Patient in der Lage ist, seine Gehirnfrequenzen durch das Training zu regulieren. Da es sich bei 
forensisch psychiatrischen Patienten um eine sehr spezialistische Patientenzielgruppe handelt, 
die schwer für eine Behandlung zu motivieren ist, ist es von großer Bedeutung, diesen Patienten 
eine Therapieform anzubieten, die ihnen die größten Erfolgschancen bietet. 
Die Identifizierung zwischenmenschlicher Mechanismen, die beeinflussen, welche Patienten am 
meisten von dieser Therapie profitieren, sollte daher große Priorität haben. Darüber hinaus ist 
es notwendig, weiter zu untersuchen, ob eine erfolgreiche Regulierung der Gehirnfrequenzen 
tatsächlich zu Veränderungen auf der Verhaltensebene führt.
Möglicherweise führt das in dieser Dissertation angewandte Protokoll für die untersuchte 
Patientengruppe nicht zu den gewünschten Ergebnissen, aber andere Protokolle können 
Veränderungen auf der Verhaltensebene bewirken. Es sollte in zukünftigen Studien auch 
untersucht werden, wie viele Therapiesitzungen nötig sind, um die bestmöglichen Ergebnissen 
zu erreichen, sowie wie viele und welche Frequenzbänder die meisten Verbesserungen zu Stande 
bringen. Die rezente Wiederbelebung von ‘personalized medicine’, bei der die spezifischen 
Eigenschaften einzelner Patienten in der Behandlungen stärker berücksichtigt werden, lässt 
auch auf eine Weiterentwicklung des Neurofeedback Trainings hoffen, bei dem individuelle 






Toen ik mijn masterscriptie in de Mesdag deed had ik me niet kunnen voorstellen dat dit 
uiteindelijk zou gaan resulteren in een promotie. Onderzoek doen in een bijzondere setting als 
de Mesdag was een ontzettend leerzaam en uitdagend proces, en ik ben heel blij dat ik deze kans 
heb mogen benutten. 
Een proefschrift beginnen, en sterker nog, afronden is een lang en soms moeilijk proces. Dat dit 
boekje er ligt heb ik te danken aan een aantal mensen in mijn leven die veel te zelden horen hoe 
belangrijk ze voor me zijn. Zonder jullie had ik het niet kunnen doen.   
Marinus, zonder jou was ik nooit aan deze proefschrift begonnen. Tijdens mijn master had 
je al een onverwoestbaar vertrouwen in een goede scriptie, en ook tijdens dit traject heb je dit 
onverwoestbaar vertrouwen op zo veel momenten laten blijken. Je onvoorwaardelijke steun, je 
eindeloze energie om “lekker te gaan spss-en”, en al de vrije tijd die je hebt opgeofferd om aan 
een nieuwe analysemethode te sleutelen die mijn artikelen vooruit zou kunnen helpen, hebben 
mijn proefschrift gemaakt tot het boekje dat er nu ligt. Ik ben je erg dankbaar voor de kansen die 
je me hebt gegeven. Onze gezamenlijke tijd in de Mesdag samen zit erop, maar ik ga je missen!   
Franc, zonder jouw komst bij dit project in 2012 was deze proefschrift nooit afgerond. Bedankt 
voor je bereidheid om tijd vrij te maken om een absolutly clueless promovenda op weg te helpen 
met de beginselen van EEG-afnames! Je was er op afstand bij betrokken, en toch altijd bereikbaar. 
Je nam er de tijd voor als dat nodig was en ik heb me altijd welkom gevoeld. Niemand heeft zo 
grondig naar artikelen gekeken als jij, en je commentaar was altijd waardevol. Daarnaast ben 
je ook gewoon een fijn mens en kon ik heel prettig met jou samenwerken. Ik wil je ontzettend 
bedanken voor alle hulp en steun! 
Stefan, zonder jouw was deze proefschrift niet mogelijk geweest. Je was altijd op de achtergrond 
bezig om ervoor te zorgen dat dit project door kon gaan. Heel erg bedankt dat je me de deze kans 
hebt gegeven!  
Grote dank gaat uit naar mijn collega’s van afdeling onderzoek (Marlies, Swanny, Martine, 
Erwin, Mariette en Harmke). Met jullie deelde ik de eerste jaren niet alleen een kamer, maar ook 
lief en leed. Jullie hebben allen op jullie eigen manier meegedacht met dit onderzoek, en niemand 
anders begreep zo goed hoe het is om onderzoek te doen in deze bijzondere setting. Erwin, the 
master of Excel, aan jou een bijzonder dank voor alle hulp met ingewikkelde spreadsheets, het 
opmaken van tabellen en figuren, en vooral voor het feit dat je me nooit het idee hebt gegeven 
dat het een ontzettend domme vraag was die ik daar stelde (al was het in de meeste gevallen 
natuurlijk wel zo). Ik waardeer het enorm dat jij na een tijd waarin we het niet altijd eens met 
elkaar waren diegene was die de eerste stap heeft genomen en dat je deur ook nu nog voor me 
open staat. 
Harmke, naast collega ook lotgenoot, en veel belangrijker, maatje. Je had altijd wel opbeurende 
woorden, en je mantra ‘Jij kunt dit’ heeft me vele malen geholpen om toch weer aan het werk te 
gaan en een aantal zinnen op papier te zetten. En op de momenten dat het dan toch echt niet wou 
stond er altijd een drankje voor me klaar. 
Mariette, in de laatste jaren een aantal keren per week mijn kamergenootje, en tegelijkertijd 
vraagbak voor alles wat met promoveren te maken heeft. Jij wist als geen ander hoe moeilijk het 
soms kon zijn, maar doordat ik via jou het proces van het schrijven EN het daadwekelijk afmaken 
van een proefschrift kon gaan volgen heeft me dat vaak gemotiveerd om weer bezig te gaan. 
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Sander, jij laat zien dat passie en bevlogenheid voor je werk ook na een aantal jaren niet hoeft af 
te nemen. Ik ben je erg dankbaar voor de kansen en verantwoordelijkheden die je me hebt 
toevertrouwt in de loop der jaren. Je deur stond altijd open om te sparren, en je warme en oprechte 
belangstelling voor je medemens maakt dat we veel gedeeld hebben. Daarnaast ben je een van 
de grappigste mensen die ik ken, en je gevoel voor humor heeft menig lange autorit en vrijdag 
middag een stuk leuker gemaakt.  
Dank aan alle stagiaires (Rick, Angela, Maureen, Ingrid) die met hun onderzoek hebben mee-
gewerkt aan dit project, draaiboeken hebben geschreven, data hebben verzameld, patiënten 
hebben geworven, diploma’s hebben geknutseld… Dank! 
Een hele grote dank gaat uit naar alle patiënten die hebben meegewerkt aan deze studie! Jullie 
zijn bereid geweest om mee te werken aan een behandeling waarvan de effecten nog ongewis zijn. 
Velen van jullie hebben deelgenomen in de hoop eindelijk af te kunnen komen van je verslaving, 
en ik hoop dat jullie op de een of andere manier iets aan dit project hebben gehad. 
Bedankt aan alle collega’s uit de Mesdag die hebben geholpen om patiënten te motiveren (en 
gemotiveerd te houden!) – zonder sociotherapeuten, behandelcoördinatoren en mentoren hadden 
we nooit zo veel patiënten kunnen overtuigen om mee te werken. 
Mama, Papa, David, eigentlich müsst ihr ganz oben auf dieser Liste stehen, denn ohne euch 
wäre ich nicht wo ich jetzt bin. Ihr habt mich immer meinen eigenen Weg gehen lassen, und stand 
jederzeit am Wegesrand um mich anzumutigen und Erfolge zu feiern. 
Gelukkig waren er gedurende de afgelopen jaren ook veel momenten dat ik even niet bezig was 
met promoveren. Ik heb altijd kunnen bouwen op mensen in mijn omgeving, die het leven een stuk 
leuker maken: mijn paranimfen - Stephanie, wat was ik blij toen je er bij kwam als promovenda 
om lief en leed mee te delen. We zaten vaak in hetzelfde schuitje, en het was ontzettend fijn om 
iemand te hebben die precies weet wat je bedoelt. Bedankt voor alle goede zorg, sushi-deliveries 
na een dag zwoegen, lieve kaartjes en idiote berichtjes. Lejanne, sinds een aantal jaren ben je een 
belangrijk mens in mijn leven en daar ben ik ontzettend blij mee. Mijn bestekla ook trouwens. 
Lise, het was mooi om je ontwikkeling van stagiair tot st, abc en uiteindelijk Gz-psycholoog 
te mogen volgen. Van schuilen in de regen op Vlieland tot met zn drieën in een veels te kleine 
auto op weg naar weer een festival, ik hoop dat er nog vele mogen volgen. Marit, dank 
voor veel gezelligheid met de mannen en lieve berichtjes. Sara, für 20 (!!) Jahre. Alessa, für 
Geburtstagskuchen und schlagermotivationsvideos. It’s a thing. Mijn volleybalmaatjes, die niet 
alleen op de donderdag avonden voor de nodige afleiding hebben gezorgd, maar waar ik ook 
heb geleerd om heel erg blij voor elkaar te zijn om soms hele kleine dingen (‘Hij is wel over!!’).
Maar als allerbelangrijkste, Koos. Bij jou thuis komen was iedere keer weer het allerleukste deel 
van mijn dag. 
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